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requirements for the Degree of Doctor of Philosophy. 
Abstract 
ISOLATION, SCREENING AND CHARACTERIZATION OF PROBIOTIC ISOLATES 
FROM FOOD AND RUMEN 
 
by 
Neethu Maria Jose 
 
Probiotics are beneficial bacteria which either imparts overall general well being in 
the host or has intended specific applications such as treating selected health conditions for 
example; gut inflammation in humans, enhancing the feed conversion and body weight gain 
in livestock or suppressing transmissible dieases in poultry. There is increasing demand for 
probiotics; to meet this demand new sources for probiotic bacteria isolation and extensive 
routine screening studies carried out in laboratories are required. This leads to new 
candidates being selected and tested for efficacy in animal models for applications in the 
health, foods, food production and neutraceutical industries. 
 
The key question investigated by this thesis was; can novel probiotic candidates be 
isolated from dairy food products and the bovine rumen? 
 
Initially twenty dairy food isolates and thirty bovine rumen isolates were collected. 
Phenotypic characterization (Gram staining and colony morphology) of these isolates 
identified twenty- six isolates for further evaluation. All dairy food isolates were found to be 
Gram- positive and colony morphologies indicating they were likely to be lactic acid bacteria. 
Only six of the thirty bovine rumen isolates met these criteria, this was not surpising 
considering the vast range of microbial species present in the bovine rumen. 
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The twenty- six isolates (twenty from dairy food and six from the bovine rumen) were 
investigated for their survival at low pH and in the presence of bile salts. These conditions 
were selected as they are major challenges probiotic bacteria encounters during gastro- 
intestinal tract transit following injestion by farmed livestock or humans. Ten isolates (five 
each from dairy food and the bovine rumen) were identified as having good adhesion and 
survival at low pH and in the presence of bile salts. The high proportion of bovine rumen 
isolates (five of six) found to have good potential probiotic characteristics reflects perhaps 
their being isolated from an environment where such characteristics would be condusive to 
survival. 
 
Species identification of these ten isolates confirmed all were Lactobacillus species. 
Extensive testing to further characterize the probiotic potential of the ten isolates included; 
inhibition of pathogens, resistance to antibiotics, biosafety (absence of haemolytic activity), 
adhesion (BATH test), carbohydrate fermentation, survival at low pH, and high bile salt 
concentrations. This testing identified two isolates (isolate MI 13 from dairy food and isolate 
RC 2 from the bovine rumen) for further evaluation. 
 
The two isolates were characterized in terms of their adhesion to and permeability 
across gut Caco- 2 cells. These isolates were also characterized under standard and stressed 
(low pH and high bile salts) conditions by proteomic assessment of protein expression 
changes, production of volatile fatty acids and composition of fatty acid methyl esters. 
 
A key conclusion from this research is that potential probiotic candidates can be 
isolated from commercial dairy food products and the bovine rumen. The data obtained 
from the screening tests indicates that overall the rumen isolates displayed better in vitro 
probiotic characteristics and isolates MI 13 and RC 2 shows promising potential for further 
development as a novel probiotic. 
 
Keywords: probiotic, dairy food product, bovine rumen, lactobacilli, screening, 
antibiotics, antimicrobial, BATH test, Caco- 2 adhesion, Caco- 2 permeability, PCR, DNA 
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sequencing, proteomics, 1 D SDS PAGE, voaltile fatty acids, GC- MS, fatty acid methyl esters, 
GLC 
 viii 
Acknowledgements 
I wish to thank, first and foremost, my supervisor Dr. Malik A. Hussain for his 
guidance, encouragement, support and advice throughout the course of this study. I owe 
him a great debt of gratitude for allowing me to do research under him. I could not have 
imagined having a better advisor and mentor for my PhD study. I consider myself lucky to 
have worked with him. 
 
I am sincerely thankful to Dr. Craig R. Bunt for agreeing to co- supervise my project. 
Completing thesis writing would have been all the more difficult were it not for the critiques, 
valuable suggestions, and editing provided by him. Also, I am thankful to him for his 
significant help with statistical analysis. I very much appreciate his enthusiasm, intensity and 
vast knowledge in the subject. He offered me advise whenever I needed them. 
 
Voltile fatty acid compounds and fatty acid methyl ester studies would not have been 
possible, hadn’t I received the GC- MS and GLC technical support from the technical staff, 
Jason Breitmeyer and Richard Hider. I share the credit of this work with them, who guided 
me with their valuable feedback. 
 
I owe my deepest gratitude to laboratory manager, Omega Amoafo who was very 
friendly and always approachable for any support. I am indebted to my colleagues and 
friends whom I have met as part of my study, for their moral support, the stimulating 
discussions we had and for all the fun we had together during our  study. 
 
And most of all, it gives me great pleasure in acknowledging the unconditional love 
and support I received from my husband, Eby Mohan, and son, Ryan Eby. My husband has 
been my pillar of strength in all stages of this PhD and it is his hard work that helped me in 
paying my tuition fees. Though too little to understand what mamma was doing, my little 
boy has always adjusted and been patient in all circumstances. His smiling innocent face 
always calmed me in difficult situations and made me face all challenges with confidence. 
This thesis is dedicated to them. Also special thanks to my family back in India, especially my 
 ix 
parents, M.U. Jose and Besy Jose, my sister, Nithya Jose and father in law, Mohan Abraham 
who have been very supportive and motivated me to complete my PhD. 
 
Last but not the least, thanks to God the Almighty for having given me this 
opportunity in life. It is only due to His grace that I have made my way through all the tests 
and troubles in life over the years. May His name be always exalted, honoured and glorified. 
 x 
Table of Contents 
Abstract ....................................................................................................................................... v 
Acknowledgements ................................................................................................................... viii 
Table of Contents ......................................................................................................................... x 
List of Tables ............................................................................................................................. xiii 
List of Figures ............................................................................................................................. xiv 
Chapter 1 Introduction ............................................................................................................... 20 
1.1 Thesis structure ............................................................................................................................ 20 
1.2 Significance of this research ........................................................................................................ 20 
1.3 Research objectives ..................................................................................................................... 21 
1.3.1 Isolation of potential probiotic bacteria from two sources ............................................ 22 
1.3.2 Preliminary screening of isolates .................................................................................... 22 
1.3.3 Identification and selective screening of the ten most promising isolates .................... 22 
1.3.4 Final characterization of one isolate from the dairy food and the bovine rumen for 
specific properties ........................................................................................................... 22 
Chapter 2 Review of Literature.................................................................................................... 24 
2.1 Probiotics ..................................................................................................................................... 24 
2.1.1 Definition of probiotics ................................................................................................... 24 
2.1.2 Ideal probiotic characteristics ......................................................................................... 25 
2.1.3 Probiotic bacteria in use ................................................................................................. 25 
2.1.4 Foods containing probiotics ............................................................................................ 29 
2.2 Safety of probiotics: routine screening tests adapted ................................................................. 31 
2.3 Applications of probiotics ............................................................................................................ 31 
2.3.1 Human health benefits ................................................................................................... 32 
2.3.2 Farmed livestock applications ......................................................................................... 34 
2.4 Future developments of probiotic research ................................................................................ 36 
2.5 Implications of antibiotic resistance in probiotics: review paper ................................................ 36 
Chapter 3 Materials and methods ............................................................................................... 48 
3.1 Materials ...................................................................................................................................... 48 
3.1.1 Bacterial isolates ............................................................................................................. 48 
3.1.2 Chemicals ........................................................................................................................ 48 
3.1.3 Reagents .......................................................................................................................... 48 
3.1.4 Stock solutions ................................................................................................................ 50 
3.1.5 Buffers ............................................................................................................................. 51 
3.1.6 Microbiological media ..................................................................................................... 51 
3.1.7 MRS broth substituted with bile salts for bile salts tolerance assay .............................. 52 
3.1.8 Antibiotic discs ................................................................................................................ 53 
3.1.9 Oxidase strips .................................................................................................................. 54 
3.1.10 Pathogens ........................................................................................................................ 54 
3.1.11 Standards and working solutions for VFA analysis using GC- MS ................................... 55 
3.1.12 Reagents and standards for FA analysis using GLC ......................................................... 56 
3.2 Methodology ................................................................................................................................ 56 
3.2.1 General methods............................................................................................................. 56 
3.2.2 Inoculum preparation ..................................................................................................... 57 
 xi 
3.2.3 Storage of isolates ........................................................................................................... 57 
3.2.4 Gram staining .................................................................................................................. 57 
3.2.5 Carbohydrate fermentation ............................................................................................ 58 
3.2.6 Determination of growth ................................................................................................ 59 
3.2.7 Determination of viable count ........................................................................................ 59 
3.2.8 Disc diffusion method ..................................................................................................... 59 
3.2.9 Well diffusion method .................................................................................................... 59 
3.2.10 Extraction of genomic DNA ............................................................................................. 60 
3.2.11 Quantification of extracted DNA ..................................................................................... 61 
3.2.12 Polymerase chain reaction (PCR) .................................................................................... 61 
3.2.13 Agarose gel electrophoresis ............................................................................................ 62 
3.2.14 DNA sequencing .............................................................................................................. 62 
3.2.15 Preparation of bacterial suspension for proteomics analysis by gel electrophoresis .... 62 
3.2.16 Whole cell protein extraction ......................................................................................... 63 
3.2.17 Cytosolic protein extraction ............................................................................................ 63 
3.2.18 Protein quantification ..................................................................................................... 64 
3.2.19 1- D SDS PAGE ................................................................................................................. 64 
Chapter 4 Isolation, identification and screening of potential probiotic lactic acid bacteria 
isolates....................................................................................................................................... 65 
4.1 Introduction ................................................................................................................................. 65 
4.2 Methods ....................................................................................................................................... 67 
4.2.1 Isolation of isolates from dairy food products and bovine rumen contents .................. 67 
4.2.2 Purification of isolates..................................................................................................... 68 
4.2.3 Storage of isolates ........................................................................................................... 70 
4.2.4 Oxidase test ..................................................................................................................... 70 
4.2.5 pH tolerance of isolates .................................................................................................. 70 
4.2.6 Bile salt tolerance ............................................................................................................ 71 
4.2.7 Extraction of DNA from gram- positive bacteria ............................................................. 71 
4.2.8 Polymerase chain reaction (PCR) .................................................................................... 71 
4.2.9 Supplementary methods for paper reported in section 4.3.7 ........................................ 72 
4.3 Results and discussion ................................................................................................................. 76 
4.3.1 Morphological characteristics ......................................................................................... 76 
4.3.2 Gram nature of isolates .................................................................................................. 76 
4.3.3 pH tolerance of isolates .................................................................................................. 79 
4.3.4 Bile salts tolerance of isolates ......................................................................................... 81 
4.3.5 Agarose gel electrophoresis ............................................................................................ 83 
4.3.6 DNA sequencing .............................................................................................................. 85 
4.3.7 Comparison of microbiological and probiotic characteristics of probiotic lactobacilli 
isolates from dairy food products and animal rumen contents ..................................... 97 
4.4 Conclusions ................................................................................................................................ 113 
Chapter 5 Characterization of selected probiotic isolates for specific properties ..........................114 
5.1 Introduction ............................................................................................................................... 114 
5.2 Methods ..................................................................................................................................... 117 
5.2.1 1 D SDS PAGE profiles of whole cell proteins and cytosolic proteins ........................... 117 
5.2.2 Identification of VFA compounds.................................................................................. 117 
5.2.3 Identification of FA methyl esters ................................................................................. 119 
5.2.4 Statistical analysis for VFA compounds and FA methyl esters production ................... 120 
5.2.5 Characterization of antimicrobial compounds produced by lactobacilli ...................... 121 
5.3 Results and discussion ............................................................................................................... 123 
 xii 
5.3.1 1 D SDS PAGE whole cell protein and cytosolic protein profiles of dairy food isolate, 
MI 13 and rumen isolate, RC 2 ...................................................................................... 123 
5.3.2 Identification of VFA compounds produced under low pH and bile salts stressed 
conditions using HS- SPME GC- MS ............................................................................... 128 
5.3.3 Identification of fatty acid methyl esters produced under low pH and bile salts 
stressed conditions using GLC ....................................................................................... 130 
5.3.4 Determination of antimicrobial compounds produced by lactobacilli ......................... 133 
5.3.5 Analysis of the adherence and permeability properties of potentially probiotic dairy 
vs rumen lactobacilli isolates to human Caco- 2 cells ................................................... 139 
5.3.6 Effect of glyphosate on rumen isolates in vitro ............................................................ 151 
5.3.7 Supplementary results for paper reported in section 5.3.7 ......................................... 160 
5.4 Conclusions ................................................................................................................................ 161 
Chapter 6 General discussion and conclusion..............................................................................162 
6.1 General discussion ..................................................................................................................... 162 
6.2 Conclusion .................................................................................................................................. 166 
6.3 Future directions ........................................................................................................................ 168 
References ............................................................................................................................... 170 
Appendix A Sources of laboratory instrumentation, equipment and chemicals ............................187 
Appendix B Gentra Puregene Yeast/ Bacterial kit contents .........................................................193 
Appendix C Assessment of DNA purity using nanodrop ...............................................................194 
Appendix D PCR primers ............................................................................................................195 
Appendix E PCR reaction mix .....................................................................................................196 
Appendix F Protein standard curve constructed by using BCA kit ................................................197 
Appendix G Statistical analysis for BATH test ..............................................................................199 
Appendix H Statistical analysis for adhesion studies ...................................................................202 
Appendix I Statistical analysis for permeability studies ...............................................................203 
Appendix J Quantification parameters for the seven analytes and four deuterated standards .....204 
Appendix K Example of a GLC chromatogram .............................................................................205 
Appendix L Conference abstracts ...............................................................................................206 
 
 xiii 
List of Tables 
Table 2.1 General screening criteria for an ideal probiotic microorganism (modified from Gupta 
& Garg, 2009). Those highlighted in bold have been selected as key characteristics 
for evaluation in this thesis. ..................................................................................... 26 
Table 2.2 Lactobacillus, Bifidobacterium and other genera bacteria and yeast species reported 
as probiotics (modified from Gupta & Garg, 2009). ................................................... 27 
Table 2.3 Proposed mode of action on human health and wellbeing for a limited list of probiotic 
bacteria. .................................................................................................................. 33 
Table 2.4 Possible probiotic bacteria for farmed livestock and proposed modes of action. ............ 35 
Table 3.1 Ingredient lists of fermented dairy food products as stated on the product label. .......... 50 
Table 3.2 Antibiotic, abbreviation and concentration (g) per disk as used for the antibiotic 
sensitivity of each lactic acid isolate. ........................................................................ 54 
Table 3.3 Pathogen and source as used to test sensitivity of each lactic acid isolate. .................... 55 
Table 3.4 Carbohydrate and type of sugar used to evaluate the carbohydrate fermentation by 
the lactic acid isolates. ............................................................................................. 58 
Table 3.5 PCR reaction cycle for three primers. A: Primer 1- Aci I and Aci II, B: Primer 2- Pr I and 
Pr II, C: Primer 3- 16-1A and 23-1B. ........................................................................... 61 
Table 4.1 Genetic identity of each isolate as established by NCBI BLAST. ...................................... 96 
Table 5.1 Inhibition halo presence or absence and its corresponding indication depending on the 
treatment applied to the supernatant. ....................................................................122 
Table 5.2 Volatile fatty acids detected in bacterial broth using HS- SPME and Shimadzu QP- 2010 
GC- MS. ..................................................................................................................128 
Table 5.3 List of fatty acid methyl esters detected by GLC. ..........................................................131 
Table 5.4 Inhibition zone of Lactobacillus isolates against E. coli for each supernatant treatment.134 
Table 5.5 Inhibition zone of Lactobacillus isolates against E. aerogenes for each supernatant 
treatment. ..............................................................................................................135 
Table 5.6 Inhibition zone of Lactobacillus isolates against S. menston for each supernatant 
treatment. ..............................................................................................................136 
Table 5.7 Inhibition zone of Lactobacillus isolates against S. aureus for each supernatant 
treatment. ..............................................................................................................137 
Table 5.8 Inhibition zone of Lactobacillus isolates against L. monocytogenes for each 
supernatant treatment. ..........................................................................................138 
 
 xiv 
List of Figures 
Figure 4.1 Flowchart illustrating isolation, purification and storage of isolates for future use as 
stock cultures. ......................................................................................................... 69 
Figure 4.2 Carbohydrate utilization of isolates. Purple colour indicates a negative (no 
carbohydrate metabolism) result, while a colour change from purple to yellow 
indicates a positive (carbohydrate metabolism) result. ............................................. 73 
Figure 4.3 Test for haemolytic activity. Negative control no culture (top), Salmonella and Listeria 
positive controls (middle) and Lactobacilli RC 2 (bottom) as a typical example for all 
isolates examined. ................................................................................................... 74 
Figure 4.4 Lactobacilli isolates MI 7, MI 10, RC 13 and RC 25 as typical examples of growth of 
isolates on MRS agar. ............................................................................................... 77 
Figure 4.5 Lactobacilli isolates MI 6, MI 10, RC 13 and RC 30 as typical examples of isolate Gram 
staining. .................................................................................................................. 78 
Figure 4.6 Growth (optical density) of dairy food (MI) and bovine rumen (RC) isolates at various 
pH after 24 h. .......................................................................................................... 80 
Figure 4.7 Growth (optical density) of dairy food (MI) and bovine rumen (RC) isolates at bile salt 
concentrations after 24 h. ........................................................................................ 82 
Figure 4.8 Agarose gels of PCR products obtained from primer Aci I and Aci II primer. M denotes 
1kb plus DNA ladder. In (A) lane 1-MI 7, lane 2-MI 10, lane 3-MI 13, lane 4- MI 17, 
lane 5- MI 18 and lane 6- non template control. In (B) lane 1- MI 6, lane 2- MI 20, 
lane 3- RC 2, lane 4- RC 5 and lane 5- non template control. In (C) lane 1- RC 7, lane 
2- RC 13, lane 3- RC 25, lane 4- RC 30 and lane5- non template control. ..................... 83 
Figure 4.9 Agarose gels of PCR products obtained from primer Pr I and Pr II primer. M denotes 
1kb plus DNA ladder. In (A) lane 1-MI 7, lane 2-MI 10, lane 3-MI 13, lane 4- MI 17, 
lane 5- MI 18 and lane 6- non template control. In (B) lane 1- MI 6, lane 2- MI 20, 
lane 3- RC 2, lane 4- RC 5 and lane 5- non template control. In (C) lane 1- RC 7, lane 
2- RC 13, lane 3- RC 25, lane 4- RC 30 and lane 5- non template control. .................... 84 
Figure 4.10 Agarose gels of PCR products obtained from primer 16-1A and 23-1B primer. M 
denotes 1kb plus DNA ladder. In (A) lane 1-MI 7, lane 2-MI 10, lane 3-MI 13, lane 4- 
MI 17, lane 5- MI 18 and lane 6- non template control. In (B) lane 1- RC 2, lane 2- RC 
7, lane 3- RC 13, lane 4- RC 30 and lane 5- non template control. In (C) lane 1- MI 6, 
lane 2- MI 20, lane 3- RC 2, lane 4- RC 25 and lane 5- non template control. .............. 84 
Figure 4.11 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 6 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 715 bp was amplified. ...................................................... 86 
Figure 4.12 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 7 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 728 bp was amplified. ...................................................... 87 
Figure 4.13 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 10 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 998 bp was amplified. ...................................................... 88 
Figure 4.14 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 13 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 1049 bp was amplified. .................................................... 89 
Figure 4.15 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 17 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 729 bp was amplified. ...................................................... 90 
Figure 4.16 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 2 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 726 bp was amplified. ...................................................... 91 
 xv 
Figure 4.17 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 5 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 731 bp was amplified. ...................................................... 92 
Figure 4.18 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 13 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 731 bp was amplified. ...................................................... 93 
Figure 4.19 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 25 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 864 bp was amplified. ...................................................... 94 
Figure 4.20 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 30 using primers 16-1A (F) and 23-1B (R). A PCR 
product of approximately 793 bp was amplified. ...................................................... 95 
Figure 5.1 One- dimensional SDS- PAGE protein profile of whole cell proteins from MI 13 
culture. The marked bands highlighted in lanes 4 and 5 showed changes in protein 
expression. Protein ladder marker (M); reference culture grown in standard MRS 
broth sampled after 24 h (lane 1); culture grown in standard MRS broth sampled 
after OD reaches 1.5- 2 approx. 8- 10 h (lane 2 and 3); culture grown in MRS broth 
of pH 3.5 a and pH 3.5 b sampled at 16 h (lane 4 and 5); culture grown in MRS broth 
containing 3.5% bile salts a and 3.5% bile salts b sampled at 16 h (lane 6 and 7). ......124 
Figure 5.2 One- dimensional SDS- PAGE protein profile of cytosolic proteins from MI 13 culture. 
The marked bands highlighted in lanes 4, 5, 6 and 7 showed changes in protein 
expression. Protein ladder marker (M); reference culture grown in standard MRS 
broth sampled after 24 h (lane 1); culture grown in standard MRS broth sampled 
after OD reaches 1.5- 2 approx. 8- 10 h (lane 2 and 3); culture grown in MRS broth 
of pH 3.5 a and pH 3.5 b sampled at 16 h (lane 4 and 5); culture grown in MRS broth 
containing 3.5% bile salts a and 3.5% bile salts b sampled at 16 h (lane 6 and 7). ......125 
Figure 5.3 One- dimensional SDS- PAGE protein profile of whole cell proteins from RC 2 culture. 
The marked bands highlighted in lanes 4, 5, 6 and 7 showed changes in protein 
expression. Protein ladder marker (M); reference culture grown in standard MRS 
broth sampled after 24 h (lane 1); culture grown in standard MRS broth sampled 
after OD reaches 1.5- 2 approx. 8- 10 h (lane 2 and 3); culture grown in MRS broth 
of pH 3.5 a and pH 3.5 b sampled at 16 h (lane 4 and 5); culture grown in MRS broth 
containing 3.5% bile salts a and 3.5% bile salts b sampled at 16 h (lane 6 and 7). ......126 
Figure 5.4 One- dimensional SDS- PAGE protein profile of cytosolic proteins from RC 2 culture. 
The marked bands highlighted in lanes 4, 5, 6 and 7 showed changes in protein 
expression. Protein ladder marker (M); reference culture grown in standard MRS 
broth sampled after 24 h (lane 1); culture grown in standard MRS broth sampled 
after OD reaches 1.5- 2 approx. 8- 10 h (lane 2 and 3); culture grown in MRS broth 
of pH 3.5 a and pH 3.5 b sampled at 16 h (lane 4 and 5); culture grown in MRS broth 
containing 3.5% bile salts a and 3.5% bile salts b sampled at 16 h (lane 6 and 7). ......127 
Figure 5.5 Different volatile fatty acid compounds produced by MI 13 and RC 2 under standard 
and pH and bile salts stress conditions. Columns with different letters differ 
significantly (p<0.05). ..............................................................................................129 
Figure 5.6 Types of fatty acid methyl esters produced by MI 13 and RC 2 under standard and pH 
and bile salts stress conditions. Columns with different letters differ significantly 
(p<0.05). .................................................................................................................132 
Figure 5.7 Gram stain images showing adhesion of lactobacilli isolates and E. coli on 2 week 
Caco- 2 cell cultures observed under oil-immersion (100x) microscope. A- rumen 
isolate, L. plantarum 16, B- dairy isolate, L. rhamnosus LOCK 908, C- E.coli, D- rumen 
isolate, L. plantarum 16 and E.coli, E- dairy isolate, L. rhamnosus LOCK 908 and E. 
coli. ........................................................................................................................160 
Figure 5.8 Average number of adhered bacteria to two week old Caco- 2 cells. Standard error of 
the mean bars (n=4). ...............................................................................................161 
  
 xvi 
SYMBOLS AND ABBREVIATIONS 
 
The following abbreviations have been used throughout this thesis: 
 
%  percentage 
µg  microgram 
µl  microlitre 
0C  degree Celsius 
1 DE  one dimensional gel electrophoresis 
ACVM               Agricultural Compounds and Veterinary Medicine 
ATCC  American Type Culture Collection 
ATP  adenosine triphosphate 
BATH  bacterial adherence to hydrocarbons 
BCA  bicinchoninic acid  
BHI  brain heart infusion medium 
BLASTN basic local alignment search tool for nucleic acids 
BSA  bovine serum albumin 
BWG  body weight gain 
CFS  cell free supernatant 
CFU  colony forming unit 
DIGE  difference gel electrophoresis 
DNA  deoxyribonucleic acid 
dNTPs  deoxyribose nucleotide triphosphates 
EDTA  ethylene diamine tetra acetic acid 
EI  electron impact 
ESR  Institute of Environmental Science and Research 
eV  electron volt 
 xvii 
FAO  Food and Agriculture Organization 
FCR  feed conversion ratio/ rate 
FID  flame ionisation detector 
FAME  fatty acid methyl esters 
g  gram 
GC- MS gas chromatography- mass spectrophotometry 
GLC  gas liquid chromatography 
GOS  galacto oligo saccharides 
GRAS  generally regarded as safe 
h  hour 
HCL  hydrochloric acid 
HS- SPME  headspace- solid phase micro extraction 
Hsps  heat shock proteins 
kDa  kilodalton 
LAB  lactic acid bacteria 
LRI  linear retention indices 
M  molar 
mg  milligram 
MgCl2  magnesium chloride 
min  minute 
ml  millilitre 
mM  millimolar 
MPI  Ministry for Primary Industries 
MRS              de Man, Rogosa and Sharpe medium 
MW  molecular weight 
N  normality 
 xviii 
NA  nutrient agar medium 
NaCl  sodium chloride 
NaOH  sodium hydroxide 
NCBI  National Centre for Biotechnology Information 
nm  nano meter 
NSLAB  non starter lactic acid bacteria 
NZ  New Zealand 
OD  optical density 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
pH  potential hydrogen 
RBCs  red blood cells 
RO  reverse osmosis 
rpm  rotations per minute 
rRNA  ribosomal ribo nucleic acid 
s  second 
SDS  sodium dodecyl sulfate 
sps.  species 
subsp.  sub- species 
TBE  tris/ borate/ EDTA buffer 
Tris  2- Amino- 2- hydroxymethyl- propane- 1, 3- diol 
UK  United Kingdom 
USA  United States of America 
uv  ultra- violet 
V  volt 
 xix 
VFA  volatile fatty acids 
w/ v  weight by volume 
WHO  World Health Organization 
WR  working reagent 
 20 
Chapter 1 
Introduction  
1.1 Thesis structure 
This thesis comprises of six chapters. Chapter one contains a concise summary of the 
research study and states the research objectives. Chapter two includes a comprehensive 
literature review notable in this field of research. A published review article on antibiotics 
has also been included at the end of this chapter. Chapter three lists the materials and 
provides a brief description of the methods used in this research. Chapters four and five are 
experimental chapters, which have been published/ submitted/ drafted for publication prior 
to the submission of this thesis to journals. In these chapters the experimental methodology 
have been explained in greater detail, than which is allowed in the journal articles. The peer 
reviewed published/ submitted/ drafted papers are assigned at the end of the respective 
chapters. In chapter six, all the results from the experimental chapters have been brought 
together for discussion and overall conclusions. This chapter ends on a note suggesting 
future directions for taking this work forward. 
 
1.2 Significance of this research 
Lactic acid bacteria (LAB) are widely used as probiotics in the agro- food industry. The 
use of probiotics to improve overall well- being of humans and animals is increasing sharply. 
There have been extensive studies describing screening characteristics of potential probiotic 
lactobacilli from diverse sources such as traditional dairy food, swine origin, cheese, infant 
gut micro- biota etc. (Bao et al. 2010; Guo et al. 2010; Zago et al. 2011; Kirtzalidou et al. 
2011).  However, not enough work has been done describing the comparison of probiotic 
properties of isolates coming from different origins. Therefore this research was undertaken 
to compare the potential probiotic characteristics of LAB isolates belonging to two different 
environments. Bovine rumen isolates were well adapted to grow and survive in the ruminant 
digestive system while the dairy food isolates were capable of surviving the food processing 
conditions.  
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This PhD research exploits the probiotic potential of LAB isolates using in vitro 
screening tests and at the same time study the characterization of specific probiotic 
properties. Not all LAB can be used in probiotic applications. They have to be first screened 
for probiotic abilities in vitro, followed by in vivo studies; before use as probiotics. 
Investigating the probiotic abilities, stress responses, adhesion and permeability studies of 
the isolates form a crucial part of this research. 1D SDS PAGE proteomic profiles, fatty acid 
profiles and metabolomic profiles of selected lactobacilli isolates under standard growth 
conditions and stress conditions have been developed; all the above mentioned features 
cannot be studied by the use of genomics. 
 
1.3 Research objectives 
This thesis investigates commercially available dairy foods and the bovine rumen as 
sources of novel probiotic bacteria. The objectives of the thesis were to isolate and screen 
for promising novel probiotic bacteria. Four key objectives of the thesis were as follows: 
 The research undertaken for this PhD attempted to isolate potential probiotic 
organisms form commercial dariy foods and the bovine rumen. Commercial dairy foods 
labelled as containing probiotics were excluded from this research. Thus any potential 
probiotics isolated would be microorganims that had not been intentially introduced but 
rather endigenous to the system form with they were recovered. This includes, for example 
the non- starter lactic acid bacteria (NSLAB) which dominate the cheese microbiota and 
contribute to the development of final characteristics of cheese during ripening stage. 
 
Objectives 
 Objective 1: Isolation of potential probiotic bacteria from two sources 
 Objective 2: Preliminary screening of isolates 
 Objective 3: Identification and selective screening of the ten most promising isolates 
 Objective 4: Final characterisation of one isolate from the dairy food and the bovine 
rumen for specific properties 
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1.3.1 Isolation of potential probiotic bacteria from two sources 
Commercial dairy food was identified as a potential source for probiotic bacteria due 
to such products being widely reported in the literature to contain such bacteria. The bovine 
rumen was identified as a potential source of probiotic bacteria as it has received far less 
attention than other sources such as commercial dairy food and would possibly produce a 
novel probiotic that would be ideally adapted for use in farmed livestock. Screening 
identified twenty and thirty isolates from commercial dairy foods and the bovine rumen 
respectively. It was likely more could have been isolated, however; the total number of fifty 
was deemed likely to be a suitable pool from which potential novel probiotic bacteria could 
be isolated.  Chapter 4 provides a detailed explanation of the origin of isolates and the 
isolation techniques adopted. 
 
1.3.2 Preliminary screening of isolates 
Isolates were categorised as LAB depending on their colony morphology and Gram 
stain nature. Twenty from dairy food and six from the bovine rumen were further 
characterized by pH and bile salt tolerance. The preliminary tests undertaken in selection of 
potential candidates for further investigation has been explained in chapter 4 of this thesis. 
 
1.3.3 Identification and selective screening of the ten most promising isolates 
Five each form dairy food and the bovine rumen were characterized for their 
antibiotic,  antimicrobial and haemolytic activity, different pH and bile salt concentrations, 
adhesion (BATH test), carbohydrate fermentation, and species identification by polymerase 
chain reaction (PCR) amplification  followed by sequence comparison using basic local 
alignment search tool for nucleic acids (BLASTN). The details of the screening tests adopted 
have been described in chapter 4. 
 
1.3.4 Final characterization of one isolate from the dairy food and the bovine 
rumen for specific properties 
Six specific properties of the final two lactobacilli isolates were further characterized 
and studied in detail in chapter 5. This included the adhesion and permeability studies using 
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Caco- 2 cells, one dimensionl sodium dodecyl sulphate polyacrylamide gel elctrophoresis (1D 
SDS PAGE) proteomic profiles, comparison of volatile fatty acids (VFA) produced, comparison 
of the fatty acid methyl esters (FAME) profiles and determination of antimicrobial 
compounds production. 
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Chapter 2 
Review of Literature 
2.1 Probiotics 
Microorganisms have been used for many centuries to preserve foods, although only 
in the previous century has the science of this process been understood. Elie Metchnikoff, a 
Russian scientist working at the Pasteur Institute in Paris is credited with calling attention to 
the health benefits of yoghurt. His hypothesis was that LAB in the yoghurt counteracts the 
harmful putrefying bacteria in the intestines. Metchnikoff’s work can be regarded as the 
birth of probiotics, i.e. microbes ingested with the aim of promoting good health. In this 
respect, probiotics are gaining widespread recognition as new prevention strategies or 
therapies for multiple gastro- intestinal diseases. Some LAB strains have clearly been shown 
to exert beneficial health effects. However, these effects are known to be strain specific and 
the underlying molecular mechanisms remain poorly understood (Senok et al. 2005; 
Oelschlaeger 2010). Therefore, scientific evidence that would help understand the 
mechanisms behind the activities of probiotics that stand the best chance of success are of 
great interest. This includes data from epidemiological studies, in vitro and in vivo trials, as 
well as from mechanistic, genomic and proteomic studies (Hamon et al. 2011). Proteomics 
helps in understanding the biological functions by linking the genome and the transcriptome. 
Comparative proteomics can be used in the protein identification and obtaining proteomic 
patterns, which will one day serve as bacterial biomarkers for probiotic features (Izquierdo 
et al. 2009). 
 
2.1.1 Definition of probiotics 
The word ‘probiotic’ is derived from the Greek word meaning ‘for life’ and it has had 
several different meanings over the years. It was first used by (Lilly & Stillwell, 1965) to 
describe substances secreted by one microorganism which stimulated the growth of 
another. It was not until 1974 that Parker defined it as ‘organisms and substances which 
contribute to intestinal microbial balance.’ In an attempt to improve this definition, Fuller in 
1989 redefined probiotics as ‘a live microbial feed supplement which beneficially affects the 
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host animal by improving its intestinal microbial balance.’ However among the scientific 
community the term ‘probiotic’ is much more complex and diverse. An expert panel 
commissioned by Food and Agriculture Organization (FAO) and the World Health 
Organization (WHO) defined it as: “live microorganisms”, which, when administered in 
adequate amounts confers a health benefit on the host (FAO & WHO, 2001). To observe a 
positive health benefit from consumption, a minimum level of microorganisms is required: 
this level depends on the strain used and the required health benefit. The dose 
recommended is usually between 109- 1011 CFU/ day (Mombelli & Gismondo, 2000).   
 
2.1.2 Ideal probiotic characteristics 
An effective probiotic is required to operate under a variety of different 
environmental conditions and to survive in many different forms. There are many 
parameters used for screening probiotics, which ones are used depend on the intended 
application of a probiotic in a specific target population (Saarela et al. 2000; Mercenier et al. 
2008). Common assessments reported in the literature have been employed to support the 
following properties; tolerance to acid and bile salts, adhesion to mucosal and epithelial 
linings, exhibition of antimicrobial activity towards pathogens, should not cause lysis of RBCs 
in vivo, and production of lactic acid. Probiotic assessment may identify the potential 
capability to influence local metabolic activity: for example, ability to stimulate intestinal 
mucosal lactase activity which can prevent some types of diarrhoea, stimulation of the 
immune system and capable of anti- carcinogenic activity (Vimala & Dileep, 2006; Gupta & 
Garg, 2009; Kechagia et al. 2013). Keeping this in mind, a combined list of criteria for ideal 
probiotic bacteria has been developed and this is listed in Table 2.1. 
 
2.1.3 Probiotic bacteria in use 
The first step in the selection of microbial strains for probiotic use: it must be 
representative of microorganisms that are Generally Regarded as Safe (GRAS). It includes 
lactic acid producers like Lactobacillus, Bifidobacterium, Streptococcus, Enterococcus, 
Leuconostoc and Pediococcus species (Fellix & Dellaglio, 2007; Kleerebezem & Vaughan, 
2009). Lactobacillus and Bifidobacterium are the two prominent groups which are frequently 
employed in foods (Klaenhammer & Kullen, 1999; Vankerckhoven et al. 2008; Seale & Miller, 
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2013). They occupy different ecological positions in the human gastro- intestinal tract. 
Lactobacilli are normal inhabitants of intestine, whereas, bifidobacteria reside in the colon 
(Wang et al. 2012).  For the list of the most common probiotic strains in use, see Table 2.2.  
 
Table 2.1 General screening criteria for an ideal probiotic microorganism (modified from 
Gupta & Garg, 2009). Those highlighted in bold have been selected as key characteristics for 
evaluation in this thesis. 
 High cell viability, they must be resistant to low pH and acids.  
 Ability to persist in the intestine even if the probiotic strain cannot colonize the gut. 
 Adhesion to the gut epithelium to cancel the flushing effects of peristalsis. 
 They should be able to interact or send signals to the immune cells associated with the gut. 
 They should be a normal inhabitant of the species targeted: for example, human 
probiotics should be of human origin. 
 Should be non- pathogenic. 
 Resistance to processing. 
 Probiotics must be safe, for example should not cause lysis of red blood cells. This is a pre- 
screening tool that helps identify isolates with haemolytic activity from further study.  
 They should be genetically stable. 
 Must have capacity to influence local metabolic activity. 
 Efficacy is proven in well- designed, placebo controlled clinical trials. 
 Ease of large scale commercial production and distribution. 
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Table 2.2 Lactobacillus, Bifidobacterium and other genera bacteria and yeast species 
reported as probiotics (modified from Gupta & Garg, 2009).  
Lactobacillus  Bifidobacterium  
 
Other 
 
L. acidophilus B. adolescentis Enterococcus faecalis 
L. casei B. animalis E. faecium 
L. crispatus B. bifidum Pediococcus. acidilactici 
L. gasseri B. infantis Bacillus cereus 
L. johnsonii 
(L. paracasei) 
B. lactis B. subtilis 
L. reuteri  Saccharomyces boulardii 
L. rhamnosus  S. cerevisiae 
L. lactis   
L. bulgaricus   
L. helveticus   
 
 
2.1.3.1 Lactobacilli species 
Lactobacilli have long been the most prominent probiotic microorganisms because of 
their association with popular fermented dairy products. Lactobacilli are Gram- positive rods 
and part of the large group of lactic acid producing bacteria. Human strains of lactobacilli 
usually are part of the normal micro- flora of mouth, lower small intestine, colon and vagina. 
Fermentation of carbohydrates by lactobacilli produces lactic acid, so it survives well in 
acidic environments like stomach. They are rarely pathogenic (Ammor et al. 2006). 
L. rhamnosus GG is the most studied lactobacilli probiotic. It was first isolated in 1987 
by Gorbach and Goldin (hence GG) from the faeces of a healthy human. This strain is stable 
in bile and acid and adheres to intestinal cells in vitro. It survives passage through the 
stomach and intestinal tract. Another useful property of this strain is the modulation of 
specific enzymes, for example feeding L. rhamnosus GG to healthy volunteers for four weeks 
decreased faecal β- glucuronidase specific activity (Goldin et al. 1992). 
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The strains of L. reuteri are widespread in nature and can be isolated from a variety 
of food products, animals and the human gastro- intestinal tract (Lionetti et al. 2006). It 
appears to survive passage through the human digestive tract and persists for at least a 
week after stopping ingestion. 
L. acidophilus  is widespread in commercially available probiotic products. It is found 
in fermented dairy products and is part of normal intestinal and vaginal micro- flora. 
However, properties of adherence and stability in the gastro- intestinal tract are strain 
specific. Several L. acidophilus strains have been shown to produce antimicrobial substances 
in vitro, but production in vivo at levels high enough for a direct inhibition of pathogen 
growth has not been demonstrated (Sanders & Klaenhammer 2001). 
L. casei is a Gram- positive, rod shaped, non- sporing, non- motile, anaerobic bacteria 
which lacks cytochromes. The lactic acid produced by it is used to make cheese and yoghurt, 
reduce cholesterol level, enhance immune response, control diarrhoea, alleviate lactose 
intolerance and inhibit intestinal pathogens (Mishra & Prasad, 2005). Similar to L. 
acidophilus, the probiotic properties of L. casei are strain specific. L. casei strain Shirota has 
received much commercial attention. It’s effectiveness against Escherichia coli was shown in 
mouse models for treatment of urinary tract infections (Asahara et al. 2001), reduction of 
influenza virus titres in aged mice (Hori et al. 2002), against Listeria monocytogenes 
infections in rats (de Waard et al. 2002) and reduction of ulcer causing Helicobacter pylori in 
humans (Sgouras  et al. 2004). 
 
2.1.3.2 Bifidobacteria species 
Bifidobacteria are Gram- positive, strict anaerobic, lactic and acetic acid producing 
bacteria, present in normal flora and are the major component in the intestinal flora of 
breast- fed infants. They are used in different conditions such as diarrhoea, immune 
stimulation, as anti- mutagens and anti- cholesterol agents. It also plays an active role in the 
de- conjugation of bile acid, catabolism of dietary carbohydrates and vitamin synthesis. In 
vivo, they are used to restore the immune defence in children (Mombelli & Gismondo, 
2000).  
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2.1.3.3 Enterococcus faecium 
A well- studied strain of Enterococcus is E. faecium SF68, which is marketed as 
Bioflorin. This microbe is found in healthy adults, capable of producing lactic acid, survives in 
an environment of low pH, resists antibiotics and inhibits pathogens (Surawicz, 2003). Other 
strains of E. faecium are pathogenic and resistant to most antibiotics. Although strain SF68 is 
non- toxic, there has been concern that the probiotic might pick up and share antibiotic 
resistance genes in the human gut (Lund & Edlund, 2001). Cats and dogs which were fed 
with E. faecium SF68, showed fewer episodes of diarrhoea when compared with controls. 
This indicates that the probiotic has beneficial effects on the gastro- intestinal tract (Bybee 
et al. 2011). 
 
2.1.3.4 Saccharomyces boulardii 
Saccharomyces boulardii is a well- studied, commercially available yeast probiotic. 
Unlike the lactobacilli, S. boulardii is not usually found in the gastro- intestinal or vaginal 
tracts. It grows best at 37 0C and survives passage into the faeces in both humans and 
animals. It does not strongly adhere to intestinal mucosa and is eliminated within one to 
three days if not re- administered. Being a yeast, it is not directly affected by antibacterial 
antibiotics, so it can be given simultaneously during antibiotic therapy. However, it can be 
adversely affected by antifungal therapy if taken at the same time. The clinical activity of S. 
boulardii is especially relevant to antibiotic- associated diarrhoea and recurrent Clostridium 
difﬁcile intestinal infections. Experimental studies clearly demonstrate that S. boulardii has 
speciﬁc probiotic properties, and recent data has opened the door for new therapeutic uses 
of this yeast as an ‘immunobiotic’ (Czerucka et al. 2007).  
 
2.1.4 Foods containing probiotics 
Probiotics can be bacteria, moulds or yeast. But most probiotics are bacteria. A 
probiotic may be made out of a single bacterial strain or it may be a consortium as well. 
Probiotics can be in powder form, liquid form, gel, paste, granules or even as capsules, 
sachets, etc. (Suvarna & Boby, 2005; Timmerman et al. 2004). Examples of foods containing 
probiotics in market are yoghurt, fermented and unfermented milk, miso, tempeh, kefir, 
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aged cheese, dark chocolate, pickled vegetables, sausages, sauerkraut, some juices and soy 
beverages.  
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2.2 Safety of probiotics: routine screening tests adapted 
Live microorganisms are used in probiotic preparations. Although, the bacteria used 
belong to the GRAS category, the possibility of infection resulting from these bacteria cannot 
be ignored. The GRAS requirements are not specific for a particular microorganism. It is 
dependent on the intended application and the governing authority. Requirements can 
include history of safety, genetic stability of the microbe, testing for virulence genes, ability 
to produce toxins, presence of transferable resistance genes etc. In New Zealand, 
Agricultural compounds and Veterinary Medicine (ACVM) of Ministry for Primary Industries 
(MPI) is responsible for GRAS approval.  This research study is limited to only screening and 
identification of potential probiotic candidates from two different sources. One of the 
studies has recommended that the use of bacteria other than Lactobacillus species should 
be strongly discouraged (Bjarnason et al. 1995). Another study based on different reports 
suggested that the risk of infections associated with probiotic bacteria is similar to 
commensals. However, the degree of risk with probiotic bacteria is lower in comparison to 
other pathogenic groups of bacteria. This is said keeping in mind not only the healthy 
consumers but also the immune- compromised customers (Ouwehand & Vesterlund, 2003). 
Therefore, FAO/ WHO recommends probiotic food manufacturers and pharmaceuticals 
producing probiotic based capsules to adopt standard screening techniques. This helps to 
minimise the chances of risk and render general safety of the probiotic product. Antibiotic 
resistance, haemolytic activity and antimicrobial activity are examples of commonly 
employed screening tests to ensure the safety of probiotic bacteria. More information on 
antibiotic resistance, the types, mechanisms and implications on probiotic bacteria can be 
found in the review paper titled “Implications of antibiotic resistance in probiotics.” The 
review paper has been attached at the end of this chapter (Jose et al. 2015b). In addition, 
testing for pH tolerance, bile salts tolerance and ability to adhere are key selective tests 
which are used for screening potential probiotic candidates.  
 
2.3 Applications of probiotics 
Antibiotics, also synonymously called antibacterials, are in use for the treatment of 
bacterial infections in humans, as growth promoters in poultry and livestock, and also in 
agriculture for controlling animal and plant pathogens (Ammor et al. 2007). The antibiotics 
kill the invasive pathogen or inhibit their growth to control infection. According to the World 
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Health Organization, the increased and inappropriate use of antibiotics has led to 
development of resistant bacteria (e.g., vancomycin resistance exhibited by Pediococcus and 
Leuconostoc species). As a result, the drug discoveries that were considered as 
breakthroughs of science in the last century might be lost due to profound and rapid 
advancement of antibiotic resistance in bacteria. If this trend continues, in the coming years 
people may have infections that are harder to treat and antibiotic therapy will no longer be 
effective; thus, we might head into a postantibiotic era. This problem can be addressed to a 
certain extent by supplementing food products and animal feed with probiotics instead of 
antibiotics. 
 
2.3.1 Human health benefits 
Probiotic bacteria are living microbial food ingredients which have a beneficial effect 
on human health. These effects are attributed to the normal restoration of increased 
intestinal permeability and unbalanced gut micro- biota, improvement of the intestine’s 
immunological barrier functions and alleviation of the intestinal inflammatory response 
(Isolauri et al. 2004). The effects of probiotics have been directly observed in some cases, in 
others it has been suggested on the basis of in vitro studies and from experimental animal 
models (Mombelli & Gismondo, 2000). For examples of various human health benefits of 
probiotics, see Table 2.3. 
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Table 2.3 Proposed mode of action on human health and wellbeing for a limited list of 
probiotic bacteria. 
Probiotic bacteria Proposed mode of action 
Lactobacillus 
acidophilus LC1 
Immune enhancing; vaccine adjuvant; adherence to human intestinal cells; 
balancing of intestinal micro- flora (Bernet et al. 1994).  
 
L. acidophilus 
NFCO1748 
Lowering of faecal enzymes; prevention of radiotherapy related diarrhoea; 
treatment of constipation (Lidbeck et al. 1992).  
 
L. casei Shirota Prevention of intestinal disturbances; balancing of intestinal bacteria; 
lowering of faecal enzyme activities; inhibition of superficial bladder 
cancer (Aso & Akazan, 1992; Aso et al. 1995).  
 
L. gasseri (ADH) Faecal enzyme reduction; survived in intestinal tract (Pedrosa et al. 1995).  
 
L. acidophilus Significant decrease of diarrhoea in patients receiving pelvic irradiation; 
decreased polyps; lowered serum cholesterol levels (Marteau et al. 2001; 
Ouwehand et al. 2002).  
 
L. plantarum Reduced incidence of diarrhoea in day care centres when administered to 
only half of the children; especially effective in reducing inflammation in 
inflammatory bowel; reduced pain and constipation of irritable bowel 
syndrome; reduced bloating, flatulence and pain in irritable bowel 
syndrome in controlled trial; positive effect on immunity in HIV + children 
(Ribeiro & Vanderhoof, 1998; Schultz & Sartor, 2000, Vanderhoof, 2001, 
Nobaek et al. 2000 
 
L. reuteri Shortened the duration of acute gastroenteritis; shortened acute 
diarrhoea (Marteau et al. 2001; Shornikova et al. 1997). 
  
L. rhamnosus Enhanced cellular immunity in healthy adults in controlled trial (Sheih et al. 
2001).  
 
L. salivarius Suppressed and eradicated Helicobacter pylori in tissue cultures & animal 
models by lactic acid secretion (Hsieh et al. 2012).  
 
L. johnsonii Reduced candidal vaginitis (Hilton et al. 1992).   
 
L. reuteri Reduces gingivitis and decreases gum bleeding (Krasse et al. 2006). 
  
Bifidobacteria species Reduced incidence of neonatal necrotizing enterocolitis (Caplan & Jilling, 
2000).   
 
Enterococcus faecium Decreased duration of acute diarrhoea from gastroenteritis (Marteau et al. 
2001).   
 
Lactobacillus brevis, L. 
lactis, Enterococcus 
faecium, Weissella 
species 
Inhibits growth and attachment of uropathogens to uroepithelial cells 
(Reid et al. 2001).   
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2.3.2 Farmed livestock applications  
Studies have reported that in chickens, the intestinal micro- biota comprises of LAB, 
which includes mainly species of Lactobacillus and Enterococcus (Lan et al. 2003). In recent 
years considerable interest has been shown in using some probiotic microorganisms and 
organic acids as an alternative to the use of antibiotics in feeds (Guerra et al. 2007). The 
selection of therapeutically efficacious probiotic cultures with marked performance benefits 
like improved production, delivery and clinical efficacy is possible (Tellez et al. 2012). 
Growing awareness on health, has created the need for quality food products, which are 
free of drug residues and pharmaceutical metabolites (Dalloul & Lillehoj, 2006). For various 
applications of probiotics in poultry, see Table 2.4. There are several mechanisms by which 
probiotics improve the poultry health. Primarily, it is by maintenance of intestinal micro- 
flora by competing with pathogens for binding sites and exhibiting antagonistic activity 
towards pathogens infecting poultry. Neutralizing the enterotoxins secreted by pathogenic 
bacteria and stimulating the immune response of the animal is another mode of action (Jin 
et al. 1998).  
Antibiotics have been widely used to promote growth of cattle. For new- born calves, 
administration of antibiotics is useful to prevent infections caused by pathogenic bacteria. 
However, its use can have serious consequences, such as the development of resistant 
populations of bacteria. Subsequent use of the same antibiotics for therapy may be 
ineffective. Also, residual antibiotics in dairy foods, meat, eggs and milk are unacceptable. In 
such a scenario, replacement of antibiotics with probiotics for use as growth promoters in 
cattle looks promising (Frizzo et al. 2011). Since 2006, the European ban on using antibiotic 
growth promoters in cattle, has led to an increase in the use of probiotics in place of 
antibiotics. This is gaining the attention of researchers (Abe et al. 1995). There are several 
mechanisms by which probiotic bacteria improves animal health by providing protection 
against various pathogens. A few of them includes competitive exclusion for mucosal binding 
sites in hosts, production of anti- microbial substances such as bacteriocins, organic acids 
and immune response modulation (Ng et al. 2009). Supplementing animal feed with 
probiotics helps in promoting overall growth and health of animals. Few noticeable changes 
include increase in body weight gain (BWG), better resistance to a number of infections 
commonly infecting cattle, increase in milk yield and an increased feed conversion ratio 
(FCR) (Irshad, 2006; Perez et al. 2007). For a list of use of probiotics in cattle, see Table 2.4. 
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Table 2.4 Possible probiotic bacteria for farmed livestock and proposed modes of action. 
Probiotic Proposed mode of action 
Bifidobacterium longum PCB 
133 
Showed anti- Campylobacter activity both in vitro and in vivo, is an 
excellent candidate for being employed as additives to feed for 
poultry for the reduction of food- borne campylobacteriosis in 
humans (Santini et al. 2010).  
 
Enterococcus faecalis, E. 
durans, E. faecium, 
Pediococcus pentosaceus 
Showed antimicrobial activity against Salmonella species, 
Staphylococcus aureus and Escherichia coli (Musikasang et al. 2009).   
 
Enterococcus faecium, 
Bifidobacterium animalis, L. 
reuteri, Baacillus subtilis 
 
Increased overall growth performance of broiler chickens infected 
with Eimeria tenella (Giannenas et al. 2012).  
B. pseudolongum (M 602) Increase in immunity; BWG and feed conversion in calves (Namioka 
et al. 1991).  
 
Lactobacillus species, 
Streptococcus species 
Prevents pathogen access by steric interactions or specific blockage 
of cell receptors in cattle (McGroarty, 1993).  
 
L. acidophilus (LAC 300) Decrease of diarrhoea by controlling the number of coliforms in 
intestine and faeces of calves; increase in number of leucocytes in 
blood of piglets; increase in BWG and FCR in piglets (Gilliland et al. 
1980; Pollman et al. 1980).   
 
L. fermentum I 5007 Enhances T- cell differentiation and induce ileum cytokine 
expression suggesting it could modulate immune function in piglets 
(Wang et al. 2009).  
 
B. pseudolongum (M 602) Increase in immunity; BWG and feed conversion in calves & piglets 
(Namioka et al. 1991).  
 
Saccharomyces cerevisiae ssp. 
boulardii (CNCM I-1079), 
Pediococcus acidilactici 
(CNCM MA 18/5 M) 
 
Increase in FCR of piglets and improved LAB/ coliform ratio with 
dramatical decrease in E. coli counts (Le Bon et al. 2010).  
L. fermentum RC-14 Inhibits Staphylococcus aureus infection and bacterial adherence to 
surgical implants in rats (Gan et al. 2002).  
 
  
 36 
2.4 Future developments of probiotic research 
In the past few years, proteomics approach has played a significant role in 
understanding the molecular basis of probiotic functionality by providing information about 
the proteins which aid in the adhesion and adaptation to the gastro- intestinal tract 
environment. However, till date we have got a limited understanding on how the probiotics 
exert the beneficial effects and their species specific mechanisms of action is still an open 
challenge to researchers. Proteomic studies carried out on epithelial and immune cells and 
meta- proteomics aimed at clarifying the physiological and pathological dynamics of the gut 
micro- biota, provide new powerful tools to discover the bacteria- host interactions and 
health effects benefitted by probiotics. Routinely, the assessment of health effects is done 
through biological tests and clinical trials. In this regard, comparative proteomics will help to 
develop protein patterns which will associate it with specific probiotic properties, which 
could prompt the new and faster in vitro assays in assessing the health effects; thus 
replacing the biological tests and clinical trials of today. In the future, this can open up paths 
for the design of molecular biomarkers for the identification and selection of innovative 
probiotic strains possessing predictable and improved functionality (Siciliano & Mazzeo, 
2012).  
 
2.5 Implications of antibiotic resistance in probiotics: review paper 
This section has been accepted for publication (Jose et al. 2015b) and is reproduced 
on the following pages as orignially published.  
  
 Pages 37-47 have been removed due to copyright 
compliance of published material.  
 
They are a reproduction of the following article: 
 
Jose, N., Bunt, C., & Hussain, M. (2015). 
Implications of Antibiotic Resistance in Probiotics. 
Food Reviews International, 31(1), 52-62. 
ISSN: 8755-9129 ; E-ISSN: 1525-6103 ; DOI: 
10.1080/87559129.2014.961075 
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Chapter 3 
Materials and methods 
3.1 Materials 
3.1.1 Bacterial isolates 
The bacterial isolates used in this research study were isolated from two different 
sources: fermented dairy food products (details in Table 3.1) and environment/ rumen 
contents from a 10 yr old Fresian x Jersey (ID 312) located at the Johnstone Memorial 
Laboratory Farm, Lincoln University. 
 
3.1.2 Chemicals 
Most of the chemicals used in this research were obtained from Sigma- Aldrich 
(Missouri, USA), Invitrogen (Massachusetts, USA) and Oxoid (Hampshire, UK). 
 
3.1.3 Reagents 
Gram stain was prepared as follows. Crystal violet (0.025 g) was dissolved in 50 ml of 
distilled water. Saffranin (0.025 g) was dissolved in 50 ml of distilled water. Gram’s iodine 
was prepared by mixing iodine (1.5 g) and potassium iodide (2 g) in 300 ml of distilled water 
and stored in a covered dark bottle. 
 
Bromocresol purple was prepared by dissolving dye (0.6 g) in 100 ml of distilled 
water and filter sterilized. 
 
Coomassie brilliant blue stain was prepared by mixing 50% methanol (125 ml), 10% 
acetic acid (25 ml), 40% water (100 ml) and 0.1% Coomassie brilliant blue dye (0.25 g).  
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Destain solution was prepared by mixing 50% methanol (125 ml), 10% acetic acid (25 
ml) and 40% water (100 ml).  
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Table 3.1 Ingredient lists of fermented dairy food products as stated on the product label. 
Meadow Fresh natural yoghurt 
(125 g) 
Mainland Epicure cheese/ Cheddar 
cheese (200 g) 
Mainland Camembert 
cheese (125 g) 
Meadow Fresh low fat milk Milk Milk 
Milk Salt Salt 
Salt Cultures Cultures 
Cultures Enzymes (rennet) Enzyme (non-animal 
rennet) 
Enzymes (rennet)   
Mineral salt (calcium)   
Cultures (including acidophilus 
and bifidus) 
  
 
3.1.4 Stock solutions 
All solutions and media were prepared using autoclaved water or reverse osmosis 
(RO) water and sterilized by autoclaving at 121 0C for 15- 20 min or unless otherwise stated. 
 
Glycerol stock was prepared by autoclaving glycerol (500 ml) at 121 0C for 12- 15 
min. It was stored at room temperature and used when required for long term storage of 
cultures by mixing with 2 X MRS broth. 
 
5 X TBE buffer (stock solution) was prepared by suspending Tris (54 g), 0.5M (pH 8) 
EDTA (20 ml) and boric acid (27.5 g) in 800 ml of distilled water and volume made upto one 
litre with distilled water.  
 
1 X TBE buffer (working stock) was prepared by mixing 5 X TBE (200 ml) and distilled 
water (800 ml). Autoclaving not necessary. 
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Tween 80 (20% stock) was prepared by dissoving Tween 80 (20 ml/ g) in distilled 
water (80 ml) and volume made upto 100 ml. 
 
Sugars: Arabinose, Cellobiose, Fructose, Galactose, Glucose, Glycerol, Lactose, 
Maltose, Mannitol, Mannose, Melibiose, Raffinose, Ribose, Sorbitol and Sucrose were 
prepared by dissolving (20 g) each in distilled water (80 ml) and volume adjusted to 100 ml. 
 
3.1.5 Buffers 
0.3M Phosphate buffer was prepared by suspending sodium dihydrogen phosphate 
(30.8 g) and disodium hydrogen phosphate (20.5 g) in one litre of distilled water. The 
solution was mixed well with frequent agitation. pH was adjusted to 6.2 with 1M HCL or 1M 
NaOH and sterilized in autoclave at 121 0C for 12- 15 min. The buffer was stored at room 
temperature. 
 
1 x Phosphate buffered saline (PBS) was prepared by suspending sodium chloride (8 
g), potassium chloride (0.2 g), disodium hydrogen phosphate (1.44 g) and potassium 
dihydrogen phosphate (0.24 g) in one litre of distilled water. The solution was mixed well 
with frequent agitation. pH of the media was 7.4. It was adjusted to pH 1 and pH 5 by 
addition of 1 M HCL for the BATH test. 
 
3.1.6 Microbiological media 
All media were supplied by Oxoid (Hampshire, UK) except Columbia blood agar plates 
and Nutrient agar plates which were supplied by Fort Richard (Auckland, New Zealand) 
unless stated otherwise. The media were sterilized by autoclaving at 121 0C for 15- 20 min. 
The desired pH of each media was checked and if necessary adjusted before autoclaving. 
Generally prepared agar plates were stored under refrigerated conditions and the liquid 
media were stored at room temperature unless stated otherwise. 
 
MRS broth was prepared by suspending MRS broth (52 g) in one litre of distilled 
water. The solution was mixed well using a magnetic stirrer until complete dissolution. Then 
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it was dispensed into appropriate containers and sterilized in autoclave at 121 0C for 12- 15 
min. The autoclaved medium was stored at room temperature. Final pH 6.2 + / - 0.2 at 25 0C. 
 
2 X MRS broth was prepared by suspending MRS broth (104 g) in one litre of distilled 
water. The solution was mixed well using a magnetic stirrer until complete dissolution. Then 
it was dispensed into appropriate containers and sterilized in autoclave at 121 0C for 12- 15 
min. The autoclaved medium was stored at room temperature. Final pH 6.2 + / - 0.2 at 25 0C. 
 
3.1.7 MRS broth substituted with bile salts for bile salts tolerance assay 
0.2%, 0.3%, 0.4%, 0.8%, 1.5%, 2%, and 3.5% bile salts were prepared by mixing bile 
salts (1, 1.5, 2, 4, 7.5, 10 or 17.5 g respectively) with MRS broth (26 g) in 0.3M phosphate 
buffer (500 ml). The solution was mixed well using a magnetic stirrer until complete 
dissolution. The medium was sterilized in autoclave at 121 0C for 12- 15 min and stored at 
room temperature. Final pH 6.2 + /- 0.2 
 
MRS broth of different pH for pH tolerance assay was prepared by dissolving MRS 
broth (26 g) in 0.3M phosphate buffer (pH 7) (500 ml). 1M HCL was added to bring down the 
pH of the media to 2, 3, 3.5, 4 and 6.4. The solutions were mixed well using a magnetic 
stirrer until complete dissolution. The media were sterilized in autoclave at 121 0C for 12- 15 
min and stored at room temperature. 
 
MRS base media for carbohydrate fermentation studies was prepared by mixing 
peptone (10 g), yeast extract (5 g), Tween 80 (1 ml/ g), sodium acetate (5 g), Tri ammonium 
citrate (2 g), magnesium sulphate (0.2 g), manganese sulphate (0.05 g) and di- potassium 
hydrogen phosphate (2 g) to one litre of distilled water. The medium was sterilized in 
autoclave at 121 0C for 12- 15 min. Final pH 6.2 + / - 0.2 at 25 0C. 
 
MRS Agar was prepared by mixing MRS broth (52 g) and 1.5% bacteriological agar (15 
g) in one litre of distilled water. The solution was mixed well using a magnetic stirrer until 
complete dissolution. The medium was sterilized in autoclave at 121 0C for 12- 15 min 
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followed by placing in a water bath at 45- 50 0C to prevent solidification of media. It was 
dispensed into petri- plates and stored at 2- 8 0C. Final pH 6.2 + / - 0.2 at 25 0C. 
 
Nutrient agar was prepared by mixing nutrient broth (20 g) and 1.5% bacteriological 
agar (15 g) in one litre of distilled water. The solution was mixed well using a magnetic stirrer 
until complete dissolution. The medium was sterilized in autoclave at 121 0C for 12- 15 min 
followed by placing in a water bath at 45- 50 0C to prevent solidification of media. It was 
dispensed into petri- plates and stored at 2- 8 0C. Final pH 7.4 ± 0.2 at 25 0C. 
 
0.1% Peptone water was prepared by dissolving peptone (1 g) in one litre of distilled 
water. The solution was sterilized in autoclave at 121 0C for 12- 15 min and stored at room 
temperature. 
 
BHI Broth was prepared by dissolving BHI (18.5 g) in 500 ml of distilled water The 
medium was mixed well using a magnetic stirrer until complete dissolution. It was sterilized 
in autoclave at 121 0C for 12- 15 min and stored at room temperature. Final pH 7.4 + /- 0.2 
 
3.1.8 Antibiotic discs 
The antibiotic discs manufactured by Oxoid (Hampshire, UK), BD BBLTM (Becton 
Dickinson and Company, New Jersey, USA) and BBLTM (New Jersey, USA) were used. The list 
of the antibiotics and the concentrations used are listed in Table 3.2. 
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Table 3.2 Antibiotic, abbreviation and concentration (g) per disk as used for the antibiotic 
sensitivity of each lactic acid isolate. 
Name of antibiotic Abbreviated form Amount in µg 
Ampicillin AMP 10 
Streptomycin ST 10 
Ciprofloxacin CIP 5 
Vancomycin VA 30 
Chloramphenicol C 30 
Gentamycin CN 10 
Nalidixic acid NA 30 
Erythromycin E 15 
Tetracycline TE 30 
Fusidic acid FA 10 
Kanamycin K 30 
 
 
3.1.9 Oxidase strips 
The Oxoid MicrobactTM Identification kit (Oxoid, Hampshire, UK) was used as 
supplied. 
 
3.1.10  Pathogens 
Five pathogens were used in testing the antimicrobial activity of the lactic acid 
bacterial isolates. For the list of pathogens used, see Table 3.3. 
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Table 3.3 Pathogen and source as used to test sensitivity of each lactic acid isolate. 
Name of pathogen Source 
Escherichia coli ESR (The Institute of Environmental Science and Research, New 
Zealand) 
Enterobacter aerogenes NCTC1006 (ATCC 13048, DSM 30053, NCIMB 10102). Type strain 
(Medium 137C) 
Staphylococcus aureus ESR (The Institute of Environmental Science and Research, New 
Zealand) 
Salmonella menston ESR (The Institute of Environmental Science and Research, New 
Zealand) 
Listeria monocytogenes LM 
V7 
ESR (The Institute of Environmental Science and Research, New 
Zealand) 
 
 
3.1.11  Standards and working solutions for VFA analysis using GC- MS 
Aroma standards All the seven standards used to generate standard curves for 
quantitative analysis, were obtained from commercial suppliers Sigma- Aldrich New Zealand 
Ltd and Merck New Zealand Ltd. The four deuterated standards used were purchased from 
Sigma- Aldrich and CDN isotopes (SciVac PTY. Ltd, Hornsby NSW, Australia). 
 
Standard and Working Solutions Primary standard solutions were prepared in 10 % 
ethanol (Scharlau Chemie SA, HPLC Grade ACS ISO UV-vis) for 5 of the 7 VFA compounds and 
2 of the 4 deuterated VFA compounds. Primary standards were made in 100% ethanol for 
octanoic acid and d2-octanoic acid due to low aqueous solubility. All primary standard 
solutions were stored in amber bottles in a freezer at -20 0C.  
A concentrated composite working standard was then made by adding appropriate 
amounts of the primary standards for the individual compounds to a solution of 20% ethanol 
in deionised water. This composite standard was then split into small amber vials and stored 
at -20 0C until it was used. 
Standards for GC- MS analysis we prepared on the day by serially diluting a top 
standard, which was made up in a deionised water matrix from the concentrated composite 
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working standard. Each standard vial was prepared in duplicate and made up in a 5 g L-1 
tartaric acid buffered at pH 3.5.  
A concentrated composite working internal standard was also made by adding 
appropriate amounts of the primary standards for the individual deuterated compounds to a 
solution of 10% ethanol in deionised water. This composite internal standard was then split 
into small amber vials and stored at -20 0C until it was used. 
 
3.1.12 Reagents and standards for FA analysis using GLC 
Solvents Methanol- HPLC grade, Fisher Scientific, Auckland New Zealand.  
Hexane- ChromasolR 95%, Sigma- Aldrich, Auckland, NZ.  
 
Solids Sodium hydroxide- BDH Laboratory Supplies, UK. 
 
Acids Hydrochloric acid- Fisher Scientific, Auckland, NZ. 
 
Standards Reference standards- Tridecanoic acid 98% p/n T0502, Sigma-Aldrich, 
Auckland New Zealand. GLC463 purchased from Nuchek Prep Inc., Minnesota, U.S.A. Two 
Alkane standard solutions C8- C20, p/n 04070- 1ml and C21- C40, p/n 04071- 1ml both from 
Sigma- Aldrich. 
 
3.2 Methodology 
3.2.1 General methods 
All media and stock solutions were prepared using autoclaved water or RO water 
after weighing by using laboratory analytical balance. pH was measured using a calibrated 
pH meter. Solutions were stored at room temperature unless otherwise specified. Optical 
densities were measured using spectrophotometer. Bacterial cultures were centrifuged 
using centrifuge (for volume 2- 50 ml) or a mini eppendorf centrifuge was used for volume 
upto 1.5 ml. Stock solutions and microbiological media were sterilized by autoclaving at 121 
0C for 15- 20 min.  
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3.2.2 Inoculum preparation 
Overnight cultures were prepared by inoculating directly from -20 0C glycerol stock 
(working stock) into 10 ml of MRS media and incubated overnight/ 24 h at 37 0C under 
anaerobic conditions. The overnight cultured cells were recovered by centrifugation, washed 
and resuspended in 0.1% peptone water before inoculating to give a starting OD600 of 0.2, 
otherwise stated. 
 
3.2.3 Storage of isolates 
Colonies were picked according to differences in their morphology on MRS agar 
plates and purified by further streaking onto MRS agar. Pure cultures were characterized 
according to colony and cell morphology, Gram staining reaction and catalase activity. 
Isolates tentatively identified as potential probiotic bacteria were stored at -20 0C and -80 0C 
in MRS broth with 40% (w/v) glycerol (modified from Ayeni et al. 2009). 
 
3.2.4 Gram staining 
The Gram stain technique was done to differentiate between the Gram- positive and 
Gram- negative bacteria. A bacterial smear was prepared. It was saturated with crystal violet 
for 1 min. Rinsed the slide gently with water. Saturated the smear with Gram’s iodine for 1 
min. Rinsed the slide gently with water. Decolourised with 50% acetone- alcohol for 3- 5 s. 
Rinsed the slide gently with water. Counterstained with saffranin for 1 min. Rinsed the slide 
gently with water. Carefully blotted the slide dry with bibulous paper. Observed the slide 
under the microscope. (Nikon Eclipse 50i). The Gram- positive bacteria appeared purple 
coloured whereas the Gram- negative bacteria were pink in colour. The Gram stain 
technique used crystal violet as primary stain, Gram’s iodine as a mordant, 95% ethyl alcohol 
as a decolouriser and saffranin as a counter stain. 
  
 58 
3.2.5 Carbohydrate fermentation 
Carbohydrate fermentation profiles were determined according to the method 
described by (Gupta et al. 1996). The list of carbohydrates used can be seen in Table 3.4. 
Briefly, MRS base medium was prepared and supplemented with appropriate sugars and 
dye. Bacterial cultures were added to the fermentation tubes prior to incubation at 37 0C for 
24 h. A positive result was recorded after a colour change of the medium from purple to 
yellow. A negative result was recorded if there was no colour change observed in the tubes 
after incubation. A negative control was prepared by inoculating culture into medium devoid 
of a carbohydrate substrate. 
 
Table 3.4 Carbohydrate and type of sugar used to evaluate the carbohydrate fermentation 
by the lactic acid isolates. 
Name of carbohydrate/ sugar Type of sugars 
Arabinose monosaccharide 
Cellobiose disaccharide 
Fructose monosaccharide 
Glucose monosaccharide 
Galactose monosaccharide 
Lactose disaccharide 
Mannose monosaccharide 
Mannitol disaccharide 
Melibiose disaccharide 
Maltose disaccharide 
Raffinose trisaccharide 
Ribose monosaccharide 
Sorbitol disaccharide 
Sucrose monosaccharide 
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3.2.6 Determination of growth 
Bacterial growth in different media was observed visually in terms of turbidity. 
However, scientifically it was determined by measuring the OD using a spectrophotometer. 
The absorbance used was 600 nm for bacterial samples. The OD was compared against a 
blank. 
 
3.2.7 Determination of viable count 
The viable plate count was done to determine the number of live cells under various 
conditions. Overnight lactobacilli cultures were inoculated into MRS broth of required 
experimental conditions. The inoculated cultures were incubated under anaerobic 
conditions. 100 µl of culture was plated onto MRS agar plates after serial dilution and 
incubated. The plates were later counted for number of colonies on the surface of agar. 
 
3.2.8 Disc diffusion method 
The antibiotic resistance of microbial isolates was assessed by the disc diffusion 
method. Microbial cultures were evenly spread on the agar surface and antibiotic discs were 
placed on the surface of the agar aseptically using sterile forceps. The antibiotic resistance 
was determined by means of measurement of zones of inhibition around the antibiotic discs. 
 
3.2.9 Well diffusion method 
This technique was used in the study of antimicrobial activity. Pathogen cultures 
were evenly spread on the agar surface and wells punctured into the media using sterile 
disposable 1 ml pipette tips. Wells were inoculated with lactobacilli cell free supernatants 
(CFS) for the antimicrobial activity determination. While wells were inoculated with treated 
supernatants for characterization of antimicrobial substances determination. Antimicrobial 
activity was determined in terms of inhibition zones developed around the wells. 
  
 60 
3.2.10 Extraction of genomic DNA 
The genomic DNA was extracted by using the Gentra Puregene Yeast/ Bacterial Kit B 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The list of contents 
in the kit is listed in Appendix B. 500 µl of overnight cell culture (containing approx. 0.5- 1.5 x 
109 cells) was transferred to 1.5 ml microcentrifuge tubes on ice. It was centrifuged for 5 s at 
13, 000- 16, 000 x g to pellet cells. Longer centrifuge times may be necessary for some 
species to form a tight pellet. Supernatant was carefully discarded by pipetting or pouring. 
300 µl of cell suspension solution was added next and pipetted up and down. Then 1.5 µl of 
lytic enzyme solution was added and mixed by inverting 25 times. This was incubated for 15- 
60 min at       37 0C. Then, it was centrifuged for 1 min at 13, 000- 16, 000 x g to pellet cells. 
Carefully the supernatant was discarded with a pipette. Carefully 300 µl of cell lysis solution 
was added and pipetted up and down to lyse the cells. An incubation for 5 min at 80 0C may 
be necessary to lyse cells of some species. Next 1.5 µl of RNase A solution was added and 
mixed by inverting 25 times. This was incubated for 20 min at 37 0C. Next it was incubated 
for 1 min on ice to quickly cool the sample. The 100 µl of protein precipitation solution was 
added and vortexed vigorously for 20 s at high speed. Note: for species with high 
polysaccharide content, sample has to be incubated on ice for 15- 60 min. Next, 
centrifugation was done for 3 min at 13, 000- 16,000 x g. The precipitated proteins should 
form a tight pellet. (If the protein pellet is not tight, incubate on ice for 5 min and repeat the 
centrifugation.) 300 µl of isopropanol was pipetted into a clean 1.5ml micro centrifuge tube 
and the supernatant from the previous step was added by pouring carefully. This was mixed 
by inverting gently 50 times. Centrifuged for 1 min at 13, 000-16, 000 x g. The DNA was 
visible as a small white pellet. Carefully supernatant was discarded by inverting the tube on a 
clean piece of absorbent paper, taking care that the pellet remained in the tube. 300 µl of 
70% ethanol was added and inverted several times to wash the DNA pellet. Centrifuged for 1 
min at 13, 000- 16,000 x g. Carefully the supernatant was discarded. The tube was drained 
on a clean piece of absorbent paper, taking care that the pellet remained in the tube. This 
was allowed to air dry for 5 min. (The pellet might be loose and easily dislodged. Avoid over 
drying the DNA pellet, as the DNA will be difficult to dissolve.) 100 µl of DNA hydration 
solution was added and vortexed for 5 s at medium speed to mix. This was incubated at 65 
0C for 1 h to dissolve the DNA. Later it was incubated at room temperature (15- 25 0C) 
overnight with gentle shaking. (Ensure tube cap is tightly closed to avoid leakage.) Samples 
were centrifuged briefly and transferred to a storage tube.  
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3.2.11 Quantification of extracted DNA 
The PCR products were analysed using a nanodrop to check the purity of DNA, see 
Appendix C. For nucleic acids the 260/ 280 ratio is generally taken into consideration. A 
value of ~1.8 is accepted as pure for DNA. The obtained DNA was stored at -20 0C in the 
freezer until further use. 
 
3.2.12 Polymerase chain reaction (PCR) 
Genomic DNA was used for the amplification. PCR was performed using three 
primers, see Appendix D, for their details. PCR reactions were performed in a total volume of 
25 µl of mixture in a thermocycler. PCR reaction mixture for a 25 µl volume can be found in 
Appendix E. The PCR reaction cycles for the three primers used is shown in Table 3.5. 
 
Table 3.5 PCR reaction cycle for three primers. A: Primer 1- Aci I and Aci II, B: Primer 2- Pr I 
and Pr II, C: Primer 3- 16-1A and 23-1B. 
A 
Initialization Denaturation Annealing Elongation Final 
elongation 
Final 
hold 
920 950 550 720 720 40 
2mins 30sec 30sec 30sec 5mins 90mins 
 
B 
Initialization Denaturation Annealing Elongation Final 
elongation 
Final 
hold 
950 940 550 720 720 40 
5mins 1min 1min 2mins 5mins 90mins 
 
C 
Initialization Denaturation Annealing Elongation Final 
elongation 
Final 
hold 
940 940 550 720 720 40 
2mins 1min 1min 1mins 5mins 90mins 
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3.2.13 Agarose gel electrophoresis 
0.45 g of agarose (1.5% gel) powder was measured and added into microwavable 
flask along with 30 ml of 1 x TBE. This was microwaved for 1- 3 min until the agarose was 
completely dissolved. Agarose solution was allowed to cool down for 5 min. 3 µl of cyber 
safe dye was added to the agarose solution. Then the agarose was poured into a gel tray 
with the well comb in place. The tray was allowed to sit at room temperature for 20- 30 min, 
until it had completely solidified. Now the agarose gel was placed in the electrophoresis 
tank. The gel tank was filled with 1 x TBE buffer until the gel was covered. Carefully 2 µl of 
DNA ladder and 2 µl dye/ loading buffer and 6 µl distilled water was loaded into the first lane 
of the gel. Similarly the samples were loaded into the remaining wells of the gel i.e, 8 µl 
sample and 2 µl dye. The gel was run at 100 V for about 40 min/ until the dye line is 
approximately 75- 80% of the way down the gel. After turning off the power, the electrodes 
were disconnected from the power source. Then carefully the gel was removed from the gel 
tank. DNA fragments were visualized with the gel reader, Geldoc EQ, using UV light. 
 
3.2.14 DNA sequencing 
The PCR products were sent to Bio- protection centre, Lincoln University for 
sequencing. The obtained sequence data was used for BLAST search and subsequent 
sequence alignment retrieved from NCBI (http://www.ncbi.nlm.nih.gov/) using BLASTN. 
 
3.2.15 Preparation of bacterial suspension for proteomics analysis by gel 
electrophoresis 
The bacterial cultures grown under different stress conditions along with standard 
conditions were harvested by centrifuging at 4000 rpm or higher for 20 min at 4 0C. After 
discarding the supernatant, cells were washed with 10 ml of 40mM Tris buffer (pH 7) twice. 
Samples were again centrifuged for 20 min at 4 0C. After discarding the supernatant, cells 
were finally suspended in calculated amount of 40 mM Tris buffer to achieve an OD of 20 ± 
0.1 at absorbance of 600 nm. The bacterial suspensions with an OD of 20 ± 0.1 were 
transferred into 1.5 ml screw capped vials and stored at -20 0C until further use (i.e., for 
protein extraction). This step was done to have a similar concentration of microbial cells for 
protein extraction. 
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3.2.16 Whole cell protein extraction 
400 µl of collected culture sample (OD 20 ± 0.1) was added to 0.5 g of beads (0.1 
mm) in a 2 ml capacity screw- top plastic tube and a Mini Bead Beater- 8 (Biospecs Products 
Inc) was used to lyse the cells using three bursts of 90, 60 and 60 s. Samples were cooled on 
ice for 5 min in between each burst. After bead beating, 200 µl of double strength SDS 
loading buffer was added and mixed well by vortexing for 30 s. The suspension was boiled 
for 10 min, cooled on ice and centrifuged (5 min at 13, 000 rpm at 4 0C) to remove cell 
debris. After centrifugation, approximately 300 µl of the protein- rich supernatant was then 
removed and transferred to a clean tube. Again centrifuged for 30 min at 13, 000 rpm at 4 
0C. Whole cell proteins were transferred into smaller vials without disturbing the pellet at 
the bottom and stored at -20 0C or loaded immediately onto the gels. 5 µl of high molecular 
weight protein marker and 30 µl of protein samples were loaded directly into the lanes of 
the gel. 
 
3.2.17 Cytosolic protein extraction 
400 µl of collected culture sample (OD 20 ± 0.1) was added to 0.5 g of beads (0.1 
mm) in a 2 ml capacity screw- top plastic tube and a Mini Bead Beater- 8 (Biospecs Products 
Inc) was used to lyse the cells using three bursts of 90, 60 and 60 s. Samples were cooled on 
ice for 5 min in between each burst. The tubes were centrifuged for 10 min at 13, 000 rpm at          
4 0C. The supernatant from the previous step was transferred into new labelled eppendorf 
tubes, without disturbing the beads settled at the bottom. The tubes were again centrifuged 
at 13, 000 rpm for 30 min at 4 0C. Without disturbing the pellet, supernatant was transferred 
into new eppendorf tubes and stored at -20 0C or until further use.  
Cytosolic proteins were quantified by using the BCA Protein Assay kit, following the 
manufacturer’s instructions. Required volume of protein sample which gives a 30 µg 
concentration was pipetted into new eppendorf tubes. 4µL dye was added into the tubes. 
Proteins were denatured by heating at 96 0C for 5 min using a heating block. Finally, 5 µl of 
high molecular weight protein marker and 23 µg of protein samples were added into the 
lanes of the gel.  
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3.2.18 Protein quantification 
The Pierce™ BCA Protein Assay Kit (Life Technologies, California, USA) was used to 
quantify the cytosolic proteins. The procedure consisted of three steps. In step 1, the diluted 
albumin standards were prepared according to the manufacturer’s instructions. Step 2, 
consisted of preparing the BCA working reagent (WR) by mixing 50 parts of BCA reagent A 
with 1 part of BCA reagent B. Step 3 consisted of the microplate procedure where 200 µl of 
WR was added into the wells containing 25 µl of albumin standards and protein samples. 
After mixing well, the plate was covered and then incubated at 37 0C for 30 min. Finally the 
absorbance was measured at 560 nm using a plate reader. The amount of proteins in 
samples were calculated from a standard curve (Appendix F). 
 
3.2.19 1- D SDS PAGE 
1-D SDS PAGE was performed using a vertical slab system. The electrophoresis tank 
was filled with NuPAGE MOPS SDS Running Buffer. Then a commercial gel (NuPAGE ® 
Novex® Tris-Acetate Mini Gels) was inserted into the vertical slab of the electrophoresis unit. 
The high molecular weight protein marker and protein samples were loaded into the lanes of 
the gel. The lid of the electrophoresis tank was closed and electrophoresis was run at 70 V 
for 200 min or until the dye front reached the bottom of the gel sandwich. The gels were 
then stained by coomassie brilliant blue stain for observing the protein bands. 
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Chapter 4 
Isolation, identification and screening of potential probiotic lactic 
acid bacteria isolates  
4.1 Introduction 
The human/ animal body plays host to indigenous microorganisms and there is a high 
degree of interdependence between them. The gastro- intestinal tract possess the second 
largest surface in the body after the respiratory tract and unlike the respiratory tract 
harbours a rich micro- biota. The continuous state of activiation or physiological 
inflammation of the gastro- intestinal tract is attributed to this rich micro- biota (Alvarez- 
Olmos & Oberhelman, 2001). LAB are normal inhabitants of the intestinal micro- biota in 
healthy humans and animals (Soto et al. 2010). Several pre- disposing factors that increase 
chances of infection include repetitive prescription of antibiotics for treating infections, 
immuno- suppressive therapies and irradiation. All these conditions alter the composition of 
the gut micro- biota, leading to a state of imbalance, which is one of the primary reasons 
leading to infections. LAB compete with the pathogenic bacteria for binding sites, or alter 
the pH by production of organic acids, which creates an unfavourable environment for the 
other microorganism. This phenomenon is known as “Bacterial Interference”, wherein 
presence of one microbe limits the pathogenic potential of the other microbe.  Thus, LAB 
plays a significant role in balancing the gut micro- biota (Mcfarlane & Cummings, 1999). This 
chapter discusses about four key aspects. Initially, isolation techniques and storage of 
isolates has been described. Secondly, preliminary screening of the isolates has been 
discussed. Third aspect describes the genetic identification of the isolates using PCR analysis. 
The last part focusses on screening of selected lactobacilli isolates for potential probiotic 
properties. 
Probiotic bacteria can exert beneficial effects in the body only when live. Hence, they 
should survive the challenges encountered when passaging through the gastro- intestinal 
tract post consumption. For example, bile is stored in the gall bladder and during digestion it 
flows to the duodenum, aiding in absorption of dietary fats. Presence of bile in the upper 
parts of the small intestine is toxic to microoragnims which are not adapted to intestinal 
conditions (Ruiz et al., 2013). Hence, the two foremost challenges probiotic bacteria 
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encounters post consumption by the host includes surviving the low pH (acidic) environment 
of stomach and presence of bile salts in the intestine (Shah, 2000; Taranto et al. 2006). From 
the probiotic point of view, the potential probiotic isolate must be capable of surviving the 
transit through the stomach and colonize the small intestine of the host. This is a 
prerequisite for the bacteria in order to impart health benefits in the host body (Strompfova 
& Laukova, 2007). Therefore survival of isolates across different pH range and different bile 
salt concentrations has been the focus in the preliminary screening section. 
Traditional phenotypic identification of the isolates included morphological 
observation, Gram- stain reactions and characterization based on carbohydrate utilization. 
However, these tests lacked reproducibility to a certain extent. Thus, genomic identification 
of isolates proved useful and they could produce the same results across labs, if carried out 
under similar experimental conditions (Tannock, 1999). With the advancement in genomic 
tools, today several molecular identification techniques are available for microbial 
identification. This includes microarray hybridization, sequence analysis of 16S rRNA gene; 
the latter being more prominent (Wagner et al. 2003). 16S rRNA sequences represent an 
evolutionary chronometer (Woese, 1987). Some regions of 16S rRNA are conserved 
throughout all bacterial species. This can be used in alignment of sequences obtained from 
different isolates. Therefore, identification of the isolates has been done using the 16S- 23S 
rRNA gene of lactobacilli. Ten isolates, five each from dairy food sources and bovine rumen 
were selected for identification by genotypic methods. This selection was based on the 
preliminary screening results.  
Lactobacilli form the major group of bacteria incorporated into foods for use as 
probiotics or functional foods. An effective probiotic is required to operate under a variety of 
different environmental conditions and survive in many different forms. Stability and shelf- 
life of the product together with viability of the organism are key factors which determine 
the efficacy of the probiotic bacteria (Johnson et al. 2012). Screening factors for analysing 
probiotic abilities, carried out in this study, were based on the following factors. Upon 
consumption, probiotic bacteria should survive the transit in the gastro- intestinal tract, 
where it is open to challenges like, low pH environment of stomach and bile salts of intestine 
(Kailasapathy & Chin, 2000; Shah, 2000; Musikasang et al. 2009; Kechagia et al. 2013). 
Stomach pH can vary from 1- 2 upto 4- 5 (Chou & Weimer, 1999). Under conditions of fasting 
or acidity, the pH can drop as low as 1- 2. And after a meal, it can rise to 4- 5 (Ranadheera et 
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al. 2012). Thus, for in vitro studies, ability of potential probiotic bacteria to survive low pH of 
2- 3 is routinely carried out (Turpin et al. 2010). Probiotic bacteria must be safe in vivo. This 
was determined in terms of haemolytic activity, which was used as a pre- screening tool to 
help identify lactobacilli isolates with ability to lyse RBC ‘s in vitro from further evaluation. 
Antibiotic resistance is necessary for survival in presence of co- administered drugs 
(Mombelli & Gismondo, 2000). The genes conferring resistance should be innate in nature 
and non- transferable to other bacteria. Display of antimicrobial activity against common 
intestinal pathogens is also highly preferred (Kechagia et al. 2013). Common mechanism 
behind this is production of organic acids by lactobacilli, which lowers the pH, thereby 
creating a hostile environment for the growth of other bacteria. Simultaneously, these 
organic acids can prove toxic to other bacteria, thereby inhibiting growth of most pathogens. 
Competitive inhibition for mucosal binding sites between pathogen and probiotic bacteria 
also limits the growth and colonization of pathogens in the body (Alvarez- Olmos & 
Oberhelman, 2001). Probiotic bacteria must be capable of adhering to intestinal epithelial 
lining for exerting it’s benefits in the host. Adherence property enables the probiotic bacteria 
to persist for a longer time in the gut and enhances the host-bacteria cross talk (Gueimonde 
& Salminen, 2006). Adherence also helps the probiotic bacteria to overcome the peristalsis 
effects of stomach (Suvarna & Boby, 2005). It has also been reported that the immune 
modulatory response of probiotic bacteria maybe because of its ability to bind to the gastro- 
intestinal tract (Turpin et al. 2010). For this purpose, their surface properties were studied 
by performing the bacterial adherence to hydrocarbons (BATH) test. 
 
4.2 Methods 
4.2.1 Isolation of isolates from dairy food products and bovine rumen contents 
The bacterial isolates were isolated from commercially available fermented dairy 
food products (yoghurt and cheese) and environment/ indigenous animal sources (rumen of 
cow). For all solid samples, 10 g of sample was added to 40 ml of MRS broth and 
homogenized by vortex mixing. For liquid samples, 10 ml of sample was added to 40 ml of 
MRS broth and homogenized by vortex mixing. The inoculated broth samples were 
incubated at 37 0C for 24 h under anaerobic conditions. The tubes showing turbidity were 
selected and growth of potential probiotic bacteria was determined by inoculating onto MRS 
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agar plates by streak plate method and incubated at 37 0C for 24 h under anaerobic 
conditions. Plates showing colony growth were selected. 
 
4.2.2 Purification of isolates 
Plates showing colony growth on MRS agar were selected. Purification 1/ subculture 
1- a single colony was picked up and streaked onto fresh MRS agar plates. The plates were 
incubated at 370 C for 24 h under anaerobic conditions. Plates showing colony growth were 
selected. Gram staining was performed. Gram- positive rods/ cocci were selected. 
Purification 2/ subculture 2 (repeat the same procedure as in purification 1). A single colony 
of Gram- positive rods/ cocci were selected and inoculated into 0.6ml vials, containing MRS 
broth media. This was mixed well, then the vials were incubated at 37 0C for 24 h under 
anaerobic conditions. Purification 3/ subculture 3- vials showing turbidity were selected. 
With the help of a micropipette the culture was poured onto fresh MRS agar plates. The 
culture was spread uniformly by means of a hockey stick. The plates were incubated at 37 0C 
for 24 h under anaerobic conditions. Plates showing colony growth were selected. Gram 
staining was performed. Gram- positive rods/ cocci were selected. For an over- view of the 
flow chart, see Figure 4.1. 
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4.2.3 Storage of isolates 
A 50 ml tube was filled with 50% glycerol (20 ml of 2 X MRS Broth and 20 ml of 
glycerol). With the help of a 1 ml micropipette, 1 ml of the glycerol stock culture was 
transferred onto the selected MRS agar plates showing colony growth. The cells were 
scraped neatly by means of a hockey stick and poured into the cryovials. The cryovials were 
stored at -20 0C and -80 0C in the freezer. In total fifty isolates were isolated; twenty isolates 
were of dairy food origin and thirty of bovine rumen origin. Glycerol stock of the microbial 
isolates were now ready for further use. 
 
4.2.4 Oxidase test 
With a tooth pick or inoculation loop a colony was picked up and spread onto the 
oxidase strip. This was observed for a colour change within 2 min. Positive reaction results in 
dark blue or purple colour change. Negative reaction is indicative of no change in colour. All 
isolates when tested showed a negative result (data not shown). This was because 
lactobacilli are oxidase negative in nature. 
Basing on colony morphology and gram stain images, twenty dairy food isolates and 
six bovine rumen isolates were selected for their pH tolerance studies and survival in 
different bile salt concentrations. 
 
4.2.5 pH tolerance of isolates 
For the determination of the pH tolerance, 0.1 ml of glycerol stock culture was 
inoculated into MRS broth medium overnight. 1% fresh overnight culture was then 
inoculated into MRS broth (0.3M phosphate buffered) of four different pH- 2, 3, 4 and 6.4. 
The broths were then incubated under anaerobic conditions at 37 0C for 24 h. After 24 h, the 
cultures were centrifuged and washed twice in 0.1% peptone water and their OD600 was 
determined against a peptone water blank.  
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4.2.6 Bile salt tolerance 
For the determination of bile salts tolerance, 0.1 ml of glycerol stock culture was 
inoculated into MRS broth medium overnight. 1% fresh overnight culture was inoculated 
into MRS broth (0.3M phosphate buffered of pH 6.4) containing bile salt concentrations of 
0.2%, 0.4%, 0.8% and 1.5%. The broths were then incubated under anaerobic conditions at 
37 0C for 24 h. After 24 h, the cultures were centrifuged and washed twice in 0.1% peptone 
water and their OD600 was determined against a peptone water blank. 
 
4.2.7 Extraction of DNA from gram- positive bacteria 
Based on the data obtained from the preliminary screening tests, ten isolates, five 
from dairy food products and five from bovine rumen contents origin; were selected for 
further analysis. They displayed potential probiotic characteristics by exhibiting good 
tolerance to low pH conditions and higher bile salts concentrations. Therefore, identifying 
each isolate by genetic methods was done prior to screening them for further specific 
probiotic abilities testing. The detailed procedure used for extraction of genomic DNA from 
gram- positive bacteria has already been explained in greater detail in section 3.2.10. 
 
4.2.8 Polymerase chain reaction (PCR) 
After the DNA was extracted in the above step, it was amplified using PCR technique. 
Typically PCR consists of the following steps: initialization step- this step consisted of heating 
the reaction to a temperature of 95 0C which was held for 12 min. Denaturation step- this 
step was the first regular cycling event and consisted of heating the reaction to 95 0C for 30 
s. It causes DNA melting of the DNA template by disrupting the hydrogen bonds between 
complementary bases, yielding single- stranded DNA molecules. Annealing step- the reaction 
temperature was lowered to 45 0C for 30 s allowing annealing of the primers to the single- 
stranded DNA template. Elongation step- the temperature at this step depends on the DNA 
polymerase used; Taq polymerase requires a temperature of 72 0C for 2 min. Final 
elongation- this single step was occasionally performed at a temperature of 72 0C for 4 min 
after the last PCR cycle to ensure that any remaining single- stranded DNA was fully 
extended. Final hold- this step at 4 0C for 50 min may be employed for short- term storage of 
the reaction. Three primers were used in this study. They were Aci I and Aci II, Pr I and Pr II, 
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16- 1A and 23- 1B. The details of the primers is shown in Appendix D. Specific reaction cycles 
inside a thermocycler were required for successful DNA amplification to be carried out. The 
three primers used in this study employed three different reaction cycles. The details of each 
PCR reaction cycle has already been explain in greater detail in section 3.2.12. 
 
4.2.9 Supplementary methods for paper reported in section 4.3.7 
4.2.9.1 Carbohydrate fermentation profile 
The test was done according to the method described by (Gupta et al. 1996). The 
isolates were grown in MRS broth (pH 6.4) overnight at 37 0C. Carbohydrate utilization of the 
isolates were determined for fourteen different sugars and glycerol. For a complete list of 
the sugars used, see Table 3.4 in chapter 3. MRS base medium was prepared and 
supplemented with appropriate sugars (1%) and dye (0.05%). The overnight culture was 
centrifuged at 4000 rpm for 15 min at room temperature. The supernatant was discarded 
and the pellet re- suspended in 20 ml of 0.1% peptone water. About 500 µl of bacterial 
inoculum was added to the tubes and mixed well. They were then incubated at 37 0C for 24 
h. The experiment was performed in duplicates. A colour change from purple to yellow 
indicated a positive result and no colour change indicated a negative test, see Figure 4.2. 
Negative controls were prepared by inoculating cultures into the base medium devoid of a 
sugar/ carbohydrate substrate. 
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4.2.9.2 Haemolytic activity 
The isolates were characterized as haemolytic, partial haemolytic or non- haemolytic 
in nature depending on the colour change of the agar underlying the colonies, see Figure 4.3. 
β- haemolysis was indicated by a colour change to lightened yellow/ transparent, α-
haemolysis was indicated by a colour change to dark green and in case of ϒ- haemolysis no 
change was observed. 
 
 
Figure 4.3 Test for haemolytic activity. Negative control no culture (top), Salmonella and 
Listeria positive controls (middle) and Lactobacilli RC 2 (bottom) as a typical example for all 
isolates examined. 
 
4.2.9.3 Antibiotic resistance 
Antibiotic resistance was examined by the disc diffusion method described by 
(Thirabunyanon et al. 2009). The isolates to be tested were grown overnight in fresh MRS 
broth of pH 6.4 at 37 0C. About 100 µl of the suspension was spread onto the surface of the 
MRS agar plates. The antibiotic disks were inserted aseptically onto the agar surface. The 
plates were then incubated under anaerobic conditions for 24 h at 37 0C. The antibiotic 
resistance of the isolates was determined by calculating the diameter of the zones of 
inhibition around the antibiotic disks. Antibiotic resistance was determined for eleven 
antibiotics. For a complete list of the antibiotics used and their concentrations, see Table 3.2 
in chapter 3. The antibiotics were grouped under three categories depending on their 
mechanism of action. It included (i) bacterial cell wall synthesis inhibitors such as ampicillin 
and vancomycin (ii) bacterial nucleic acid synthesis inhibitors such as ciprofloxacin and 
nalidixic acid (iii) bacterial protein synthesis inhibitors such as streptomycin, 
chloramphenicol, gentamicin, erythromycin, tetracycline, fusidic acid and kanamycin. 
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4.2.9.4 Statistical analysis 
The statistical analysis for the BATH test was done using the IBM SPSS statistics 
(version 21, IBM, Armonk, NY, USA). A one way analysis of variance (ANOVA) was used to 
evluate the experimental data. The significant differences were accepted at p<0.05 by 
Duncan’s test. More details can be found in Appendix G. 
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4.3 Results and discussion 
4.3.1 Morphological characteristics 
When grown on MRS agar plates, the bacteria produced round, opaque, milky white/ 
creamy colonies; typical of lactobacilli, see Figure 4.4. 
 
4.3.2 Gram nature of isolates 
All isolates which produced typical lactobacilli colonies on MRS agar surface were 
selected. Their Gram nature was studied by performing the Gram- staining test. The Gram 
staining procedure has been described in section 3.2.4. All isolates which appeared as purple 
coloured rods/ cocci when observed under the microscope were classified as Gram- positive 
bacteria (lactobacilli are Gram- positive in nature) and selected for further screening. The 
Gram stain images of the isolates are shown in Figure 4.5. 
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Figure 4.4 Lactobacilli isolates MI 7, MI 10, RC 13 and RC 25 as typical examples of growth of 
isolates on MRS agar. 
  
RC 25 
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Figure 4.5 Lactobacilli isolates MI 6, MI 10, RC 13 and RC 30 as typical examples of isolate 
Gram staining. 
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4.3.3 pH tolerance of isolates 
The tolerance of the isolates towards four different pH is shown in Figure 4.6. All the 
isolates showed maximum tolerance at pH 6.4 and pH 4. It indicated the optimum pH for 
growth of lactobacilli. With a decrease in pH, the tolerance level of isolates also declined. pH 
2 showed the least absorbance values for all the isolates. 
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Figure 4.6 Growth (optical density) of dairy food (MI) and bovine rumen (RC) isolates at various pH after 24 h. 
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4.3.4 Bile salts tolerance of isolates 
The tolerance of the isolates in different bile salt concentrations is described in Figure 
4.7. All isolates showed maximum tolerance at 0.2%. Poor tolerance was recorded at a bile 
salts concentration of 1.5%. With increase in bile salts concentration, the tolerance level of 
isolates declined. Rumen isolates showed better bile salts tolerance property in comparison 
to dairy isolates. 
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Figure 4.7 Growth (optical density) of dairy food (MI) and bovine rumen (RC) isolates at bile salt concentrations after 24 h. 
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4.3.6 DNA sequencing 
PCR samples were sent for sequencing to Bio- protection department at Lincoln 
University. NCBI BLAST program was used to match the sequence similarity. The sequence 
analysis of MI 6 is shown in Figure 4.11. The sequence analysis of MI 7 is shown in Figure 
4.12. The sequence analysis of MI 10 is shown in Figure 4.13. The sequence analysis of MI 13 
is shown in Figure 4.14. The sequence analysis of MI 17 is shown in Figure 4.15. The 
sequence analysis of RC 2 is shown in Figure 4.16. The sequence analysis of RC 5 is shown in 
Figure 4.17. The sequence analysis of RC 13 is shown in Figure 4.18. The sequence analysis of 
RC 25 is shown in Figure 4.19. The sequence analysis of RC 30 is shown in Figure 4.20. The 
genetic identities of the ten isolates has been listed in Table 4.1. 
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MI 6 
>MI_6-16IA_2013-10-14_C11_0419.seq 
 
Score = 634 bits (343), Expect = 3e-178, Identities = 429/469(91%), Gaps = 
12/469(2%), Strand = Plus/Plus 
 
 
Figure 4.11 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 6 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 715 bp was amplified. 
 
  
Query  13      CGTT-CCGGG-CTTGTACACACCGCCCGTCACACCAT-GGAGTTTGTAACGCCCAAAGTC  69 
               |||| ||||| |||||||||||||||||||||||||| |||||||||||||||||||||| 
Sbjct  205062  CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAAGTC  205121 
 
Query  70      GGTGGACGAAGGCTTTATGGAGGGAGCCGCCTAAGG-GGGACAGATGACTGGGGTGAAGT  128 
               ||||| | ||  |||||||||||||||||||||||| ||||||||||||||||||||||| 
Sbjct  205122  GGTGGCCTAA-CCTTTATGGAGGGAGCCGCCTAAGGCGGGACAGATGACTGGGGTGAAGT  205180 
 
Query  129     CGTAACAAGGTAGCCGTAGAAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAAAA  188 
               ||||||||||||||||||| |||||||||||||||||||||||||||||||||||||||| 
Sbjct  205181  CGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAAAA  205240 
 
Query  189     CGGAACCTACACATCGAAGAAACTTTGTTTAGTTTTGAGGGTTTCCCCCTC-GAGACTTG  247 
               ||||||||||||||||||||||||||||||||||||||||| ||  ||||| ||| |||| 
Sbjct  205241  CGGAACCTACACATCGAAGAAACTTTGTTTAGTTTTGAGGGGTTTACCCTCAGAG-CTTG  205299 
 
Query  248     TACTTTGAAACCTAAATACTATCAAATTTCTT-ATTAAG-AAACAATAAACCGAGAAAAC  305 
               |||||||||| |||||||||||| |||||||| |||||  ||||||||||||||||| || 
Sbjct  205300  TACTTTGAAAACTAAATACTATCTAATTTCTTTATTAACAAAACAATAAACCGAGAACAC  205359 
 
Query  306     CGGGTTATTTGAGTTTTACTTAACCAATTATAATCGCTAACTCAATAAATCAGACCATCT  365 
               || ||||||||||||||| ||||| ||||||||||||||||||||| |||||||| |||| 
Sbjct  205360  CGCGTTATTTGAGTTTTAATTAACGAATTATAATCGCTAACTCAATTAATCAGACAATCT  205419 
 
Query  366     TTGATTGTTCAGTTAAAGTTAGGAAAGGGCGCATGGGGAATCCCTCGCTACTAGGAGCCG  425 
               ||||||||| || | |||||| | |||||||||||| |||| ||| | |||||||||||| 
Sbjct  205420  TTGATTGTTTAGGTTAAGTTATG-AAGGGCGCATGGTGAATGCCTTGGTACTAGGAGCCG  205478 
 
Query  426     TATGAAGGACGGGACTAACACCGAATTGCTCTCGGGGAGCGGGAACTAC  474 
                |||||||||||||||||||||||  |||| ||||||||||| || ||| 
Sbjct  205479  -ATGAAGGACGGGACTAACACCGATATGCT-TCGGGGAGCGGTAAGTAC  205525 
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MI 7 
>6_7P3-161A_2013-09-24_A01_0379.seq  
Score = 270 bits(146), Expect = 1e-68, Identities = 255/308(83%), Gaps = 
6/308(1%), Strand = Plus/Plus 
 
 
Figure 4.12 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 7 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 728 bp was amplified. 
 
 
  
Query  9       TACGTTCCCGGG-GTTGT-CACACCGCCCGTCACACCATGATAGTTTGTAACGCCCAAAG  66 
               ||||||||||||  |||| |||||||||||||||||||||  |||||||||||||||||| 
Sbjct  313613  TACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAAG  313672 
 
Query  67      TCGGTGGCCTAACCTTTATGGAGCTAGCCGCCTAAGGCCAAAGAGATGACTGTTAAGAAG  126 
               |||||||||||||||||||||||  |||||||||||||   | |||||||||    |||| 
Sbjct  313673  TCGGTGGCCTAACCTTTATGGAGGGAGCCGCCTAAGGCGGGACAGATGACTGGGGTGAAG  313732 
 
Query  127     GCGTGCCATGATAACTGGATA-ATTAAAAG-T-CAAA-GGATGACCTGCTTTCTAAGTAA  182 
                |||  || | || | | ||| |  | ||  | |    |||| |||| ||||||||| || 
Sbjct  313733  TCGTAACAAGGTAGCCGTATATAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAA  313792 
 
Query  183     TAAAACGGAACCTACACATCTTAGATACTTTTTATATTTTTGAGGGGTTTACCTTCAGAG  242 
               ||||||||||||||||||||  ||| ||||| | || |||||||||||||||| |||||| 
Sbjct  313793  TAAAACGGAACCTACACATCGAAGAAACTTTGTTTAGTTTTGAGGGGTTTACCCTCAGAG  313852 
 
Query  243     CTTGTACTTTGAAAAATACATACTTTCTACTTTCTTTAGTTACAAAATAATAAATCGAGA  302 
               ||||||||||||||| || ||||| |||| |||||||| | |||||| |||||| ||||| 
Sbjct  313853  CTTGTACTTTGAAAACTAAATACTATCTAATTTCTTTATTAACAAAACAATAAACCGAGA  313912 
 
Query  303     ACACAGCG  310 
               |||| ||| 
Sbjct  313913  ACACCGCG  313920 
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MI 10 
>7_10P3-161A_2013-09-24_B01_0379.seq  
Score = 883 bits(478), Expect = 0.0, Identities = 484/487(99%), Gaps = 
0/487(0%), Strand = Plus/Plus 
 
 
Figure 4.13 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 10 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 998 bp was amplified. 
 
  
Query  26   TTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAAGTCGGTGGCCTAACC  85 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  53   TTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAAGTCGGTGGCCTAACC  112 
 
Query  86   TTTATGGAGGGAGCCGCCTAAGGCGGGACAGATGACTGGGGTGAAGTCGTAACAAGGTAG  145 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  113  TTTATGGAGGGAGCCGCCTAAGGCGGGACAGATGACTGGGGTGAAGTCGTAACAAGGTAG  172 
 
Query  146  CCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAAAACGGAACCTACACA  205 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  173  CCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAAAACGGAACCTACACA  232 
 
Query  206  TCGAAGAAACTTTGTTTAGTTTTGAGAGGTTTACCTTCAGAGCTTGTACTTTGAAAACTA  265 
            |||||||||||||||||||||||||| |||||||| |||||||||||||||||||||||| 
Sbjct  233  TCGAAGAAACTTTGTTTAGTTTTGAGGGGTTTACCCTCAGAGCTTGTACTTTGAAAACTA  292 
 
Query  266  AATACTATCTAATTTCTTTATTAACAAAACAATAAACCGAGAACACCGCGTTATTTGAGT  325 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  293  AATACTATCTAATTTCTTTATTAACAAAACAATAAACCGAGAACACCGCGTTATTTGAGT  352 
 
Query  326  TTTAATTAACGAATTATAATCGCTAACTCAATTAATCAGACAATCTTTGATTGTTTAGGT  385 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  353  TTTAATTAACGAATTATAATCGCTAACTCAATTAATCAGACAATCTTTGATTGTTTAGGT  412 
 
Query  386  TAAGTTATGAAGGGCGCATGGTGAATGCCTTGGTACTAGGAGCCGATGAAGGACGGGACT  445 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  413  TAAGTTATGAAGGGCGCATGGTGAATGCCTTGGTACTAGGAGCCGATGAAGGACGGGACT  472 
 
Query  446  AACACCGATATGCTTCGGGGAGCGGTAAGTACGCTTTGTTCCGGAGATTTCCGAATGGGG  505 
            |||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| 
Sbjct  473  AACACCGATATGCTTCGGGGAGCGGTAAGTACGCTTTGATCCGGAGATTTCCGAATGGGG  532 
 
Query  506  GAACCCA  512 
            ||||||| 
Sbjct  533  GAACCCA  539 
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MI 13 
>8_13P3-161A_2013-09-24_C01_0379.seq 
Score = 950 bits(514), Expect = 0.0, Identities = 517/518(99%), Gaps = 
1/518(0%), Strand = Plus/Plus 
 
 
Figure 4.14 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 13 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 1049 bp was amplified. 
 
  
Query  13      CGTT-CCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCGAAGCC  71 
               |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298562  CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCGAAGCC  298621 
 
Query  72      GGTGGCGTAACCCTTTTAGGGAGCGAGCCGTCTAAGGTGGGACAAATGATTAGGGTGAAG  131 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298622  GGTGGCGTAACCCTTTTAGGGAGCGAGCCGTCTAAGGTGGGACAAATGATTAGGGTGAAG  298681 
 
Query  132     TCGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAAACAG  191 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298682  TCGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAAACAG  298741 
 
Query  192     ACTGAAAGTCTGACGGAAACCTGCACACACGAAACTTTGTTTAGTTTTGAGGGGATTACC  251 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298742  ACTGAAAGTCTGACGGAAACCTGCACACACGAAACTTTGTTTAGTTTTGAGGGGATTACC  298801 
 
Query  252     CTCAAGCACCCTAGCGGGTGCGACTTTGTTCTTTGAAAACTGGATATCATTGTTGTAAAT  311 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298802  CTCAAGCACCCTAGCGGGTGCGACTTTGTTCTTTGAAAACTGGATATCATTGTTGTAAAT  298861 
 
Query  312     GTTTTAAATTGCCGAGAACACAGCGTATTTGTATGAGTTTCTAATAATAGAAATTCGCAT  371 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298862  GTTTTAAATTGCCGAGAACACAGCGTATTTGTATGAGTTTCTAATAATAGAAATTCGCAT  298921 
 
Query  372     CGCATAACCGCTGACGCAAGTCAGTACAGGTTAAGTTACAAAGGGCGCACGGTGGATGCC  431 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298922  CGCATAACCGCTGACGCAAGTCAGTACAGGTTAAGTTACAAAGGGCGCACGGTGGATGCC  298981 
 
Query  432     TTGGCACTAGGAGCCGATGAAGGACGGAACTAATACCGATATGCTTCGGGGAGCTATAAG  491 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  298982  TTGGCACTAGGAGCCGATGAAGGACGGAACTAATACCGATATGCTTCGGGGAGCTATAAG  299041 
 
Query  492     TAAGCTTTGATCCGGAGATTTCCGAATGGGGGAACCCA  529 
               |||||||||||||||||||||||||||||||||||||| 
Sbjct  299042  TAAGCTTTGATCCGGAGATTTCCGAATGGGGGAACCCA  299079 
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MI 17 
>9_17P3-161A_2013-09-24_D01_0379.seq 
Score = 475 bits(257), Expect = 2e-130, Identities = 427/508(84%), Gaps = 
15/508(2%), Strand = Plus/Plus 
 
 
Figure 4.15 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate MI 17 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 729 bp was amplified. 
 
  
Query  12   ATA-GTTCCCGGG-CTTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAA  69 
            ||| ||||||||| |||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  38   ATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTAACGCCCAAA  97 
 
Query  70   GTCGGTGGCCTAACCTTTATGGAGGGAGCCGCCTAA---GGGACAGATGACTGGGGGGAA  126 
            ||||||||||||||||||||||||||||||||||||   ||||||||||||||||| ||| 
Sbjct  98   GTCGGTGGCCTAACCTTTATGGAGGGAGCCGCCTAAGGCGGGACAGATGACTGGGGTGAA  157 
 
Query  127  GGCGTAACCAGGTAGCCGGAGGA-AACCTGGGGGTGGATCACCTCCTTTCTTAGGGATTA  185 
            | |||||| ||||||||| |||| |||||| || ||||||||||||||||| ||| || | 
Sbjct  158  GTCGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAA  217 
 
Query  186  AAAGGAACCTACCCCTCGGAGGAACTTTGGTTAGTTTTGAGGGGTTTACCCTTAGAAGTT  245 
            || ||||||||| | ||| || ||||||| |||||||||||||||||||||| |||  || 
Sbjct  218  AACGGAACCTACACATCGAAGAAACTTTGTTTAGTTTTGAGGGGTTTACCCTCAGAGCTT  277 
 
Query  246  TTTCATTGAAAACTAAATTCTTTCTTAtttttttttttACGAAACAATTAACCGGGGACC  305 
             | | ||||||||||||| || ||| |||| ||| || || ||||||| ||||| | ||  
Sbjct  278  GTACTTTGAAAACTAAATACTATCTAATTTCTTTATTAACAAAACAATAAACCGAGAACA  337 
 
Query  306  CCGGGTTTATTGGGTTTTAATTTACCAATTATTATTCCTAACTCAATTTATCAGACAATC  365 
            ||| |||  ||| ||||||||| || |||||| ||  ||||||||||| ||||||||||| 
Sbjct  338  CCGCGTTATTTGAGTTTTAATTAACGAATTATAATCGCTAACTCAATTAATCAGACAATC  397 
 
Query  366  TTTGGATGGTTT-GGTTAAGGTATGGAGGGCCCATGGGGAATACCTTTGTACTTGGAGCC  424 
            |||| || |||| ||||||| |||| ||||| ||||| |||| |||| ||||| |||||| 
Sbjct  398  TTTG-ATTGTTTAGGTTAAGTTATGAAGGGCGCATGGTGAATGCCTTGGTACTAGGAGCC  456 
 
Query  425  GGTTAAAGGA-GGGACTTAAAACGAATTTGCCTTggggggggggTTACGTAACCTTTGGA  483 
            | | || ||| |||||| | | ||| | || ||| |||| | ||| | |||  ||||| | 
Sbjct  457  GATGAA-GGACGGGACTAACACCGA-TATG-CTTCGGGGAGCGGTAA-GTACGCTTTG-A  511 
 
Query  484  TCCCAAAAAATTCCGAATGGGGGAACCC  511 
            |||  | |  |||||||||||||||||| 
Sbjct  512  TCCGGAGAT-TTCCGAATGGGGGAACCC  538 
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RC 2 
>RC_2-16IA_2013-10-14_E11_0419.seq  
Score = 850 bits(460), Expect = 0.0, Identities = 479/488(98%), Gaps = 
1/488(0%), Strand = Plus/Minus 
 
Query  17       CCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTCGGTGG  76 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884796  CCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTCGGTGG  
1884737 
 
Query  77       GGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTCGTAAC  136 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884736  GGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTCGTAAC  
1884677 
 
Query  137      AAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTACGGAAA  196 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884676  AAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTACGGAAA  
1884617 
 
Query  197      CCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTTGTTCT  256 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884616  CCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTTGTTCT  
1884557 
 
Query  257      TTGTAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGCGtttt  316 
                ||| |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884556  TTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGCGTTTT  
1884497 
 
Query  317      ttgagttttttATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGTTAGGT  376 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884496  TTGAGTTTTTTATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGTTAGGT  
1884437 
 
Query  377      AAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCGGATGAAG  436 
                |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct  1884436  AAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCCGATGAAG  
1884377 
 
Query  437      AACGGGACTAACACCAATATGCTTGGGGGAGCTGTACGTAAGCTATGATCAAAAGATTTC  496 
                 |||||||||||||| |||||||| |||||||||||||||||||||||||   ||||||| 
Sbjct  1884376  GACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGGAGATTTC  
1884317 
 
Query  497      -GAATGGG  503 
                 ||||||| 
Sbjct  1884316  CGAATGGG  1884309 
 
Figure 4.16 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 2 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 726 bp was amplified. 
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RC 5 
>RC_5-16IA_2013-10-14_F11_0419.seq  
 
Score = 881 bits(477), Expect = 0.0, Identities = 492/499(99%), Gaps = 
2/499(0%), Strand = Plus/Minus 
 
Query  12       CGTT-CCGGG-CTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  69 
                |||| ||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884801  CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  
1884742 
 
Query  70       GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  129 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884741  GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  
1884682 
 
Query  130      GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  189 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884681  GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  
1884622 
 
Query  190      GGAAACCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  249 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884621  GGAAACCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  
1884562 
 
Query  250      GTTCTTTGTAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  309 
                |||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884561  GTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  
1884502 
 
Query  310      GttttttgagttttttATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  369 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884501  GTTTTTTGAGTTTTTTATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  
1884442 
 
Query  370      TAGGTAAATGAGGTTAAGTTAACAAGGGCACATGGTGAATGCCTTGGCACTAGGAGCGGA  429 
                ||||||||||||||||||||||||||||| ||||||||||||||||||||||||||| || 
Sbjct  1884441  TAGGTAAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCCGA  
1884382 
 
Query  430      TGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGAAG  489 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct  1884381  TGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGGAG  
1884322 
 
Query  490      ATTTCCGAATGGGGAAACC  508 
                |||||||||||||| |||| 
Sbjct  1884321  ATTTCCGAATGGGGCAACC  1884303 
 
Figure 4.17 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 5 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 731 bp was amplified. 
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RC 13 
>RC_13-16IA_2013-10-14_G11_0419.seq 
    
Score = 885 bits(479), Expect = 0.0, Identities = 492/498(99%), Gaps = 
2/498(0%), Strand = Plus/Minus 
 
 
Query  10       CGTT-CCGGG-CTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  67 
                |||| ||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988882  CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  
1988823 
 
Query  68       GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  127 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988822  GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  
1988763 
 
Query  128      GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  187 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988762  GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  
1988703 
 
Query  188      GGAAACCTACACATTCTTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  247 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988702  GGAAACCTACACATTCTTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  
1988643 
 
Query  248      GTTCTTTGATAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  307 
                ||||||||| |||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988642  GTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  
1988583 
 
Query  308      GttttttgagttttttATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  367 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988582  GTTTTTTGAGTTTTTTATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  
1988523 
 
Query  368      TAGGTAAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCCGA  427 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988522  TAGGTAAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCCGA  
1988463 
 
Query  428      TGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGAAA  487 
                ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |  
Sbjct  1988462  TGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGGAG  
1988403 
 
Query  488      ATTTCCGAATGGGGAAAC  505 
                |||||||||||||| ||| 
Sbjct  1988402  ATTTCCGAATGGGGCAAC  1988385 
 
Figure 4.18 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 13 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 731 bp was amplified. 
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RC 25 
>RC_25-16IA_2013-10-14_H11_0419.seq   
 
Score = 880 bits(476), Expect = 0.0, Identities = 494/502(98%), Gaps = 
4/502(0%), Strand = Plus/Minus 
 
Query  10       CGTT-CCGGG-CTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  67 
                |||| ||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884801  CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTC  
1884742 
 
Query  68       GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  127 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884741  GGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAAGTC  
1884682 
 
Query  128      GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  187 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884681  GTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATATTAC  
1884622 
 
Query  188      GGAAACCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  247 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884621  GGAAACCTACACACGCGTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAACTT  
1884562 
 
Query  248      GTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  307 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884561  GTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACACCGC  
1884502 
 
Query  308      GttttttgagttttttATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  367 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1884501  GTTTTTTGAGTTTTTTATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTACCGT  
1884442 
 
Query  368      TAGGTAAATGAGGGTTAAGTTAACAAGG-CGCATGGTGAATGCCTTGGCACTAGGAGCGG  426 
                ||||||||||||| |||||||||||||| ||||||||||||||||||||||||||||| | 
Sbjct  1884441  TAGGTAAATGAGG-TTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGCCG  
1884383 
 
Query  427      ATGAAGGACGCGACTAACACCAATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGGA  486 
                |||||||||| |||||||||| |||||||||||||||||||||||||||||||||||||| 
Sbjct  1884382  ATGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCGGA  
1884323 
 
Query  487      GATTTCCGAATGGGGAAACCCA  508 
                ||||||||||||||| |||||| 
Sbjct  1884322  GATTTCCGAATGGGGCAACCCA  1884301 
 
Figure 4.19 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 25 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 864 bp was amplified. 
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RC 30 
>RC_30-16IA_2013-10-14_A12_0419.seq   
Score = 902 bits(488), Expect = 0.0, Identities = 499/504(99%), Gaps = 
2/504(0%), Strand = Plus/Minus 
 
Query  9        ATA-GTT-CCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAA  66 
                ||| ||| |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988885  ATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAA  
1988826 
 
Query  67       GTCGGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAA  126 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988825  GTCGGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGGGACAGATGATTAGGGTGAA  
1988766 
 
Query  127      GTCGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAT  186 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988765  GTCGTAACAAGGTAGCCGTAGGAGAACCTGCGGCTGGATCACCTCCTTTCTAAGGAATAT  
1988706 
 
Query  187      TACGGAAACCTACACATTCTTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAA  246 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988705  TACGGAAACCTACACATTCTTCGAAACTTTGTTTAGTTTTGAGAGATTTAACTCTCAAAA  
1988646 
 
Query  247      CTTGTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACAC  306 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988645  CTTGTTCTTTGAAAACTAGATAATATCAAATATATTTTTTCATAATGAAACCGAGAACAC  
1988586 
 
Query  307      CGCGttttttgagttttttATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTAC  366 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988585  CGCGTTTTTTGAGTTTTTTATTGAAGTTTAATTATCGCTAAACTCATTAATCGCATTTAC  
1988526 
 
Query  367      CGTTAGGTAAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGC  426 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988525  CGTTAGGTAAATGAGGTTAAGTTAACAAGGGCGCATGGTGAATGCCTTGGCACTAGGAGC  
1988466 
 
Query  427      CGATGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCG  486 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1988465  CGATGAAGGACGGGACTAACACCGATATGCTTCGGGGAGCTGTACGTAAGCTATGATCCG  
1988406 
 
Query  487      AAGATTACCGAATGGGGAAACCCA  510 
                 ||||| |||||||||| |||||| 
Sbjct  1988405  GAGATTTCCGAATGGGGCAACCCA  1988382 
Figure 4.20 Sequence obtained by amplification of the 16S- 23S rRNA gene (intergenic spacer 
region) of Lactobacillus isolate RC 30 using primers 16-1A (F) and 23-1B (R). A PCR product of 
approximately 793 bp was amplified. 
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Table 4.1 Genetic identity of each isolate as established by NCBI BLAST. 
Isolate Source Genetic identification 
MI 6 Dairy food Lactobacillus reuteri TD1, complete genome 
 
 
MI 7 Dairy food Lactobacillus reuteri JCM 1112 DNA, complete genome 
 
MI 10 Dairy food Lactobacillus reuteri strain C16 
 
MI 13 Dairy food Lactobacillus rhamnosus LOCK908, complete genome 
 
MI 17 Dairy food Lactobacillus rhamnosus LOCK908, complete genome 
 
RC 2 Bovine rumen Lactobacillus plantarum 16, complete genome 
 
RC 5 Bovine rumen Lactobacillus plantarum 16, complete genome 
 
RC 13 Bovine rumen Lactobacillus plantarum subsp. plantarum ST-III, complete genome 
 
RC 25 Bovine rumen Lactobacillus plantarum 16, complete genome 
 
RC 30 Bovine rumen Lactobacillus plantarum subsp. plantarum ST-III, complete genome 
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4.3.7 Comparison of microbiological and probiotic characteristics of probiotic 
lactobacilli isolates from dairy food products and animal rumen contents 
The above (Table 4.1) listed ten lactobacilli isolates were screened for potential 
probiotic abilities. This study was undertaken to characterise and draw a comparison of 
potential probiotic characteristics of dairy versus rumen isolates. The FAO/ WHO screening 
guidelines 2006 were adopted for screening the lactobacilli isolates with potential probiotic 
features. This criteria included testing for haemolytic activity, antibiotic resistance, anti- 
microbial activity, survival at low pH of 2 and 3, survival in presence of 0.3% and 2% bile salts 
and determination of adherence properties in vitro.  
Basing on in vitro studies and cellular models, the probiotic bacteria are routinely 
screened for certain parameters. After obtaining the preliminary screening data, ten 
lactobacilli isolates, five each from dairy and rumen sources were screened next for potential 
probiotic abilities. The screening tests employed are detailed as follows. Most common 
method is to check the ability of isolates to survive in the presence of low pH and presence 
of bile salts (Pfeiler & Klaenhammer, 2009). Lactobacilli and bifidobacteria have a known 
history of safe use. Therefore characterization of these two groups of bacteria based on 
antimicrobial and antibiotic resistance is often ignored in routine screening. This can pose a 
threat considering the vast demand for probiotic foods and development of multi- drug 
resistant bacteria (D’Aimmo et al. 2007). Thus, pathogen inhibition, antibiotic resistance and 
haemolytic activity testing were few characteristics that were also closely observed in this 
research study. Competing with other gut bacteria for binding/ adhesion sites explains how 
the probiotic bacteria is able to adhere to the gut lining to exert beneficial effects in host. 
This feature is one of the key characteristics which distinguishes a probiotic bacteria (Ryan et 
al. 2008; Todorov et al. 2008). Hence, determination of the adherence abilities of the 
isolates were carried out by the bacterial adherence to hydrocarbons (BATH) method. 
This section has been accepted for publication (Jose et al. 2015a) and is reproduced 
on the following pages as orignially published. 
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4.4 Conclusions 
Initially twenty dairy food isolates and thirty bovine rumen isolates were collected. 
Phenotype characterisation (gram staining and colony morphology) of these isolates 
identified twenty- six isolates for further evaluation. All dairy food isolates were found to be 
Gram-  positive and colony morphologies indicating they were likley to be lactic acid 
bacteria. Only six of the thirty bovine rumen isolates meet these criteria, this is not surpising 
considering the vast range of microbial species present in the bovine rumen. 
The twenty- six isolates (twenty from dairy food and six from the bovine rumen) were 
investigated for their survival at low pH and in the presence of bile salts. These conditions 
were selected as they are major challenges probiotic bacteria encounter during gastro- 
intestinal tract transit following injestion by farmed livestock or humans. Ten isolates (five 
each from dairy food and the bovine rumen) were identified as having good adhesion and 
survival at low pH and in the presence of bile salts. The high proportion of bovine rumen 
isolates (five of six) found to have good potential probiotic characteristics reflects perhaps 
their being isolated from an environment where such characteristics would be condusive to 
survival. 
Species identification of the ten isolates confirmed all were Lactobacillus sps. 
Extensive testing to further characterise the probiotic potential of the ten isolates included; 
inhibition of pathogens, resistance to antibiotics, biosafety (absence of haemolytic activity), 
adhesion (BATH test), carbohydrate fermentation, survival at low pH, and high bile salt 
concentration. This testing identified two isolates (isolate MI 13 from dairy food and isolate 
RC 2 from the bovine rumen) for further evaluation. 
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Chapter 5 
Characterization of selected probiotic isolates for specific properties 
5.1 Introduction 
This chapter focusses on the characterization of two selected lactobacilli isolates, one 
each from dairy food and bovine rumen source. MI 13 (L. rhamnosus LOCK 908) was the 
dairy food isolate and RC 2 (L. plantarum 16) was the rumen isolate selected for further 
characterization of specific properties. This selection was based on the selective screening of 
isolates done in section 4.3.7. Seven different aspects of these two isolates were studied 
intensively in this chapter, which included adhesion onto Caco- 2 cells, monolayer integrity 
studies, 1 D SDS PAGE proteomic profiles, production of volatile compounds, alterations in 
fatty acid profiles, characterization of antimicrobial compounds produced and effects of 
glyphosate. In the last study, which includes effects of glyphosate, dairy isolate was not used 
as they had no prior exposure to this herbicide. Only the rumen isolates were included were 
a part of this study. 
It is believed that the probiotic bacteria should adhere to the intestinal epithelial 
lining to exert beneficial effects in the host. Any bacteria that is not adhered to the intestinal 
epithelial lining physically would be washed away along with the flow rate of the digesta 
through the small intestine. Therefore, the physical adsorption of probiotic bacteria to 
gastric epithelial cells determines it’s colonization in the gut (Robins- Browne & Levine, 1981; 
Savage, 1978). The adhesion mechanism is influenced by several physical and bio- chemical 
factors. Hydrophobic nature, electrostatic and interactions, steric and passive forces and 
presence of cell surface components are few of these factors (Servin & Coconnier, 2003). 
Beneficial properties resulting due to adhesion include initiating an immune response 
(Kimura et al. 1997) and competing with pathogens for binding sites and nutrients in the 
host (Hirano et al. 2003). Understanding the mechanisms responsible for probiotic bacterial 
adhesion in vivo is quite challenging. This has led to the development of Caco- 2 cell line, one 
of the human adenocarcinoma cell lines used extensively in the study of bacterial adherence 
in vitro (Duary et al. 2011). Caco- 2 cells resemble physiologically and functionally the 
enterocytes lining the intestine. They are excellent models which help in understanding how 
the probiotic bacteria interacts with the intestinal epithelial lining (Wang et al. 2008; 
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Moussavi & Adams, 2010). They also help in investigating how the probiotic bacteria 
competes with human commensals for attachment sites in the gut. Another remarkable 
feature of Caco- 2 cells is that they are useful in studying the bacteria which target only 
humans; as animal model studies lack efficacy in such cases (Chauviere et al. 1992). 
Proteomics involves the study of proteomes, which represents a moving target. 
Proteomic studies investigate the functional molecules and not the source code, unlike 
genomics. Previously, in probiotics field, many studies revolved around studying their 
adaptation to environmental growth parameters, their metabolism and genomics. However, 
more recently, understanding the probiotic properties and mechanisms underlying the 
probiotic characteristics became more prominent. Proteomics techniques were widely used 
for this purpose. Genomics includes bacterial characterization and identification by DNA 
sequencing in vitro. Proteomic approaches comprises of the in silico analysis of predicted 
protein sequences (van de Guchte et al. 2012). Proteins are produced in abundance by an 
organism and they are highly diverse in their properties. The protein expression profile of an 
organism under standard growth conditions and stressful environmental conditions varies 
widely. It is not possible to study and analyse the entire proteome in one single step. 
Therefore, entire proteome is characterized into different protein subsets comprising of 
intracellular proteins, membrane proteins or extracellular proteins (Garrigues et al. 2005). In 
the field of probiotics, proteomic tools have been used primarily for focussing on bacterial 
stress response encountered during food production and processing conditions. Variations in 
temperature, presence of bile salts, acidic environment, oxidative stress, presence of NaCl, 
nutrient limitation are examples of stress conditions which are commonly used. The stress 
response of an organism is highly complex and unique to that particular organism. It is 
influenced by the environmental conditions and experimental setup. A proper 
understanding of the stress response followed by identification of the stress response 
proteins, makes it easier to design methods to grow the bacteria. 
The stress response can affect the synthesis of several proteins, which are called as 
stress proteins. There are three different groups of stress proteins. (i) general stress 
proteins- they are the most commonly expressed proteins under nearly all different kinds of 
stresses and probably noticed in all bacteria. They are induced non- specifically and are 
involved in DNA or protein repair. Examples include DnaK, GroEL, GroES or proteases like Clp 
proteases. (ii) specific stress proteins- they are proteins which are expressed under specific/ 
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particular stress condition. (iii) proteins of general metabolism, that can be affected by some 
specific stresses (Champomier-Vergès et al. 2002). The procedure for protein analysis by gel 
electrophoresis method has already been described in section 3.5.  
Microorganisms produce VFA compounds as a result of anaerobic fermentation of 
complex carbohydrates. The nature of the substrate plays a key role in determining the type 
of VFA commpounds produced. Ruminants are known to depend on VFA compounds to 
meet majority of their maintenance energy requirements. Acetic acid, propionic acid and 
butyric acid are known for their role in stimulation of sodium and fluid absorption in colon 
(Tagang et al. 2010). With regard to role of VFA compounds in probiotics, the ability to 
impart flavours to food products is of interest. However, very little is known about it’s 
production mechanism in LAB (Nakae & Elliott, 1965). The fatty acid profiles of bacteria are 
species specific. However, conditions of stress/ environmental factors can induce a change in 
the fatty acid profiles. In this case, low pH and increased bile salts concentration have been 
used to create stress conditions for growth of lactobacilli. There is limited literature 
reporting whether the stress induced changes are essential for survival and also whether the 
ability to alter the fatty acids composition is predetermined nature (Suutari et al. 1990). 
Depending on the degree of saturation/ unsaturation in the carbon chain fatty acids can be 
divided into three classes: saturated fatty acids (SFA), monounsaturated fatty acids (MUFA) 
and polyunsaturated fatty acids (PUFA). SFA do not have a double bond. MUFA contain only 
one double bond and PUFA contain two or more double bonds. 
With an increase in antibiotic resistance amongst bacteria, interest in the use of 
probiotics and their antimicrobial compounds as an alternative to treat and prevent 
infections are on the rise (Shokryazdan et al. 2014). The common antimicrobial compounds 
produced by lactobacilli species includes organic acids, hydrogen peroxide or bacteriocins. 
Only few bacteria are capable of bacteriocin production (Moraes et al. 2010). The most 
common mechanism of inhibition of pathogens by lactobacilli includes the production of 
organic acids, which lowers the pH in the environment thereby inhibiting growth of the 
pathogen. Hence exhibition of antimicrobial activity against pathogens is a selective property 
of potential probiotic candidates. 
Roundup® is a commercial herbicide that is manufactured by Monsanto. It is applied 
in agricultural fields to control the growth of weeds. Glyphosate (N- phosphonomethyl 
glycine) is the active ingredient present in Roundup®, a broad spectrum herbicide which 
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interferes with the synthesis of aromatic amino acids in plants and microorganisms by 
inhibiting the activity of enzyme, 5- enolpyruvyl shikimate 3- phosphate synthase (EPSPS) 
(Cerdeira & Duke, 2006). It is claimed that Roundup® influences soil and gut microbial 
diversity, however very little research has been presented to support this. In the present 
work, the effects of Roundup® and glyphosate along with a widely reported organic spray 
was studied on five lactobacilli isolates of rumen origin. 
 
5.2 Methods 
5.2.1 1 D SDS PAGE profiles of whole cell proteins and cytosolic proteins 
5.2.1.1 Bacterial culturing conditions to study low pH and and bile salts stressed cells  
Glycerol stock cultures of RC 2 and MI 13 were inoculated into MRS broth media of 
pH 6.4 (phosphate buffered). It was mixed well and incubated at 37 0C overnight. The 
following day, the overnight culture OD was measured. This can be done using a 
spectrophotometer. The absorbance was set at 600 nm. Now the overnight culture was 
inoculated into MRS broth containing two conditions of stress: pH 3.5 and 3.5% bile salts at 
an initial OD of 0.3. The inoculated broths were incubated at 37 0C for 16 h. Overnight 
culture was also added to standard MRS broth at an initial OD of 0.15. The cells were 
harvested after OD reached 1.5- 2.0. approximately 8- 10 h or until pH stays above 5. 
Because further incubation can lead to a drop in the pH, which can induce a stress level.  
 
5.2.1.2 Visualization of protein bands 
In order to visualize the protein bands, the gel after electrophoresis step was placed 
in a staining ray containing Coomassie brilliant blue stain overnight. After staining, the gel 
was washed a couple of times with RO water and then placed in a tray containing destaining 
solution. The destaining solution was replaced every two to three hours until the protein 
bands could be clearly visualized with the naked eye.  
5.2.2 Identification of VFA compounds 
5.2.2.1 Bacterial culturing conditions for volatile fatty acid (VFA) analysis in bacterial broth 
of low pH and bile salts stressed cells by HS- SPME GC- MS 
The analysis of VFA compounds in bacterial broth was determined using an 
automated Headspace Solid-Phase Micro-Extraction (HS- SPME) based on the method 
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published by (Tomasino et al. 2015). The bacterial cultures were grown under similar 
conditions as previously described in section 5.2.1. After 16 h incubation time, the bacterial 
cultures were centrifuged at 10, 000 rpm for 10 min at room temperature. The CFS was 
transferred into smaller 1.5 ml eppendorf tubes and stored at -20 0C in the freezer until gas 
chromatography- mass spectrophotometry (GC- MS) was carried out for detecting the VFA 
compounds. 
 
5.2.2.2 Sample preparation for VFA analysis 
Sample preparation involved pipetting 0.45 ml of broth sample, 0.45 ml of deionised 
water and 8.06 ml of 5 g L-1 tartaric acid buffer (pH 3.5) into 20 mL SPME sample vials (a 20 
fold dilution of the broth), followed by 40 µl of the internal standard solution (4 internal 
standard mix see Appendix J). 4.5 g of crystalline sodium chloride was then added to the 
SPME vial just prior to capping. Samples were incubated initially for 10 min at 50 0C during 
which time the vial was agitated at 500 rpm. After 10 min the SPME fiber (2 cm long 
Stableflex DVB/CAR/PDMS, p/n 57348-U, Sigma- Aldrich Australia) was exposed to the 
headspace of the vial for a period of 30 min at 50 0C. During this exposure period the 
headspace volatiles were adsorbed onto the fiber. Desorption of these volatiles occurred 
when the fiber was inserted into the GC injection port for 5 min at 250 0C. Prior to use the 
SPME fiber was conditioned at 270 0C in the injection port for 1 h. Before each sample was 
run the SPME fiber was conditioned for 10 min at 270 0C in a fiber conditioning station 
attached to the Combi- Pal auto sampler used with the Shimadzu GC- MS instrument. Helium 
was used in the fiber conditioning station to create an oxygen free atmosphere. 
 
5.2.2.3 GC- MS analysis conditions 
GC- MS analysis was carried out on a Shimadzu GC- MS- QP2010 gas chromatograph– 
mass spectrometer equipped with a Combi- Pal autosampler ready for automated SPME. GC- 
MS solution version 2.72 was used as the data acquisition software. The chromatography 
was performed using two GC columns in series namely a Rtx- Wax 30.0 m x 0.25 mm ID x 0.5 
μm film thickness (Polyethylene Glycol- Restek, Bellefonte, PA, USA) and a Rxi- 1MS 15 m x 
0.25 mm ID x 0.5 μm (100% dimethyl polysiloxane- Restek, Bellefonte, PA, USA). Helium was 
used as the carrier gas with the GCMS set to a constant linear velocity of 46.8 cm sec- 1. The 
injector was operated in splitless mode for 3 min then switched to a 20:1 split ratio. The 
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column oven was held at 50 0C for 3 min (during desorption of the SPME fiber), then heated 
to 240 0C at   10 0C min- 1 then further increased to 250 0C at 30 0C min- 1 and held at this 
temperature for 5 min. Total run time was 27.33 min. The interface and MS source 
temperatures were set at  250 0C and 200 0C respectively. The MS was operated in electron 
impact (EI) mode at an ionization energy of 70 eV. All analytes were analysed in full scan 
mode. Selected ions were used for the quantification of these analytes, see Appendix J. 
5.2.3 Identification of FA methyl esters 
5.2.3.1 Bacterial culturing conditions for fatty acid (FA) analysis of low pH and bile salts 
stressed cells using GLC 
The bacterial cultures were grown under similar conditions as previously described in 
section 5.2.1. After 16 h incubation time, the bacterial cultures were centrifuged at 10, 000 
rpm for 10 min at room temperature. The pellet was washed in 0.1% in peptone water and 
again centrifuged at 10, 000 rpm for 10 min. This step was repeated three times and the final 
pellet was transferred into 0.5 ml eppendorf tubes and stored at -20 0C until sample 
preparation for GLC analysis. 
 
5.2.3.2 Sample preparation for FA analysis 
Bacterial cells, 50- 70 mg, were added to a 1.7 ml eppendorf tube followed by the 
addition of 0.1 ml of C13:0 Tridecanoic acid 167 µgmL-1 (Internal standard). These cells were 
then transferred to a glass tube (13 mm x 100 mm) with the aid of 1 ml of 3.75 N sodium 
hydroxide added to the eppendorf tube. 
The reaction conditions for both saponification and methylation reactions used were 
described by (Whittaker et al. 2005). However the isolation of the fatty acid methyl esters 
(FAMES) used differed from that described by these authors. In detail 3 mL of hexane was 
added before vortexing the tubes (5 min) with the lower phase then removed and 3 ml of 
0.3 N sodium hydroxide added. Further vortexing of the tubes (5 min) was carried out before 
0.5 ml of saturated sodium chloride was added (Sherlock MIS operating manual). To enhance 
separation of the organic and aqueous layers the tubes were centrifuged at 1384 g for 5 min 
at room temperature. After this approximately 2.9 ml of the organic layer was transferred to 
clean glass tube (13 mm x 100 mm) and evaporated to dryness with oxygen free nitrogen. 
The residue was then reconstituted in 50 µl of hexane, vortexed mixed, and transferred to a 
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vial insert where it was further diluted with an additional 50 µl hexane used to rinse out the 
glass tube (Moss et al. 1974).  
The internal standard was prepared by diluting 0.1001 g of Tridecanoic acid in 20 ml 
of methanol (HPLC grade) to make a primary standard. An aliquot of 0.334 ml of the primary 
standard was then added to a 10 ml volumetric flask and made up to the mark with 
methanol to make a final concentration of 167 µg ml-1. 
 
5.2.3.3 GLC analaysis conditions 
A fatty acid methyl ester profile was then obtained using capillary GC column CP7420 
100 m x 0.25 mm i.d. x 0.25 µm film thickness (Varian Column from Agilent Technologies s/n 
6005241). This column was installed in a Shimadzu GC2010 gas chromatograph equipped 
with a flame ionisation detector (FID). The GC conditions were as follows; the injector was 
operated in split mode at a ratio of 15:1 with helium used as the carrier gas at a constant 
linear velocity of 16.7 cm sec- 1, a sample volume of 1 µl was injected, the GC oven ramp 
(modified from that published by (Rugoho et al. 2014) was initially held at 45 0C for 4 min 
and then ramped to     175 0C at 13 0C min- 1 held for 27 min and then further ramped to 215 
0C at 4 0C min- 1 and held for 35 min before a final ramp to 245 0C at 25 0C min- 1 which was 
held for 10 min. The total run time was 97.2 min with both the injector and detector 
temperatures set at 250 0C. Fatty acid method esters were identified using retention time 
designations accompanying the Nuchek standard GLC 463.A. Linear Retention Indices (LRI) 
were also calculated for each fatty acid methyl esters. This involved injecting two Alkane 
standard mixes C8- C20 and C21- C40 under the same GC conditions as the samples with the 
LRI value for each fatty acid methyl ester calculated based on the equation derived by (van 
Den Dool & Kratz, 1963) and reviewed by (Zellner et al. 2008). A typical example (RC 2 under 
bile salts stress) of a GLC chromatogram has been shown in Appendix K. 
5.2.4 Statistical analysis for VFA compounds and FA methyl esters production 
A general linear model was employed for the statistical analysis using the program 
Minitab 17 (Minitab Incorporation, USA) to evaluate the experimental data for VFA 
componds production and FA methyl esters production. The significant differences were 
accepted at p<0.05 by Tukey’s post hoc analysis for differences between treatments. 
 
 121 
5.2.5 Characterization of antimicrobial compounds produced by lactobacilli 
The well diffusion method described by (Toure et al. 2003) with modifications was 
followed to characterize the antimicrobial substances produced by lactobacilli. Lactobacilli 
isolates were grown in MRS broth and the five pathogens were grown in BHI broth at 37 0C 
overnight. Cultures centrifuged at 4000 rpm for 10 min at 4 0C. The supernatant obtained 
after centrifugation was divided into three different portions for different assays. 
1. 5ml of supernatant was treated with 1mg/ ml trypsin for determining bacteriocin 
activity. 
2. 5ml of supernatant was treated with 0.5mg/ ml catalase for determining hydrogen 
peroxide production. 
3. 5ml of supernatant, pH was adjusted to 6.5 ± 0.1 using 1N NaOH. 
The treated supernatants were filter sterilized. Wells are punctured into the nutrient 
agar plates which were spread with 200 µl of L. monocytogenes/ S. menston (indicator 
strain). Now 100 µl of the treated supernatant was added into the wells. The plates were left 
in the refrigerator for 3 h/ until diffusion of the supernatant into the agar. Then incubated at 
37 0C for 48 h. The plates were observed for development of zones of inhibition. The type of 
antimicrobial substance responsible for pathogen inhibition was determined based on the 
presence/ absence of inhibition zones, see Table 5.1. 
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Table 5.1 Inhibition halo presence or absence and its corresponding indication depending on 
the treatment applied to the supernatant. 
Supernatant 
treatment 
Inhibition halo presence or 
absence 
Antagonistic substance present 
non-treated present organic acids, hydrogen peroxide or 
bacteriocins. 
treated with trypsin absent bacteriocin 
 present hydrogen peroxide or organic acids 
treated with catalase absent hydrogen peroxide 
 present bacteriocin or organic acids 
treated with NaOH absent organic acids 
 present bacteriocin or hydrogen peroxide 
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5.3 Results and discussion 
5.3.1 1 D SDS PAGE whole cell protein and cytosolic protein profiles of dairy food 
isolate, MI 13 and rumen isolate, RC 2 
The comparison of the protein profile banding patterns with pH stress and bile salts 
stress revealed a number of protein bands which were differentially expressed. With the 
whole cell proteomic profile, the most noticeable difference was the presence of dominant 
bands of MW ~40 kDa and ~78 kDa, which was seen after 16 h incubation with pH 3.5. It was 
visually difficult to detect any changes in protein expression banding patterns in case of bile 
salts stress with the whole cell profiles, see Figure 5.1. The cytosolic protein banding 
patterns were much more clear and distinct. Presence of dominant bands of MW ~32 kDa 
was observed after 16 h incubation with pH 3.5. Presence of dominant bands of MW ~32 
kDa and ~30 kDa was observed after 16 h incubation with 3.5% bile salts, see Figure 5.2. 
Unlike the dairy food isolate, clear distinguishable changes at pH 3.5 and 3.5% bile 
salts after 16 h incubation could be noticed in case of rumen isolate with whole cell protein 
profile. The comparison of the protein profile banding patterns with pH stress and bile salts 
stress revealed a number of protein bands which were differentially expressed. With the 
whole cell proteomic profile, the most noticeable difference was the presence of dominant 
bands of MW ~78 kDa and ~110 kDa, which was seen after 16 h incubation with pH 3.5. With 
3.5% bile salts, the presence of dominant bands of MW ~78 kDa was observed after 16 h 
incubation, see Figure 5.3. In case of cytosolic profiles, protein bands of MW ~110 kDa was 
observed after 16 h incubation with pH 3.5. Presence of dominant bands of MW ~80 kDa, 
~100 kDa and ~160 kDa was observed after 16 h incubation with 3.5% bile salts, see Figure 
5.4. 
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5.3.2 Identification of VFA compounds produced under low pH and bile salts 
stressed conditions using HS- SPME GC- MS 
The GC- MS technique detected seven different VFA compounds in bacterial broth of 
low pH and bile salts stressed cells. The names of each VFA compounds identified has been 
listed in Table 5.2. The different VFA compounds produced under standard and low pH and 
bile salts stress conditions is shown in Figure 5.5. Statistical analysis showed that the amount 
of acetic acid produced under standard and stress conditions were  significantly different 
from each other. There was no significant difference between MI 13 and RC 2 under 
standard and stress conditions in the production of isobutyric acid. Butanoic acid, isovaleric 
acid and 2- methylbutanoic acid produced under standard and low pH stress were 
significantly different from those produced under bile salts stress. Hexanoic acid and 
octanoic acid production was observed only in the case of bile salts stress conditions in MI 
13 nad RC 2. 
 
Table 5.2 Volatile fatty acids detected in bacterial broth using HS- SPME and Shimadzu QP- 
2010 GC- MS. 
Volatile fatty acid 
compounds 
MI 13 
standard 
MI 13 pH 
stress 
MI 13 bile 
salts stress 
RC 2 
standard 
RC 2 pH 
stress 
RC 2 bile 
salts stress 
Acetic Acid (mg/l) 4225 2192 3375 4411 2371 3091 
Isobutyric Acid (µg/l) 8852 8905 9917 8853 9476 9745 
Butanoic Acid (µg/l) 5810 5505 7832 5747 5889 7695 
Isovaleric Acid (µg/l) 3424 3138 4881 3423 3412 4801 
2-methylbutanoic 
acid (µg/l) 
1235 1099 1719 1221 1178 1696 
Hexanoic Acid (µg/l) 0 0 13770 0 0 13441 
Octanoic Acid (µg/l) 0 0 777 0 0 724 
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Figure 5.5 Different volatile fatty acid compounds produced by MI 13 and RC 2 under 
standard and pH and bile salts stress conditions. Columns with different letters differ 
significantly (p<0.05). 
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5.3.3 Identification of fatty acid methyl esters produced under low pH and bile 
salts stressed conditions using GLC 
GLC technique helped in detection and identification of twenty four fatty acid methyl 
esters under standard and low pH and bile salts stress conditions. The names of each 
identified fatty acid along with their systematic name and structure has been listed in Table 
5.3. The different types of fatty acids produced by MI 13 and RC 2 under standard and low 
pH and bile stress conditions is shown in Figure 5.6. In MI 13, the SFA and MUFA levels were 
significantly different for all treatments. The PUFA levels for standard and low pH stress 
were same but increased for bile salts stress. In RC 2, SFA and MUFA levels were significantly 
different from each other for all treatments. The PUFA levels for standard and low pH stress 
were same but increased for bile salts stress. In general an increased level of PUFA 
production in both the isolates under bile salts stress was observed. 
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 Table 5.3 List of fatty acid methyl esters detected by GLC. 
Fatty acid Systematic name Structure CAS Noa RTb  
GC-FID 
(mins) 
LRIc 
Tridecylic d Tridecanoic C13:0 1731-88-0 27.42 2024 
Tetradecanoic  Myristic  C14:0 124-10-7 29.70 2129 
Petadecylic Pentadecanoic C15:0 7132-64-1 32.65 2227 
Palmitic Hexadecanoic C16:0 112-39-0 36.53 2336 
Margaric Heptadecanoic C17:0 1731-92-6 41.65 2431 
Stearic Octadecanoic C18:0 112-61-8 46.91 2539 
Nonadecylic Nonadecanoic C19:0 1731-94-8 51.00 2646 
Myristoleic  c9-Tetradecenoic C14:1c9 1120-25-8 31.4 2189 
trans-Palmitoleic  t9-Hexadecenoic C16:1t9 1937-62-8 37.94 2357 
cis-Palmitoleic  c9-Hexadecenoic C16:1c9 1120-25-8 38.85 2376 
 no namee Heptadecenoic C17:1 75190-82-8 44.39 2483 
Elaidic t9-Octadecenoic C18:1t9 1937-62-8 48.04 2566 
trans -Vaccenoic t11-Octadecenoic C18:1t11 52380-33-3 48.26 2572 
Petroselinic c6-Octadecenoic C18:1c6 2777-58-4 48.51 2578 
Oleic c9-Octadecenoic C18:1c9 112-62-9 48.70 2582 
cis -Vaccenoic c11-Octadecenoic C18:1c11 1937-63-9 49.03 2590 
no namee c7-nonadecenoic C19:1 146407-37-6 52.22 2682 
 no namee c5-Eicosenoic C20:1c5 20839-34-3 55.39 2777 
Gondoic c11-Eicosenoic C20:1c11 2462-85-3 55.98 2795 
Nervoic c15-Tetracosenoic C24:1c15 2733-88-2 74.41 3210 
Linoleic c9,12-Octadecadienoic C18:2c9,12 2462-85-3 51.32 2656 
gamma -Linolenic c6,9,12-Octadecatrienoic C18:3c6,9,12 16326-32-3 52.99 2705 
Linolenic c9,12,15-Octadecatrienoic C18:3c9,12,15 301-00-8 54.20 2741 
homo ϒ linolenic c8,11,14-Eicosatrienoic C20:3c8,11,14 17364-32-8 60.49 2918 
a CAS numbers are for the methyl esters of the fatty acid listed. 
b GC Retention Time in minutes.   
c LRI values calculated from alkane mixes C8-C20 and C21-C40 (H.van Den Dool and P.Dec. Kratz (1963)). 
d Internal standard added - 0.1 mL of 167 µg mL-1 Tridecanoic acid.  
e No commercial name available for these fatty acids, systematic name used uniformally. 
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Figure 5.6 Types of fatty acid methyl esters produced by MI 13 and RC 2 under standard and 
pH and bile salts stress conditions. Columns with different letters differ significantly (p<0.05).  
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5.3.4 Determination of antimicrobial compounds produced by lactobacilli 
Inhibition zones were observed around the supernatant samples treated with trypsin, 
catalase and untreated sample. Around the neutralized supernatant, no inhibition zones 
were seen. This indicated that the inhibition ability of the lactobacilli towards pathogens was 
due to organic acids production. The inhibitory activity of lactobacilli isolates against E. coli  
is shown in Table 5.4. The inhibitory activity of lactobacilli isolates against E. aerogenes is 
shown in Table 5.5. The inhibitory activity of lactobacilli isolates against S. menston is shown 
in Table 5.6. The inhibitory activity of lactobacilli isolates against S. aureus is shown in Table 
5.7 and the inhibitory activity of lactobacilli isolates against L. monocytogenes is shown in 
Table 5.8. 
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Table 5.4 Inhibition zone of Lactobacillus isolates against E. coli for each supernatant treatment. 
Lactobacillus isolate Supernatant + trypsin 
Inhibition zone (mm) 
Supernatant + catalase  
Inhibition zone (mm) 
Neutralized supernatant  
Inhibition zone (mm) 
Untreated supernatant  
Inhibition zone (mm) 
MI 6 12.7 ± 1.5 11.2 ± 1.6 10.8 ± 0.3 - 
MI 7 16.3 ± 1.2 15.3 ± 0.6 13.0 ± 0 - 
MI 10 15.0 ± 0 15.7 ± 0.6 15.3 ± 0.6 - 
MI 13 16.0 ± 0 15.0 ± 0 14.3 ± 0.6 - 
MI 17 17.0 ± 2 14.2 ± 0.7 14.5 ± 0.8 - 
RC 2 14.3 ± 1.2 16.0 ± 1.7 18.7 ± 2.3 - 
RC 5 16.3 ± 0.6 13.7 ± 2.1 17.0 ± 0 - 
RC 13 12.1 ± 1.8 14.7 ± 1.5 10.9 ± 1.1 - 
RC 25 13.0 ± 0 14.7 ± 0.6 16.7 ± 1.5 - 
RC 30 12.8 ± 0.3 16.0 ± 2 10.5 ± 1.3 - 
                                  Values are means ± SD done in triplicate. 
                                  - No inhibition 
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Table 5.5 Inhibition zone of Lactobacillus isolates against E. aerogenes for each supernatant treatment. 
Lactobacillus isolate Supernatant + trypsin Supernatant + catalase Neutralized supernatant Untreated supernatant 
MI 6 12.7 ± 0.6 12.8 ± 1.0 - 13.7 ± 1.5 
MI 7 12.0 ± 1.0 10.3 ± 0.6 - 13.2 ± 1.6 
MI 10 12.3 ± 2.1 11.7 ± 0.6 - 13.3 ± 2.1 
MI 13 15.0 ± 0 12.7 ± 1.5 - 9.8 ± 0.8 
MI 17 16.1 ± 1.0 13.4 ± 1.2 - 16.3 ± 1.5 
RC 2 15.3 ± 0.6 13.0 ± 1.0 - 16.3 ± 0.6 
RC 5 16.8 ± 0.8 12.7 ± 1.5 - 12.3 ± 1.5 
RC 13 15.1 ± 1.8 13.6 ± 1.2 - 13.6 ± 0.5 
RC 25 16.0 ± 0 13.3 ± 1.5 - 15.3 ± 0.6 
RC 30 16.0 ± 2 16.0 ± 0 - 15.4 ± 1.2 
                                  Values are means ± SD done in triplicate. 
                                  - No inhibition 
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Table 5.6 Inhibition zone of Lactobacillus isolates against S. menston for each supernatant treatment. 
Lactobacillus isolate Supernatant + trypsin Supernatant + catalase Neutralized supernatant Untreated supernatant 
MI 6 15.3 ± 1.2 14.0 ± 1.0 - 11.0 ± 0 
MI 7 16.7 ± 1.2 16.0 ± 0 - 16.3 ± 0.6 
MI 10 16.0 ± 0 17.3 ± 1.2 - 14.3 ± 1.2 
MI 13 16.7 ± 2.9 17.0 ± 0 - 16.0 ± 0 
MI 17 16.5 ± 1.5 15.3 ± 1.5 - 14.0 ± 2.0 
RC 2 17.7 ± 0.6 17.0 ± 0 - 14.7 ± 1.2 
RC 5 15.7 ± 0.6 16.3 ± 1.5 - 15.0 ± 0 
RC 13 13.7 ± 1.5 15.0 ± 0 - 13.7 ± 0.6 
RC 25 13.7 ± 0.6 15.3 ± 1.2 - 14.3 ± 1.2 
RC 30 10.7 ± 0.6 12.3 ± 0.6 - 12.7 ± 1.5 
                                  Values are means ± SD done in triplicate. 
                                  - No inhibition 
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Table 5.7 Inhibition zone of Lactobacillus isolates against S. aureus for each supernatant treatment. 
Lactobacillus isolate Supernatant + trypsin Supernatant + catalase Neutralized supernatant Untreated supernatant 
MI 6 11.9 ± 1.4 10.3 ± 0.6 - 12.7 ± 0.6 
MI 7 13.7 ± 0.6 12.7 ± 1.2 - 12.5 ± 1.5 
MI 10 13.0 ± 1.0 10.7 ± 1.2 - 10.9 ± 1.0 
MI 13 15.3 ± 0.6 15.0 ± 0 - 12.8 ± 1.1 
MI 17 13.2 ± 1.3 12.2 ± 0.3 - 13.7 ± 0.6 
RC 2 16.0 ± 1.0 15.7 ± 2.1 - 12.7 ± 1.5 
RC 5 10.7 ± 2.1 11.3 ± 0.6 - 10.0 ± 0 
RC 13 17.3 ± 0.3 14.3 ± 1.2 - 11.8 ± 0.3 
RC 25 14.3 ± 2.1 10.8 ± 0.3 - 15.0 ± 1.7 
RC 30 13.2 ± 1.0 13.5 ± 0.6 - 16.3 ± 0.6 
                                  Values are means ± SD done in triplicate. 
                                  - No inhibition 
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Table 5.8 Inhibition zone of Lactobacillus isolates against L. monocytogenes for each supernatant treatment. 
Lactobacillus isolate Supernatant + trypsin Supernatant + catalase Neutralized supernatant Untreated supernatant 
MI 6 11.7 ± 0.6 12.3 ± 1.5 10.3 ± 0.6 - 
MI 7 17.7 ± 1.5 10.7 ± 0.6 10.8 ± 1.0 - 
MI 10 11.7 ± 0.6 13.0 ± 0 - 10.7 ± 0.6 
MI 13 13.3 ± 1.2 12.7 ± 2.1 - 14.7 ± 1.5 
MI 17 14.7 ± 1.5 13.7 ± 1.5 - 14.7 ± 2.3 
RC 2 10.7 ± 0.6 10.0 ± 1.0 - 11.0 ± 1.0 
RC 5 11.0 ± 0 12.0 ± 2.0 - 12.0 ± 1.0 
RC 13 11.0 ± 1.0 12.0 ± 1.0 - 16.3 ± 1.5 
RC 25 15.3 ± 1.5 16.8 ± 1.0 - 15.7 ± 1.5 
RC 30 12.0 ± 1.7 15.0 ± 2.6 - 18.8 ± 1.0 
                                  Values are means ± SD done in triplicate. 
                                  - No inhibition
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Abstract 
The selection criteria of an ideal probiotic bacteria is complex and involves a range of factors. 
One of the key criterion for this selection is based on the adhesion abilities of the probiotic 
bacteria onto the gastro- intestinal epithelial lining. The objective of this study was to evaluate 
and compare the adherence and permeability potential of two selected lactobacilli isolates, 
one from dairy food products and one from bovine rumen contents. The adhesion and 
permeability abilities of the two lactobacilli isolates were compared against an Escherichia 
coli, which is a human commensal. Genetically the lactobacilli isolates were identified as 
Lactobacillus rhamnosus LOCK 908 (dairy food origin) and L. plantarum 16 (bovine rumen 
origin). From the adhesion studies, it was concluded that the rumen isolate exhibited better 
adherence to Caco- 2 cells in comparison with the dairy isolate. On the contrary, presence of 
the dairy food isolate showed a high TEER value for the membrane integrity studies.  
Keywords: Lactobacilli; Escherichia coli; Caco- 2 cells; adherence; permeability 
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1. Introduction 
      An effective probiotic bacteria is required to operate under a variety of different 
environmental conditions and survive in many different forms. It should therefore possess 
ideal probiotic characteristics such as, high viability, resistance to acidic and bile salt 
conditions, ability to interact and trigger immune cells of the gut, should be non- pathogenic, 
genetically stable and exhibit resistance to processing conditions (Gupta and Garg, 2009). 
However, the key criterion for selection is believed to be the adherence to the intestinal 
epithelial lining and ability to colonize the gut (Alander et al., 1999; Mattila- Sandholm et al., 
1999). This characteristic feature best describes a bacteria as a potential probiotic. It is 
because, after consumption and gastro-intestinal tract transit, the survival and prolongation of 
the probiotic bacteria in the gut is determined by the host- bacterial interaction. This 
phenomenon is dependent on the adhesion abilities of the probiotic bacteria (Gueimonde and 
Salminen, 2006). Therefore, adhesion to human adenocarcinoma cell lines, which mimics the 
human intestinal cells is considered to be a prominent feature of potentially probiotic bacteria 
(Kleeman and Klaenhammer, 1982; Conway et al., 1987). 
    Understanding the mechanisms responsible for probiotic bacterial adhesion in vivo is quite 
challenging. This has led to the development of Caco- 2 cell line, one of the human 
adenocarcinoma cell lines used extensively in the study of bacterial adherence in vitro (Duary 
et al., 2011). Caco- 2 cells resemble physiologically and functionally the enterocytes lining 
the intestine. They are excellent models which help in understanding how the probiotic 
bacteria interacts with the intestinal epithelial lining (Wang et al., 2008; Moussavi and 
Adams, 2010). They also help in investigating how the probiotic bacteria competes with 
human commensals for attachment sites in the gut. 
     Integrity of the intestinal barrier plays a significant role in maintenance of good health. 
This is attributed to the formation of tight junctions between adjacent intestinal epithelial 
cells, thereby sealing any gaps (Schneeberger and Lynch, 2004). Any compromise of the 
intestinal barrier makes it “leaky”, resulting in infections (Anderson et al., 2010). 
Determination of the ability of probiotic bacteria in maintenance of intestinal lining integrity 
is measured in vitro in terms of trans- epithelial electrical resistance (TEER) (Klingberg et al. 
2005). 
    In our initial study, ten lactobacilli isolates, five each from dairy food products and bovine 
rumen contents were assessed for their hydrophobicity by the bacterial adherence to 
hydrocarbons (BATH) method. From the study it was evident that the rumen isolates 
exhibited better adherence to hydrocarbons in comparison to dairy isolates (Jose et al., 2015). 
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In the present study, only two of the ten isolates, one from dairy and one from rumen were 
further investigated for their adhesion and permeability properties in vitro. For determining 
the adhesion and permeability properties, the two lactobacilli isolates which possessed 
potential probiotic properties were made to grow on a Caco- 2 cell monolayer.  
    
2. Materials and methods 
2.1 Bacterial strains and growth conditions  
L. rhamnosus LOCK 908 was isolated from dairy food product and L. plantarum 16 was 
isolated from bovine rumen. The two lactobacilli isolates were inoculated in de Man, Rogosa, 
Sharpe (MRS) broth (Oxoid, Basingstoke, UK) of pH 6.4 ± 0.2, whereas E. coli was 
inoculated into Brain Heart Infusion (BHI) broth (Oxoid, Basingstoke, UK) of pH 7.4 ± 0.2. 
The cultures were incubated at 370 C overnight. After incubation the cultures were centrifuged 
at 4,000 rpm for 10 min. The cells were washed and suspended in phosphate buffered saline 
(PBS) of pH 7.4 after adjusting the Optical Density (O.D.) to 2.0.   
 
2.2 Culturing Caco- 2 cells 
The Caco- 2 cell line used for the adhesion studies were propagated and maintained at the 
University of Otago, Dunedin, New Zealand. Caco-2 cells were cultured in BD FalconTM Cell 
culture flasks of surface area of 75 cm2 (BD Biosciences, Bedford, MA, USA) following 
standard protocols (Gao et al., 2000). Cells were fed on alternate days with 15 ml Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% Foetal Bovine Serum (FBS) 
(Moregate® Australia and New Zealand, Queensland, Australia) 1% non-essential amino acid 
and 1% penicillin-streptomycin. Upon 70% cell confluency, cells were detached from the 
flask with 2 ml trypLETM Express Enzyme (1X) (Gibco® Life Technologies Corporation, NY, 
USA) for seeding.  
 
2.3 Seeding Caco- 2 cells 
Caco- 2 cells were seeded on the permeable supports (Corning® Incorporated, NY, USA) at 
50,000 cells/ well (0.5 ml of 100,000 cells/ ml) for 21 to 28 days (to obtain fully differentiated 
monolayer) for uptake studies. The cells grown on the permeable support were fed on 
alternate days with fresh medium (0.5 ml in the donor compartment and 1.5 ml in the receiver 
compartment).  
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2.3 Adhesion studies 
Caco- 2 cells were seeded with culture medium in transwell membrane tissue culture plates. 
The two lactobacilli isolates, L. rhamnosus LOCK 908 and L. plantarum 16 and E. coli were 
added individually and also each lactobacilli isolate was added in combination with E. coli 
into the wells of the tissue culture plates. They were then incubated at 370 C in 10% carbon 
dioxide- 90% air. After incubation, the Caco- 2 monolayers were washed with sterile PBS 
several times to remove the unattached bacteria. It was later fixed with methanol, gram 
stained. The gram stained slides were observed under the oil- immersion objective (100x) for 
counting the number of bacteria that had adhered to the Caco- 2 cells, see Figure 1. The 
bacteria in 25 random microscopic fields were counted for each test (Thirabunyanon et al., 
2009 and Liu et al., 2013). 
 
2.4 Monolayer integrity studies 
 The matured Caco-2 cell monolayers were washed with diluted DMEM (1:1 ratio of 
completed DMEM to PBS) twice. Then the cells were incubated with 0.5 ml and 1.5 ml of 
diluted DMEM in the donor compartment and the receiver compartment, respectively, at 370 
C for 30 min prior to the permeability study. The diluted DMEM in the donor compartment 
then was replaced with diluted DMEM containing either 1% ethanol (to challenge the 
integrity of the monolayer), E. coli (0.4 ml), dairy isolate (0.4 ml), or rumen isolate (0.4 ml), 
(see Table 1) and the co- incubation with the Caco-2 cell monolayers was carried out at 370 C 
over 90 min. Transepithelial electrical resistance (TEER) measurements were taken at 90 min 
using Millicell®-ERS (EMD Millipore® Corporation, Billerica, MA, USA). 
 
Table 1. Samples co-incubated with the Caco- 2 cells monolayers over 90 min. 
Sample 1% Ethanol E. Coli Dairy isolate Rumen isolate 
A 
(positive control) 
+ - - - 
B + - + - 
C + - - + 
D + + - - 
E + + + - 
F + + - + 
G 
(negative control) 
- - - - 
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how the lactobacilli isolates compete with a human commensal for binding sites. From our 
study, it was evident that the rumen isolate, L. plantarum 16 remained unaffected by the 
presence of E. coli. It adhered in significantly large numbers onto the Caco- 2 cells. However, 
the dairy isolate, L. rhamnosus LOCK 908, adhesion numbers were greatly lowered in the 
presence of E. coli. The trend observed was similar in both the two week and three week old 
Caco- 2 cells. Although the adhesion numbers overall were higher in case of two week old 
Caco- 2 cells. It was previously reported that L. plantarum of faecal origin recorded a higher 
adherence rate to Caco- 2 cells, whereas, a dairy isolate, L. delbrueckii subsp. bulgaricus 
showed a lower adherence rate (Duary et al., 2011). This suggests that the adherence property 
of Lactobacillus species is strain specific (Chauviere et al., 1992). With membrane integrity 
studies, it can be concluded that the presence of the rumen isolate did not affect the intestinal 
lining permeability. On the other hand, the dairy food isolate was capable of strengthening the 
intestinal barrier function, which was demonstrated by an increase in TEER values over the 
90 min incubation period. Previous studies have reported a noticeable increase in TEER 
values with L. plantarum species (Anderson et al. 2010; Klinberg et al. 2005). This is not 
surprising as different strains of L. plantarum can have different effects on membrane 
integrity studies in vitro. It can either show no increase in TEER value as seen in our study or 
it can show an increase in TEER value, as evident from studies carried by Anderson et al. in 
2010 and Klinberg et al. in 2005. From the results obtained from this study it has been 
understood that the ability to adhere and enhance the expression of tight junction- related 
genes are two different mechanisms, which are strain specific. 
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5.3.6 Effect of glyphosate on rumen isolates in vitro 
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Glyphosate (N-(phosphonomethyl) glycine) is widely used in agricultural fields for control of 
weeds. Genetically modified soy, corn, canola, alfalfa, cotton, and sorghum have been 
developed to be resistant to glyphosate allowing farmers to control weeds without damage to 
crops. The use of glyphosate for weed control is controversial (James 2009; Johal and Huber 
2009). Glyphosate is a broad spectrum herbicide which interferes with the synthesis of 
aromatic amino acids in plants and microorganisms by inhibiting the activity of the 5-
enolpyruvyl shikimate 3-phosphate synthase (EPSPS) enzyme (Cerdeira and Duke 2006). It is 
assumed that glyphosate does not directly affect vertebrates as they lack this enzyme (Schrodl 
et al. 2014; Solomon et al. 2007). It has been claimed that it may be possible for glyphosate to 
influence microorganism for example Lactobacillus spp., which form part of the normal 
microbiota of humans and animals (Mercola 2015). Lactobacillus spp. are beneficial bacteria, 
which promote general wellbeing in the host by balancing the gut. The response of lactobacilli 
to different stress conditions like low pH, bile salt stress, high or low temperature stress, 
nutrient stress etc. has been widely studied, due to their applications in health food and 
complementary medicines (Hyronimus et al. 2000; Hamon et al. 2011; Koponen et al. 2012; 
Jose et al. 2015). It has been suggested that impacts on beneficial microbes by glyphosate 
may interference with human and animal health (Claire et al. 2012; Johal and Huber 2009; 
Mercola 2015), although this is not a widely held opinion. A number of recipes for so called 
“organic roundup” or “organic herbicide” have become widely distributed on the internet 
(Kniss 2014) as a way to address the perceived problems with glyphosate. It is claimed that 
unlike glyphosate containing products these organic herbicides do not impact microbes, be 
they be in the soil or gut of animals. 
To our knowledge there are no reports investigating possible glyphosate effects on bacteria 
from the bovine rumen. We have compared a commercial glyphosate herbicide (Zero 
Weedkiller – Super Concentrate; Yates Ltd, Auckland, New Zealand) containing glyphosate 
(3.92 mg/ml once diluted 8 ml/l for application) against a recipe widely distributed on the 
internet (Kniss 2014) described as an organic herbicide on the growth of five lactobacilli 
isolated from the bovine rumen. Variations in the amounts of each component of the organic 
herbicide are common; for this study we used the following recipe; 1.89 l white vinegar 
(Pams Products Ltd; Auckland, New Zealand), 120 g salt (Cerebos Ltd; Dunedin, New 
Zealand) and 30 ml dish soap (Ecostore Ltd; Auckland, New Zealand). The isolates used were 
genetically identified as, RC 2 (Lactobacillus plantarum 16), RC 5 (L. plantarum 16), RC 13 
(L. plantarum subsp. plantarum ST- III), RC 25 (L. plantarum 16) and RC 30 (L. plantarum 
subsp. plantarum ST- III). The microbiological and probiotic characteristics of these 
Lactobacillus have been previously reported (Jose et al. 2015). 
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The disc diffusion method was used to assess the antimicrobial activity of commercial 
glyphosate, glyphosate (N-phosphonomethyl glycine, Sigma-Aldrich New Zealand; 
Auckland, New Zealand), organic herbicide and the organic herbicide individual ingredients. 
One hundred microliter of overnight lactobacilli cultures were evenly spread onto the surface 
of MRS agar plates (Oxoid, Basingstoke, UK) and 7 mm diameter blank sterile paper discs 
(Oxoid, Basingstoke, UK), antibiotic (ampicillin) discs or papers discs dipped in commercial 
glyphosate, organic herbicide, white vinegar, glyphosate (3.92 mg/ml), salt (62.5 mg/ml) or 
detergent (15.6 l/ml) were transferred aseptically onto the surface of the agar. Replicate 
plates (n=3) were prepared for this study. All test solutions were sterilised by filtration 
through a 0.10 m filter. The plates were then incubated for 24 h at 37oC under anaerobic 
conditions. Following incubation the plates were then inspected for zones of inhibition around 
the paper discs, see Figure 1 for typical examples. The sizes of zones were measured from the 
outer edge of the disc to the outer edge of the zone. 
Small inhibition zones of up to approximately 1 mm were observed around commercial 
herbicide, organic herbicide, glyphosate and the individual components of the organic 
herbicide (Figure 2). The inhibition zones for ampicillin ranged from about 5 to 10 mm 
depending on the isolate. The inhibition zone produced by ampicillin was significantly greater 
(p<0.01) compared to the commercial, organic herbicide and blank discs. Differences between 
the commercial, organic herbicide and glyphosate and the individual components of the 
organic herbicide were not significant (P>0.10). 
In a similar study that compared the effects of glyphosate potential pathogens and beneficial 
members from poultry it was reported that most pathogenic bacteria were highly resistant 
towards the glyphosate, although Campylobacter spp. were susceptible. However, the 
beneficial bacteria had a moderate to high degree of susceptibility to glyphosate (Shehata et 
al. 2013). It has also been reported that commercial glyphosate products, such as Roundup® 
are more toxic towards food microorganisms than glyphosate alone at similar concentrations 
(Clair et al. 2012). Many substances have either positive or negative influence on the growth 
of microbes. Some studies of glyphosate and bacteria growth have drawn conclusions about 
the toxicity of glyphosate towards microbes without suitable controls or specifically isolating 
a component such as glyphosate from a mixture as having an influence without examining it 
alone or in comparison with positive and negative control. Kurenbach et al. 2014 have 
reported that glyphosate can reduce antibiotic susceptibility in Escherichia coli and 
Salmonella enterica serovar Typhimurium. While these researchers did not investigate 
glyphosate alone (they evaluated a commercial glyphosate containing product) the claim 
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glyphosate reduced antibiotic sensitivity is not supported by the data, furthermore many of the 
test combinations they evaluated actually increased antibiotic sensitivity. 
We have shown that for 5 isolates from the bovine rumen glyphosate, a commercial 
glyphosate herbicide, and an organic herbicide and its components appear to have a similar 
influence on microbial growth. This very small influence by glyphosate (be it alone or in the 
form of a commercial product) and organic alternatives when compared to that of an 
antibiotic that the isolates are known to be sensitive to suggest that this influence is minor and 
likely to be of no consequence in vivo. 
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Figure 1. Inhibition of rumen isolates RC 2 (a) and RC 25 (b) by the agar disc diffusion 
assay. RC 2 (a) plate shows zone of inhibition around discs containing clockwise from top 
left; antibiotic, blank (control), organic herbicide or commercial glyphosate. The RC 25 (b) 
plate shows zone of inhibition around discs containing clockwise from top left; vinegar, salt, 
detergent or glyphosate. 
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Figure 5.8 Average number of adhered bacteria to two week old Caco- 2 cells. Standard error 
of the mean bars (n=4). 
 
5.4 Conclusions 
The two isolates were characterised in terms of their adhesion to and permeability 
across gut Caco- 2 cells. These isolates were also characterised under standard and stressed 
(low pH and high bile) conditions by proteomic assessment of protein expression, production 
of volatile fatty acids and fatty acid methyl esters. Overall isolate RC 2 from the bovine 
rumen appears the be a superior candidate for further evaluation as a novel probiotic. 
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Chapter 6 
General discussion and conclusion 
6.1 General discussion 
Objective 1: Isolation of potential probiotic bacteria from two sources 
As part of this research study, fifty isolates were isolated from dairy food products 
and bovine rumen contents in New Zealand. Out of which twenty isolates were of dairy food 
origin and thirty isolates were of bovine rumen origin. 
 
Objective 2: Preliminary screening of isolates 
Basing on the morphology and gram- nature, twenty- six isolates in total were 
selected for preliminary screening, which has been previously described in sections 4.3.3 and 
4.3.4. Ten isolates which portrayed better performance characteristics in vitro for the 
preliminary screening tests were identified by genetic methods as Lactobacillus sps. 
 
Objective 3: Identification and selective screening of the ten most promising isolates 
MI 6, MI 7, MI 10, MI 13, MI 17 were the five dairy food isolates and RC 2, RC 5, RC 
13, RC 25, RC 30 were the five bovine rumen isolates that were genetically identified, see 
section 4.3.6. 
After genetic identification the ten selected lactobacilli isolates were subjected to 
screening for potential probiotic abilities, see section 4.3.7. From the screening results, it 
was evident that all the isolates proved capable of tolerating low pH conditions (pH 2 and pH 
3). However, viability decreased with a decrease in pH. In similar studies, it was found that 
the strains could tolerate and survive in MRS broth of pH 3, whereas low viability was 
observed at pH 2 (Mishra & Prasad, 2005; Liu et al. 2013). Bile salt at a concentration of 0.3% 
is the maximum that can be found in an average healthy person. Thus, in this study 0.3 % 
was selected as the starting range for screening the isolates. The result showed that all 
isolates could tolerate the 0.3% and 2% bile salt condition. However, higher growth was 
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monitored at 0.3% concentration of bile salt. Our findings are similar with other study were 
lactobacilli was found to grow well and multiply in 0.3% of bile salt (Hoque et al. 2010).  
As per safety concerns, a potential probiotic bacteria should not cause lysis of RBC’s 
in the body. In vitro investigation of this was done by testing the isolates for haemolytic 
activity. Lactobacilli are usually non- haemolytic in nature. In our study, all the ten isolates 
were incapable of exhibiting haemolysis on the agar media containing 5% sheep blood. 
Previous studies done on lactic acid bacteria and bifidobacteria species demonstrated that 
they were non-haemolytic in nature (Santini et al. 2010).  
The antibiotic resistance profiles of lactobacilli species showed that all the ten 
isolates were resistant to vancomycin. This is because they possess D-Ala-D-Lactate in their 
peptidoglycan instead of D-Ala-D-Ala dipeptide. The resistance is of intrinsic type because 
the target site for antibiotics is absent (Klein et al. 2000). There has been no reported cases 
of transferable resistance genes with vancomycin so far. However, resistance to this 
antibiotic is of major concern as it is the last remaining choice for treating infections caused 
by the multi-drug resistant Staphylococcus aureus (Pfeltz & Wilkinson, 2004). 
Chloramphenicol, erythromycin and tetracycline are examples of antibiotics which inhibit 
the protein synthesis mechanism. Lactobacilli are usually susceptible to such antibiotics. 
However, aminoglycosides, which are also protein synthesis inhibitors are not effective 
against gram- positive bacteria and gram- negative anaerobes. They exhibit bactericidal 
activity against gram- negative aerobes and facultative anaerobic bacilli. Lactobacilli are 
usually resistant towards these aminoglycosides which includes kanamycin, streptomycin 
and gentamycin (Charteris et al. 1998b; Coppola et al. 2005; Zhou et al. 2005). According to 
the experimental data obtained, three dairy isolates: MI 6 (L. reuteri TD1), MI 7 (L. reuteri 
JCM 1112) and MI 10 (L. reuteri strain C16) showed resistance against chloramphenicol. 
Previous studies have also reported chloramphenicol resistance in L. reuteri species because 
they possess a plasmid- borne (pTC82) cat gene which confers resistance against 
chloramphenicol (Lin et al., 1996). All five dairy isolates and five rumen isolates showed 
resistance against nalidixic acid. There are previous studies that reported resistance of 
lactobacilli against antibiotics targeting nucleic acid synthesis. An example of such an 
antibiotic is nalidixic acid. According to the studies, the resistance in this case was found to 
be intrinsic in nature (Charteris et al. 1998b; Coppola et al. 2005). LAB and bifidobacteria 
have been used in the food and dairy industry over a long span of time and there were no 
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issues concerning it’s safety. It has been generally concluded that the chances of acquiring 
infection from ingested food containing probiotic bacteria is not very high (Gasser, 1994; 
Ouwehand et al. 2002). 
 One of the beneficial effects of probiotic consumption is attributed to the ability of 
the probiotic bacteria to inhibit the growth of pathogens such as bacteria, viruses or fungi. 
At the time of infection, the host initiates the immune system functioning. Probiotic bacteria 
work synergistically with the host immune system and helps maintain the intestinal barrier 
integrity, or breaks down the toxins produced by the pathogens, or creates a low pH 
environment which is unfavourable for the growth of pathogens, or it produces metabolites. 
Some of the metabolites synthesized by LAB includes hydrogen peroxide (H2O2), bacteriocin, 
lactic acid, acetic acid and nitric oxide to name a few. Bacteriocins produced by the probiotic 
bacteria show antimicrobial activity against bacteria of the same species or different species. 
All the above mechanisms inhibit the adherence/ establishment and/ or replication of the 
pathogens in the gastro-intestinal tract, thereby protecting the host from infections. The 
antimicrobial activity profile shows that all the isolates were incapable of inhibiting the 
growth of E. coli. Maximum inhibition was observed against L. monocytogenes.  Inhibition of 
Gram- positive bacteria such as L. monocytogenes and S. aureus by lactobacillus species 
were already described (Bao et al. 2010). A mixed response was seen with E. aerogenes, S. 
aureus and S. menston inhibition. 
Determining the hydrophobicity of the bacterial strains plays a crucial role in their 
selection as potential probiotics. Strains with a good adherence property indicates that they 
are better capable of binding to the intestinal epithelial lining and improving the cell barrier 
functions (Resta- Lenert & Barrett, 2003). This mechanism is one of the major factors by 
which a probiotic bacteria exerts beneficial effects in the host. With a decrease in pH, the 
adsorbence to dichloromethane increased. In general, rumen isolates portrayed better 
adherence properties in comparison with dairy isolates. RC 2 and RC 25 rumen isolates 
showed maximum adherence percentage. 
 
Objective 4: Final characterisation of one isolate from the dairy food and the bovine rumen 
for specific properties 
The further characterization of selected two isolates, MI 13 and RC 2 for specific 
properties has been described in chapter 5. The adhesion and permeability studies using 
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Caco- 2 cells can be found in section 5.3.7. From the results on adhesion studies, it was 
evident that the rumen isolates showed higher adherence numbers than the dairy food 
isolates to Caco- 2 cells independently and also in presence of E. coli. For the paper 
publication only the three week adhesion studies were reported as there was no significant 
changes observed within the two and three week Caco- 2 cells. The adhesion numbers of the 
isolates across the two kinds of Caco- 2 cells followed a similar trend. With the monolayer 
integrity studies, in the presence of dairy isolates, an increased TEER values was recorded 
over a 90 min incubation. It was previously reported that L. plantarum of faecal origin 
recorded a higher adherence rate to Caco- 2 cells, whereas, a dairy isolate, L. delbrueckii 
subsp. bulgaricus showed a lower adherence rate (Duary et al. 2011). This suggests that the 
adherence property of Lactobacillus species is strain specific (Chauviere et al. 1992). 
From the 1D SDS PAGE protein profiles, dominant protein bands was observed with 
isolates MI 13 and RC 2 under pH 3.5 and 3.5% bile salts stress after 16 h incubation. In MI 
13, bands were over- expressed for pH stress with whole cell protein profiles and bands 
were over- expressed with pH and bile salts stress for cytosolic profiles. In RC 2, dominant 
and clear bands were seen for pH and bile salts stress with both whole cell and cytosolic 
protein profiles. These results support the screening test results carried out for probiotic 
abilities screening where, rumen isolate, RC 2, displayed better tolerance to presence of bile 
salts and dairy isolate, MI 13 displayed better tolerance to acidic environment.  
Seven different VFA compounds were produced by MI 13 and RC 2 under standard 
and stress conditions. However, their levels of production were different with each 
treatment. One key finding was the detection of hexanoic and octanoic acids which were 
produced only under the bile salts stress conditions. They production was not observed 
under standard conditions of growth and low pH stress. In case of fatty acid analysis, twenty 
four different fatty acids were identified by GLC technique. Although SFA, MUFA and PUFA 
were produced both under standard and stress conditions, their percentage levels varied 
with each treatment. Myristoleic, trans- palmitoleic,  cis- palmitoleic,  elaidic, trans- 
vaccenoic, petroselinic, oleic, cis- vaccenoic, gondoic and nervoic fatty acids (MUFA) showed 
the highest levels in all the three treatments, followed by tridecylic, teradecanoic, 
petadecylic, palmitic, margaric, nonadecyclic and stearic fatty acids (SFA). Linoleic, gamma- 
linolenic, linolenic and homo ϒ linolenic fatty acids (PUFA) showed an increase in case of 
stress conditions, particularly bile salts stress. 
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In characterization of antimicrobial substances produced by lactobacilli isolates, it 
was found that the culture supernatants treated with catalase and trypsin did not affect the 
inhibitory activity. However, with neutralized supernatants, inhibitory activity was affected. 
This was attributed to the production of organic acids by the lactobacilli isolates.  A similar 
result was previously reported by (Shokryazdan et al. 2014). Testing the rumen isolates for 
effects of glyphosate and organic herbicide showed that there was no significant effect on 
them.  
 
6.2 Conclusion 
Demand for probiotic food market is on the rise and people are becoming more 
conscious of their health and nutrition. In such a scenario, it is necessary that the probiotic 
foods which are designed and developed for either improving general health and well- being 
or targeting specific health conditions, are by all means safe to the consumer.  
Traditionally lactobacilli have been isolated from fermented foods, gut of animals, 
faecal content etc. for applications as probiotics. It was always assumed that lactobacilli 
from natural/ indigenous origin possessed better potential probiotic properties. However, 
there is no available literature which substantiates this belief. Our research study provides 
experimental data which proves, that the best candidates for use as probiotics can be 
isolated from indigenous sources instead of commercial or food origin. After subjecting the 
dairy food isolates and bovine rumen isolates to similar screening tests and analysing the 
results, a conclusion can be made that the bovine rumen isolates possess better potential 
probiotic properties. However, probiotic properties and related mechanisms are linked to 
the strain used, and hence arriving to a general conclusion, is a difficult task in probiotic 
study. With the availability of large genomic and proteomic data on LAB, it is expected that 
greater insights into understanding the probiotic mechanisms will soon take place. This 
might open up new avenues where specific genes conferring probiotic characteristics will be 
identified.  
A key conclusion from this research is that potential probiotic candidates can be 
isolated from commercial dairy food products and the bovine rumen. The data obtained 
from the screening tests indicates that overall the rumen isolates displayed better in vitro 
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probiotic characteristics and isolates MI 13 and RC 2 shows promising potential for further 
development as a novel probiotic. 
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6.3 Future directions 
This research study started with fifty isolates and ends with selected two lactobacilli 
isolates which can serve as potential probiotic candidates in future. A few suggestions in 
order to take this work further includes: 
 
 Proteomics to select a single candidate for further evaluation. 
 Following up the 1 D SDS PAGE with advanced proteomic tools such as 2 D DIGE, can 
help identify the different proteins expressed by the isolates under standard and stress 
conditions. In the field of probiotic studies, characteristic proteomic profiles can be 
identified for individual properties that may serve as bacterial biomarkers for the selection 
of strains with the best probiotic potential. 
Translating research from the lab to the consumer market comes with consideable 
added cost. Clearly a key mechanims to reduce cost is to reduce the number of candidates to 
assess in vivo. 
 
 Feeding rats/ other animal models with the probiotic supplement and trying to 
recover the probiotic bacteria from the faeces of the animal to confirm if it survives 
the gastro- intestinal transit.  
The lactobacilli isolates exhibited good performance characteristics in vitro, this could 
be followed up with in vivo studies. 
Before introducing a potential probiotic organims to human subjects safety much be 
established. In vivo small animal safety studes are essential and accepted as an impotrant 
requirment prior to human consumption. 
 
 A sensory evaluation of the probiotic bacteria for smell, appearance, taste and 
texture and incorporating the potential lactobacilli candidates into food products and 
testing for shelf- life. 
Probiotic food products should be appealing with a good safety profile. Therefore, a 
sensory evaluation could help identify this. Any unpleasant sensory properties could be 
corrected through formulations. 
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Ultimatley human consumers and to a certain estend animal consumers must be 
convinced to consume a priorbiotic organism. A key requirment will be acceptable sensory 
characteristics. 
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Appendix A 
Sources of laboratory instrumentation, equipment and chemicals  
Instrumentation and equipment 
AccuBlock™ Digital Dry Baths 
Supplied by Labnet International Inc. USA 
 
Anaerobic jars and anaerobic sachets 
Supplied by AnaeroGen™, Thermo Scientific, USA 
 
Analytical Balance, 
Mettler AE 200, supplied by Marshall Scientific, USA 
 
Autoclave 
Supplied by Astell Scientific Limited, UK 
 
Centrifuge 
Heraeus Multifuge X3R centrifuge, supplied by Thermo Scientific, USA 
 
Contherm Digital series Incubators 
Supplied by Contherm Scientific Limited, NZ 
 
Electrophoresis qeuipment (vertical slab system) 
Supplied by Bio- Rad, NZ 
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Eppendorf minispin 
Supplied by Eppendorf, Germany 
 
GelDoc transilluminator 
Supplied by Bio- Rad, NZ 
 
Magnetic stirrer 
Stuart heat- stir CB162, supplied by Stuart Equipments, NZ 
 
Micro- plate reader 
FLUOstar Omega, supplied by BMG Labtech, NZ 
 
Mini bead beater 
Supplied by BioSpec Products, USA 
 
Nikon Eclipse 50i Microscope 
Supplied by Nikon Instruments Inc., USA 
 
pH meter 
Orion 3 star pH benchtop, supplied by Thermo Scientific, USA 
 
Spectrophotometer 
Biorad smartspec 3000, supplied by Bio- Rad, NZ 
 
Stuart see- saw rocker SSL4 
Supplied by Stuart Equipments, NZ 
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Thermocycler 
BIOER Gene Pro thermocycler, supplied by Alpha Laboratories, NZ 
 
Water baths 
Supplied by Grant Instruments, UK 
 
Chemicals 
Agar Bacteriological 
Supplied by Oxoid, UK 
 
Ampicillin 
Supplied by Oxoid, UK 
 
Amoxicillin 
Supplied by BBLTM, USA 
 
BHI Broth 
Supplied by Oxoid, UK 
 
Bile salts 
Supplied by Oxoid, UK 
 
Chloramphenicol 
Supplied by Oxoid, UK 
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Ciprofloxacin 
Supplied by Oxoid, UK 
 
Columbia blood agar plates 
Supplied by Fort Richard, NZ 
 
Crystal violet 
Supplied by Sigma- Aldrich, USA 
 
D- Glucose anhydrous 
Supplied by Thermo Fisher Scientific, USA 
 
Disodium hydrogen phosphate anhydrous 
Supplied by Thermo Fisher Scientific, USA 
 
Erythromycin 
Supplied by Oxoid, UK 
 
Fusidic acid 
Supplied by BD BBLTM, USA 
 
Gentamycin, 
Supplied by Oxoid, UK 
 
Kanamycin 
Supplied by Oxoid, UK 
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MRS Agar 
Supplied by Oxoid, UK 
 
MRS Broth 
Supplied by Oxoid, UK 
 
Nalidixic acid 
Supplied by Oxoid, UK 
 
Nutrient Agar 
Supplied by Oxoid, UK 
 
Peptone Bacteriological 
Supplied by Oxoid, UK 
 
Safranin 
Supplied by Sigma- Aldrich, USA 
 
Sodium dihydrogen orthophosphate 
Supplied by Thermo Fisher Scientific, USA 
 
Sodium hydroxide 
Supplied by BDH Laboratories, UK 
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Streptomycin 
Supplied by Oxoid, UK 
 
Sucrose 
Supplied by Thermo Fisher Scientific, USA 
 
Tetracycline 
Supplied by Oxoid, UK 
 
Vancomycin 
Supplied by Oxoid, UK 
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Appendix B 
Gentra Puregene Yeast/ Bacterial kit contents   
Sl. No Reagents and buffers Volume 
1 Cell lysis solution 125 ml 
2 Protein precipitation solution 50 ml 
3 DNA hydration solution 25 ml 
4 Cell suspension solution 125 ml 
5 Lytic enzyme solution 650 µl 
6 RNase A solution 650 µl 
 
Gentra Puregene Kit buffers and reagents must be stored dry at the temperature 
indicated on the kit label. RNase A solution, and Lytic enzyme solution must be refrigerated 
at the temperatures marked on the labels. All other reagents can be stored at room 
temperature (15– 25°C). When stored at the indicated temperatures, Gentra Puregene Kits 
are stable until the expiration date printed on the label and on the kit box. 
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Appendix C 
Assessment of DNA purity using nanodrop   
Isolate DNA 
ng/µl 
Ration of absorbance at 260nm/280nm 
MI 6 16.97 2.07 
MI 7 7.06 1.76 
MI 10 8.40 1.81 
MI 13 12.44 1.89 
MI 17 6.49 1.82 
MI 18 7.32 1.78 
RC 2 5.00 1.86 
RC 5 2.48 1.97 
RC 13 9.53 1.74 
RC 25 5.97 1.92 
RC 30 7.83 1.74 
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Appendix D 
PCR primers  
 
  
Primer Name                                                     Primer sequence       
Forward primer: Aci I                                    TCTAAGGAAGCGAAGGAT     Primer length : 18 
                                                                                                                               Tm (1 M Na+)   : 62 
                                                                                                                             Tm (50 Mm Na+): 41 
                                                                                                                                % GC : 44 
Reverse primer: Aci II                                     CTCTTCTCGGTCGCTCTA        Primer length : 18 
                                                                                                                                Tm (1 M Na+)   : 67 
                                                                                                                             Tm (50 Mm Na+): 45 
                                                                                                                                % GC : 55 
Primer Name                                                      Primer sequence      
Forward primer: Pr I                                      CAGACTGAAAGTCTGACGC    Primer length : 19 
                                                                                                                                Tm (1 M Na+)   : 68 
                                                                                                                             Tm (50 Mm Na+): 46 
                                                                                                                                % GC : 52 
Reverse primer: Pr II                                     GTACTGACTTGCGTCAGCGG   Primer length : 20 
                                                                                                                                Tm (1 M Na+)   : 72 
                                                                                                                             Tm (50 Mm Na+): 51 
                                                                                                                                % GC : 60 
Primer Name                                                       Primer sequence      
Forward primer: 16-1A                                   GAATCGCTAGTAATCG            Primer length : 16 
                                                                                                                                Tm (1 M Na+)   : 57 
                                                                                                                             Tm (50 Mm Na+): 36 
                                                                                                                                % GC : 43 
Reverse primer: 23-1B                                    GGGTTCCCCCATTCGGA         Primer length : 17 
                                                                                                                                Tm (1 M Na+)   : 68 
                                                                                                                             Tm (50 Mm Na+): 47 
                                                                                                                                % GC : 64 
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Appendix E 
PCR reaction mix    
PCR buffer 2.5µl 
dNTPs 0.5µl 
Taq polymerase 0.5µl 
MgCl2 1.5µl 
Nuclease free water 17.25µl 
Template DNA 1.25µl 
Forward primer 0.75µl 
Reverse primer 0.75µl 
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Appendix F 
Protein standard curve constructed by using BCA kit 
Diluted albumin standards 
Vial Volume of diluent, cold 
40 mM Tris (µl) 
Volume of BSA (µl) Final BSA 
concentration (µg/ ml) 
A 0 300 of stock 2000 
B 125 375 of stock 1500 
C 325 325 of stock 1000 
D 175 175 of vial B solution 750 
E 325 325 of vial C solution 500 
F 325 325 of vial E solution 250 
G 325 325 of vial F solution 125 
H 400 100 of vial G solution 25 
I 400 0 0 
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y = 0.0016x + 0.3567 
R² = 0.9799 
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Appendix G 
Statistical analysis for BATH test 
pH 1 
Post Hoc Tests 
Homogeneous Subsets 
Percent 
 Strains N Subset for alpha = 0.05 
a b c d e f 
Duncana 
RC 2 3 68.3727      
RC 25 3  83.6335     
RC 13 3   92.2956    
RC 5 3    93.8802   
MI 10 3    94.3128   
MI 6 3     98.0218  
MI 17 3      99.6212 
MI 13 3      100.3157 
RC 30 3       
MI 7 3       
Sig.  1.000 1.000 1.000 .469 1.000 .250 
 
 
Percent 
 Strains Subset for alpha = 0.05 
g h 
Duncana 
RC 2   
RC 25   
RC 13   
RC 5   
MI 10   
MI 6   
MI 17   
MI 13 100.3157  
RC 30 101.3346  
MI 7  104.7889 
Sig. .097 1.000 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
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pH 5 
Post Hoc Tests 
 
Homogeneous Subsets 
Percent 
 Strains N Subset for alpha = 0.05 
a b c d e f 
Duncana 
RC 2 3 59.8143      
RC 25 3  76.6268     
RC 5 3   80.3711    
RC 13 3    82.8535   
RC 30 3    83.3976   
MI 7 3     92.1459  
MI 6 3     92.8868 92.8868 
MI 17 3      93.2888 
MI 10 3      93.4755 
MI 13 3       
Sig.  1.000 1.000 1.000 .229 .106 .218 
 
Percent 
 Strains Subset for alpha = 0.05 
g 
Duncana 
RC 2  
RC 25  
RC 5  
RC 13  
RC 30  
MI 7  
MI 6  
MI 17 93.2888 
MI 10 93.4755 
MI 13 93.8850 
Sig. .212 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
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pH 7.4 
Post Hoc Tests 
 
Homogeneous Subsets 
Percent 
 Strain N Subset for alpha = 0.05 
a b c d e f 
Duncana 
RC 25 3 74.0847      
RC 2 3  77.9221     
RC 5 3  78.1013     
RC 13 3  79.3308     
RC 30 3   81.3613    
MI 13 3    86.6068   
MI 7 3    87.9258   
MI 17 3     89.8961  
MI 6 3     90.9566  
MI 10 3      93.9726 
Sig.  1.000 .098 1.000 .102 .184 1.000 
 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
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Appendix H 
Statistical analysis for adhesion studies 
Tukey Pairwise Comparisons  
  
Grouping Information Using the Tukey Method and 95% Confidence 
  
Test                 N    Mean  Grouping 
E. coli              4   24.37  A 
E.coli (with rumen)  4  10.027    B 
Rumen (with E.coli)  4   7.562    B C 
E.coli (with Food)   4   7.322    B C 
Rumen                4   6.450      C 
Food                 4   3.571        D 
Food (with E.coli)   4  0.2205          E 
  
Means that do not share a letter are significantly different. 
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Appendix I 
Statistical analysis for permeability studies 
Tukey Pairwise Comparisons  
  
Grouping Information Using the Tukey Method and 95% Confidence 
  
Treatment                   N    Mean  Grouping 
EtOH 1% + E. Coli           3   493.5  A 
EtOH 1% + dairy             3  484.23  A B 
EtOH 1% + dairy + E. Coli   3  471.43  A B C 
No treatment (Control)      4   459.2  A B C 
EtOH 1% + rumen             3   449.4  A B C 
EtOH 1% (Negative control)  3   439.0    B C 
EtOH 1% + rumen + E. Coli   3  429.17      C 
  
Means that do not share a letter are significantly different. 
 
 204 
 
Appendix J 
Quantification parameters for the seven analytes and four deuterated standards    
                 
Analyte   ISTD
a
 Retention      Target Confirming Ions m/z      Calibration Range Standard Purity    CAS No.  
   Time (min)    Ion m/z        (% to Target Ion)       (1/20 dilution) (µg/l) Curve (R
2
)
b
 (%)     
d4-acetic acid   (1) 12.02  46   63 (72.3)      99.5    141-78-6 
d7-butanoic acid  (2) 14.41  63   46 (27.3), 58 (7.1)     98    73607-83-7 
d11-hexanoic acid  (3) 16.99  63   77 (42.9), 93 (12.4)     99    97-62-1  
d2-octanoic acid  (4) 19.44  62   74(32.9), 102 (12.0)     99    105-54-4 
acetic acid  1 12.08  43   60 (82.1), 45 (84.4) 0 – 205479
c
 0.9994      98    66-25-1  
isobutyric acid  2 13.77  88   42 (25.6)  0 – 3201
c
 0.9960  99    79-31-2 
butanoic acid  2 14.53  60   73 (26.6)  0 – 780.6
c
 0.9999       98    539-82-2 
isovaleric acid  2 15.08  60   87 (18.0)  0 – 298.3 0.9996       98    123-66-0  
2-methylbutanoic acid  2 15.10  74   57 (65.7)  0 – 199.1
c
 0.9995  98    116-53-0 
hexanoic acid  3 17.15  60   73 (41.2), 87 (11.7) 0 – 1279.6
c
 0.9999        99    111-27-3 
octanoic acid  4 19.47  60   73 (56.0), 101 (20.4) 0 – 800.1
d
 0.9999        98    928-97-2    
          
a
           ISTD = internal standard  
b A quadratic function was fitted to each aroma compound standard curve.  Up to seven standards were used to generate each curve. 
c Six standards were used for these calibration curves. 
d five standards were used for these calibration curves. 
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Appendix K 
Example of a GLC chromatogram    
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Appendix L 
Conference abstracts  
New Zealand Microbiological Society Conference, 2013- Oral abstract 
low pH tolerance and antibiotic resistance in lactobacilli isolates 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
Lactobacilli are the major group of health promoting microorganisms, generally 
known as probiotics. When probiotics are consumed by humans, they must survive transit 
through the stomach, where the pH can be as low as 1.5 to 2, in order to reach the intestinal 
tract. Lactobacilli normally grow at a pH range of 4 to 6. Moreover, to prevent intestinal 
disorders, probiotics must be resistant to antibiotics in order to survive in the presence of 
co-administered antibiotics. The objective of this study was to investigate the low pH 
tolerance and antibiotics resistance in twenty lactobacilli isolated from New Zealand dairy 
products. The isolates were tested for low pH tolerance by growing them in MRS broths (pH 
2 and 3).  The resistance against twelve different antibiotics was determined by the disc 
diffusion method. The results indicate that all isolates were tolerant to pH 3; however only a 
few isolates were able to survive at pH 2. The antibiotic sensitivity test provided the 
resistance profile of the isolates. All isolates exhibited resistance to ciprofloxacin, nalidixic 
acid and vancomycin. Majority were sensitive to ampicillin. Isolates, that can survive low pH 
conditions, may have better potential to be successfully incorporated in foods as probiotics. 
Antibiotic resistance of isolates suggests that their use in patients treated with antibiotic 
therapy might prove beneficial and aid recovery of the patients by helping to re-establish 
desirable microflora. This study of lactobacilli isolates screening has identified candidates for 
further investigation and development as potential probiotics in foods and complementary 
and alternative medicines. 
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Asia Pacific Probiotic Workshop, 2014- Poster abstract 
Comparison of adherence properties and antibiotic resistance in potential probiotic 
lactic acid bacteria isolated from dairy products and bovine rumen contents 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
 
Lactobacilli are one of the major groups belong to health promoting microorganisms 
generally known as probiotics. The objective of this study was to investigate the adherence 
properties and antibiotics resistance in ten potential probiotic bacteria isolated from 
commercial dairy products and bovine rumen contents. Adherence ability enables the 
probiotic bacteria to persist for a longer time in the gut and enhances the host-bacteria cross 
talk.  It also helps the probiotic bacteria to overcome the peristalsis effects of stomach. For 
these reasons, their surface properties were studied by performing the BATH test i.e. testing 
bacterial adherence to hydrocarbons. According to the results of our study, bacterial 
adherence properties increased with an increase in pH. Results showed a clear strain and pH 
effect involved in demonstration of adherence. Moreover, to prevent intestinal disorders, 
probiotics must be resistant to antibiotics in order to survive in the presence of co-
administered antibiotics. Antibiotic resistance profiles of isolates indicated that all of them 
exhibited resistance to ciprofloxacin, nalidixic acid and vancomycin antibiotics. Majority 
were sensitive to ampicillin drug. Antibiotic resistance of isolates suggests that their use in 
patients treated with antibiotic therapy might prove beneficial and aid recovery of the 
patients through re-establishment of desirable microbiota in the gut. This screening study of 
lactobacilli isolates has provided a comparison of probiotic properties of dairy vs rumen 
bacterial isolates and generated useful information to identify candidate which could serve 
as potential probiotics. 
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New Zealand Microbiological Society conference, 2014- Oral abstract 
Screening of lactobacilli isolates from dairy food products and bovine rumen 
contents for application as probiotics 
 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
 
“Let food be thy medicine and medicine be thy food,” the age-old quote by 
Hippocrates, is certainly the tenet of today. Lactobacilli are employed in probiotic food 
preparations and as feed additives in poultry and livestock, due to health benefits associated 
with their consumption. The objective of this study was to evaluate and compare the 
probiotic potential of ten lactobacilli isolates from commercial dairy food products and 
bovine rumen contents in New Zealand. These isolates were genetically identified by 
amplification and sequencing of 16S-23S rRNA gene (intergenic spacer region) using primers 
16-1A (F) and 23-1B (R). Phenotypic confirmation was achieved through morphological 
characterisation, growth-kinetics and carbohydrate utilisation profiles. FAO/ WHO screening 
guidelines (2006) were followed to assess probiotic potentials of the isolates through in vitro 
testing for haemolytic activity, low pH tolerance, bile salt tolerance, antibiotic resistance 
against eleven commonly prescribed antibiotics, antimicrobial activity against selected five 
pathogens and adherence to hydrocarbons. The results showed that all isolates were non-
haemolytic in nature. Isolates of dairy origin showed better tolerance to low pH stress. On 
the other hand, rumen isolates exhibited a higher tolerance to the presence of bile salts. All 
isolates exhibited resistance to ciprofloxacin, nalidixic acid and vancomycin antibiotics. 
Majority were sensitive to ampicillin drug. Isolates of rumen origin demonstrated a higher 
inhibitory effect on Listeria monocytogenes, Enterobacter aerogenes and Salmonella 
menston species. In case of adherence test, bacteria became more adsorbent with an 
increase in pH. These screening studies on lactobacilli isolates have helped in assessing and 
identifying candidates for further investigation and development as potential probiotics. 
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International Journal of Food Science and Technology Conference, 2015- Poster 
abstract 
Comparative proteomic analysis of L. plantarum and L. rhamnosus cells exposed to 
acid and bile stresses 
 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
 
Increased consumer awareness regarding importance of gut health has led to the 
demand of probiotic food products. Probiotic bacteria should be in a live form in order to 
exert beneficial effects in the host. Probiotic abilities of lactobacilli are strain specific. 
Proteomic tools were employed to analyse the changes in protein expression of lactobacilli 
exposed to specific stress conditions. The objective of this study was to investigate 
proteomic changes in two different species of lactobacilli, namely L. plantarum and L. 
rhamnosus in response to acid and bile stress conditions. These two conditions were 
selected on a rationale that upon consumption probiotic bacteria should survive during the 
transit in the gastro-intestinal tract where it is open to challenges such as low pH 
environment of stomach and bile salts of the upper intestinal tract. Cells were exposed to 
acid stress (pH 3.5) and bile salts stress (3.5%) using MRS broth.  Cells grown in standard 
MRS broth were used as control. This poster presents the changes observed in protein 
expression of these two strains in response to acid and bile stress factors.  
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Lincoln University Thr3sis competition, 2014- Oral abstract 
Developing a NOVEL PROBIOTIC bacteria: The answer to many underlying health 
questions 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
 “Let food be thy medicine and medicine be thy food,” the age-old quote by 
Hippocrates, is certainly the tenet of today. This research study envisioned the necessity for 
developing a novel probiotic bacterial strain with intended specific applications such as 
promoting health benefits in humans, enhancing growth promotion in livestock or increasing 
health improvements in poultry. As part of this research programme, bacterial strains were 
isolated from commercial and indigenous sources in New Zealand, identified and screened 
for probiotic abilities,   and ultimately selected strains are to be analysed using proteomics 
tools to compare the proteome profiles of probiotic vs non- probiotic bacteria. 
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Lincoln University Thr3sis competition, 2015- Oral abstract 
Universal or application specific probiotics 
Authors: 
Neethu Maria Jose [1], Craig Bunt [2], and Malik Altaf Hussain [1] 
[1] Department of Wine, Food and Molecular Biosciences, Lincoln University, Lincoln, 
New Zealand  
[2] Department of Agricultural Sciences, Lincoln University, Lincoln, New Zealand  
 
This research study focusses on the development of bacterial isolates which possess 
potential probiotic properties. The selected bacterial isolate can be used to generate an 
overall health benefit in the host, by altering the gut micro flora upon consumption. 
Probiotics applications could also be specific targeting poultry and livestock. This includes 
increase in body weight gain (BWG), better resistance to a number of infections commonly 
infecting cattle, increase in milk yield and an increased feed conversion ratio (FCR). 
 
